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2General introduction
Introduction
Parkinson’s disease (PD) is a severe progressive neurological disorder. A walking 
problem is one of the main problems for patients suffering from this disease. Physical 
therapy (PT), and especially training with the help of external rhythms, also named 
cues, can help to optimize gait and gait-related activities. The present thesis is about 
the effects of cueing training on gait and gait-related activities in PD. 
This introduction outlines the focus of this thesis. First, background information on PD 
is presented from the perspective of history, epidemiology and medical management, 
including pharmaceutical and neurosurgical treatment options for patients with PD. 
Subsequently, the state of the art will be given about the role of rehabilitation medicine 
in the management of patients with PD and in particular about the use of external 
rhythms to improve gait and gait-related activities. 
History and diagnosing Parkinson’s disease
In 1817, James Parkinson wrote his essay on the ‘shaking palsy’.1 Shaking palsy was 
defined as: 
‘involuntary tremulous motion, with lessened muscular power, in 
parts not in action and even when supported; with a propensity to 
bend the trunk forwards, and to pass from walking to a running 
pace: the senses and intellects being uninjured’.
It was Jean-Martin Charcot who named shaking palsy ‘Parkinson’s disease’ (PD), and 
who gave lectures about PD in the famous Parisian Salpêtrière in the late nineteenth 
century.2 It took until 1912 for Fritz Heinrich Lewy to discover the abnormal proteins 
accumulations in neurons leading to PD, later named the ‘Lewy bodies’. Finding Lewy 
bodies in the substantia nigra or locus ceruleus still provides the only evidence for 
having PD.3 This assessment can only be done by autopsy.3 The surest diagnosis of PD, 
while the patient is alive, can be obtained using neuroimaging techniques, magnetic 
resonance imaging (MRI) or positron emission tomography (PET). These techniques 
are very expensive and not widely available. Therefore patients are mostly diagnosed on 
three out of the four cardinal signs of PD: tremor, rigidity, bradykinesia and unilateral 
onset, together with a substantial and sustained response to Levodopa or dopamine 
agonists (criteria for probable diagnosis of PD).3 Ninety-two percent of the clinical 
diagnoses of PD are confirmed at autopsy, largely because cardinal symptoms also 
occur in other extra-pyramidal diseases than PD, such as multiple system atrophy or 
progressive supranuclear palsy.4 
Apart from the cardinal motor signs, also non-motor clinical features of PD are 
known; these can include psychiatric problems, cognitive disorders, autonomic 
dysfunction, oculomotor abnormalities and characteristic abnormalities of olfactory 
and visual perception.3 However, the most prominent symptoms in patients with PD 
are impairments of automatic motor control. As a consequence, patients suffer from 
difficulties in four key areas within the field of activities: gait, balance, posture and 
transfers (e.g. moving in and around the bed, getting in and out of a chair).5
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Epidemiology 
PD is one of the most common neurological disorders.6 In a prospective study an 
incidence of 19 PD patients on 100.000 people per year was shown.7 The prevalence is 
estimated at 160 patients per 100.000 people.8 The population of the European Union 
counted approximately 485 million people in 2002,9 meaning that approximately 
776.000 European inhabitants suffered from PD. PD shows a strong and consistent 
increase with age, with a peak incidence between 70 and 79 years.10 With the expected 
rise in life expectancy in Europe, approximately 5.5 years in 2050, the number of PD 
patients will rise.9 The greying European population will lead to a shortage of working 
people in the future, including health professionals.
The increase of PD patients will lead to great economic burden, acknowledging that 
health care costs for PD patients are relatively high. A PD patient in the Western and 
Northern European countries costs between 4700 and 8160 euros per year, increasing 
with the stage of the disease.11 In particular, the costs of ‘fallers’ are estimated to be 
twice as much than of ‘non-fallers’.12
Need for the development of a home-based rehabilitation programme 
With the increasing pressure to overcome the economic burden of medical management 
in the next future, the European Commission (EC) is aware that patients need to stay 
independent for a longer time, preferably in their own home situation.13 This aim 
phrased in the fifth framework of the EC is important, acknowledging that 40 to 60% 
of the patients show difficulties with walking, and increased risk for falling.14-15 As a 
consequence, patients experience increasing problems in their activities of daily living 
(ADL) and lose their autonomy. 
Optimal medication is not always able to reduce all motor problems.16 Moreover, 
medication intake needs to be raised over the course of the disease because of wearing-
off effects. As a result, the increasing dose of medication intake can lead to severe side 
effects, varying from motor complication to psychological problems.17 Neurosurgery can 
be a worthwhile addition to medication, but is not available for every PD patient, due 
to its high costs and because it is not appropriate for all patients (e.g., PD patients with 
dementia are excluded from this technique). Because of the non-optimal availability and 
effects of medication and neurosurgery, additional rehabilitation care is necessary. 
Rehabilitation programmes should be aimed at maintaining or increasing patients’ 
mobility. Unfortunately, high qualitative rehabilitation programmes to fulfil this need 
have not been developed prior to 2002. Finding innovative techniques to maintain 
patients’ autonomy is in line with the fifth framework, key action 6 of the EC:13 ‘the 
ageing population and disabilities’ of the Quality of Life and Management of Living 
Resources Work programme, and specifically 6.4. ‘Coping with the functional limitation 
of old age’. The priorities described in this action, line 6.4, are: (1) the development of 
technological products and systems contributing to greater mobility and less dependency, 
both inside and outside the home, including the work place; (2) the development of 
caring and nursing products designed to support older people in their own homes; (3) 
improving postural stability and preventing falls; (4) technical aids to rehabilitation; and 
(5) optimum forms of physical and/or cognitive exercises. 
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Rehabilitation management in PD patients should preferably be a multidisciplinary effort, 
due to the multidimensional character of symptoms that accompany PD. Examples of 
the different professionals involved in the care for PD patients are medical specialists 
(neurologists/rehabilitation physicians) to assess and make an inventory of the PD-related 
symptoms, instalment of medical treatment and referral to other disciplines, physical 
therapists to work on movement related problems, speech therapists in case of speech 
problems or problems with drooling or swallowing, occupational therapists to help 
improve limitations in participation and activities, and dieticians in case of excessive 
weight loss.
Professionals should work together as a team targeted on patients’ needs in order to 
remain independent in activities of daily living (ADL) preferably in patients’ own home 
situation. Since walking problems are amongst the main problems in PD, physical 
therapists are considered to be key members of the multidisciplinary team. The main 
aim of PT is to maximize functional ability, and to minimize secondary complications 
through movement rehabilitation within a context of education and support for the 
whole person.18 PT is relatively cheap and can reduce the economic burden by keeping 
patients in their own home situation, especially when PT prevents PD patients from 
falling and hospitalization.12,19
PT —both individual and group treatment— often focuses on functional limitations 
(e.g., transfers, walking, stair climbing, reaching, grasping) and disabilities (e.g., hobbies, 
sports, social activities) and comprises mobility exercises, gait training (with or without 
the use of external rhythmic cues), training of daily activities, relaxation therapy and 
breathing exercises. Another aspect is that of educating patients (as well as their partners 
and families) about the disease process and the benefits of exercise therapy. 
Results of a systematic review by de Goede et al.20 supported the hypothesis that patients 
with PD may benefit from exercise therapy in terms of ADLs and walking ability (walking 
speed, stride length), but not in terms of neurological signs. The meta-analysis shows 
small improvements in ADLs (approximately 5%), walking speed (approximately .08 m/s 
or .29 km/h) and stride length (approximately 6 cm).20 However, it is unclear whether 
these effect sizes are clinically relevant. The conclusions of two Cochrane reviews 
suggested that there was insufficient evidence to support or refute the efficacy of PT in 
PD, or to favour the use of one form of PT over another.18,21 
One form of PT is therapy with the help of visual or auditory rhythms (i.e., rhythmic 
cues). A number of uncontrolled studies suggest that using cues is a promising tool to 
improve parkinsonian gait, but the methodological quality of most studies is low. 
Studies on cueing: state of the art
Using a rhythm to improve gait in PD is mentioned in the literature since 1924,22 but 
was not scientifically studied until 1967.23 It was Von Meyer-Königsberg, in 1924, who 
described several cases of patients with parkinsonism who responded well to rhythmic 
dancing.22 He noticed that dancing on march music, guided by a nurse, improved gait 
and posture in patients with parkinsonism. In his book ‘Methods of treatment in post 
encephalitic parkinsonism’ Witzleben wrote about visual rhythmical patterns that could 
be used to improve gait.24 Examples of these visual rhythmical patterns were stepping 
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over pieces of wood, and over balls. An inverted cane was used as visual cue as well.
In 1967, Martin executed the first experiment on cueing.23 He presented different 
patterns on the floor and instructed patients with PD to walk over these patterns. After 
analyzing the gait pattern of his subjects, he concluded that parallel lines, perpendicular 
to the walking direction, resulted in a maximum improvement of gait. In 1994, the first 
study on the effect of auditory cues on gait in PD was published,25 whereas the first 
and only randomized controlled trial (RCT) was published in 1996.26 This RCT was 
of low methodological quality and was underpowered. In one other RCT, PD patients 
received cueing training as part of a training programme.27 In a narrative review, 
Rubinstein and colleagues found 18 studies about rhythmic cueing published until 
2002.28 Unfortunately, all studies included in this narrative review were non-controlled 
and of low methodological quality, heavily underpowered and mostly executed in a 
laboratory, except for the RCT of Thaut et al.26 In addition, a wide variety of measurement 
instruments were used, which made it difficult to cluster these studies and draw a general 
conclusion about the effect of cueing.28 A systematic review of published cueing studies 
until 2005 is presented in Chapter 2 of this thesis. 
The lack of studies with high quality on the effect of cueing in PD and the call from the 
EC for development and evaluation of technologies and systems designed to reduce 
the impact of disabilities on older people, to restore their functions and to mitigate the 
challenge of their social and physical environments,13 stimulated the initiation of the 
Rescue project. ‘Rescue’ is an acronym for ‘Rehabilitation in Parkinson’s Disease: Strategies 
for Cueing’.29 This project is a collaboration of the VU University Medical Center in 
Amsterdam (The Netherlands), the Northumbria University in Newcastle upon Tyne 
(UK) and the Katholieke Universiteit Leuven (Belgium) and was financed by the EC.13 
The Rescue project’s aims were: 
(1) obtaining new knowledge on the mechanisms behind the effect of 
different cue types on gait parameters during stable condition and 
after contextual manipulation, and exploring the optimal conditions 
for effective cueing; 
(2) composing a clinical battery of valid and reliable clinical tests measuring 
the symptoms of the disease, motor performance, functional disability, 
cognitive profiles, fatigue, mood disorders, quality of life and care giver 
strain, and find a way to monitor walking activity in daily life; 
(3) developing a cueing device to facilitate gait and gait-related activities 
for use in the daily context; 
(4) developing guidelines for the optimal use of cues, delivered by a cueing 
device or patterns on the floor, in the daily context; 
(5) investigating the effects of an optimal therapeutic cueing programme 
in a single blind crossover, multicentre RCT; 
(6) determining the transferability of identified and tested optimal cue 
types to symptoms of the disease, motor performance, amount of 
walking activity, functional disability, fatigue, mood disorders, quality 
of life and care giver strain; and 
(7) determining the predicting factors for falls. 
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The Rescue project contained three phases: a preparation phase, a generalization phase, 
and a dissemination phase. The first phase was aimed to develop a cueing device, to 
establish guidelines and a test battery for evaluation. In addition, therapists and assessors 
in the Rescue project were trained to conduct the trial. In the generalization phase, the 
RCT was conducted, whereas in the dissemination phase found effects of the RCT were 
published and presented on an international European Conference in Amsterdam. In the 
final year of the Rescue project, the cueing guidelines were converted into an instruction 
CD for physical therapists and leaflets were developed to provide patients and caregivers 
with information about how to use cues in their own environment.
Development of a cueing device and therapeutic guidelines
For optimal use of cueing in patients’ own home setting, there was a need for the 
development of a simple cueing device to provide different types of cueing in a 
manageable and comprehensive way. The development of innovative devices to 
improve parkinsonian gait was in line with the wishes of the EC.13 Especially for PD 
patients, the device should be (1a) able to provide different types of cues; (2a) easy 
to handle; (3a) light weight; (4a) easy to attach to clothes to keep the arms free; and 
(5a) shock proof. 
The cueing device was developed within the Rescue project for use in the cueing 
training of the RCT and met the above described criteria. The cueing device had the 
following characteristics: (1b) is able to provide an auditory cue (a rhythmic beep), 
a visual cue (a flashing light on the side of the spectacles), and a somatosensory cue 
(a rhythmic vibrating mini cylinder on the wrist); (2b) has two switches, one on-off 
switch and a switch to change modality, and two buttons, one to increase and to reduce 
the rhythm by one beat per minute ; (3b) is small and light weight (170 grams, 64.77 
mm  111.75 mm  23.37 mm); (4b) has a clip to attach it to a belt or pocket and 
(5) is shock proof (see Figure 1a−d). 
Cueing training was received from trained therapists, one in each participating country. 
To optimize and standardize the cueing training, guidelines were needed, knowing 
that there were no guidelines or treatment protocols available for optimal application 
of cueing in patients with PD. Therefore, a number of experiments were conducted in 
the gait laboratories of the VU University Medical Centre, the Katholieke Universiteit 
Leuven as well as in patients own homes in the environment of the University of 
Northumbria in order to develop guidelines and treatment protocols. The effect 
of different frequencies of auditory cueing (using a beep) and visual cueing (using 
a flashing light on the spectacles) on spatiotemporal and kinematic parameters of 
gait were determined. The stability of cues was tested as well, by making a walking 
adjustment while using auditory cues or visual cues. The experiments on auditory 
cueing and on visual cueing were executed in Leuven and Amsterdam, respectively. 
In addition to the temporal cues, experiments were conducted on spatial visual cues 
in the form of parallel lines on the floor to step over. These lines were projected on 
a screen in front of a patient, who was walking on a treadmill. This experiment on 
temporal and spatial visual cueing is presented in Chapter 4 of this thesis. The British 
members of the Rescue team conducted studies to determine cognitive profiles that 
facilitate cueing. Studies were conducted to determine the cognitive and behavioural 
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effective cueing.
All developed guidelines were linked to 15 therapy aims, distributed over five 
categories:
(1) Gait: improving walking speed, normalizing step/stride length, 
normalizing step frequency, management of freezing/festinating, 
training initiation of walking, improving turning; 
(2)  Balance: improving balance; 
(3) Posture: training in sitting position, training in standing position, 
training when walking; 
(4) Transfer: training in standing up from a chair/bed, training in sitting 
down on a chair/bed; 
(5) Other aims: performing complex functional/double tasks, improving 
fitness, general exercises (e.g. mobility, coordination, strength). 
The three physical therapists in the Rescue trial used these 15 cueing aims to tailor an 
optimal training programme for each participant in the study. Before the start of the 
Rescue trial, the three physical therapists in each country were trained in an identical 
application of the cueing guidelines. A diary was developed to record the used aims 
and cueing types during the therapy sessions.
Chapter 1
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Composing a test battery to evaluate effects of a home-based cueing 
programme 
There is a large variety of measurement instruments to evaluate gait and gait-related 
activities as well as the effects of cueing in PD. Knowing that PD is a complex 
disease, affecting bodily functions, cognitive, psychological and social functions, a 
composed test battery should preferably reflect the different levels of the International 
Classification of Functioning (ICF).30 The ICF is the WHO’s framework for measuring 
health and disability at both individual and population levels.30 The ICF framework 
describes how people live with their health condition, from body, individual and 
societal perspectives. With that, the ICF is helpful to structure a test battery and 
to ensure that all levels, related to PD, are included. In addition, the composed test 
battery should be easy to apply, and obey the main clinimetric properties such as 
reliability, validity and responsiveness for change, to evaluate the impact of a cueing 
programme on the different levels of the ICF. For the Rescue project, a choice was made 
in available tests that proved to be reliable and valid in laboratory settings. To confirm 
the reliability of the selected tests in the patients’ own home situation, a reliability 
study was conducted to determine the inter- and intrareliability of all tests. Twenty-
six patients were assessed by three assessors, reflecting the three European countries 
collaborating in the Rescue project. Responsiveness and feasibility of all tests in the 
home situation were determined as well. A part of this study is presented in Chapter 
3 of this thesis. The three assessors in the Rescue trial were trained prior to the start 
of the trial to calibrate the assessment techniques.
It should be acknowledged that assessment instruments are random indications 
of patients’ performance and not a continuous reflection of patients’ ‘real world’ 
performance during a day. Especially in PD, clinical measurements can be very time 
specific, due to medication induced fluctuations and fatigue. Since the last decade, light 
weighted, portable equipment is available to monitor gait and gait-related activities.31 
Activity Monitoring (AM) enables collection of continuous data about patients’ real 
performance in their own home environment, for example by using four or five 
accelerometers attached to the patient’s body. In Chapter 5 results are presented of 
the effects of cueing in the home situation on the amount of walking activity, when 
measured with AM.
In addition to clinical assessments and AM, falling needs to be assessed. One concern 
of giving cueing training is that cueing may lead to an increase in fall events. Walking 
with cues can be experienced as a double task (paying attention to the rhythm and 
walking at the same time), leading to falls while walking due to loss of stability32 or 
increase of gait variability.33 Patients may walk more when learning how to facilitate 
walking with the help of cues. This may be another reason for a raise of falls: an 
increased walking activity means a higher risk to fall. 
Recording falls (e.g. using post cards, calendars, phone calls, etc.) is frequently discussed 
in literature,34 but there are several problems with existing methods. First, there is 
a recall problem: because most patients and health care providers tend to focus on 
consequences of falls, there is a possibility that non-injurious falls are disregarded.35 
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Cognitive impairments can worsen recall problems. The second problem for optimal 
recording of falls, is the variety of definitions for falling: seniors often have another 
perception of a fall than health care providers.35 Frequently asking for falls and near falls, 
as clearly defined before the study, should be the optimal way to obtain information 
about the frequency of falling. In the Rescue project ‘falls’ were defined as ‘an event 
that results in a person coming to rest unintentionally on the ground or lower level, 
not as a result of a major intrinsic event or overwhelming hazard’36 and ‘near falls’ were 
defined as ‘loss of balance where an actual fall could be prevented’. For the Rescue trial, 
a fall diary was developed, asking about falls and near falls, their circumstances and 
consequences. In Chapter 7 a model to predict falling is presented.
Aims and outline of the present thesis
The aim of the present thesis is to determine the effectiveness of identified and tested 
optimal therapeutic treatment and self management strategies for improving functional 
performance, improving the amount of physical activity and reduce the risk of falls. 
The transferability of identified and tested optimal cue types to a functional social 
setting was studied as well.
Initially, effects of external cueing will be investigated in Chapter 2, by a systematic 
review of all published studies on cueing training in PD until 2005. The objective of 
Chapter 3 was to identify reliable instruments to evaluate the effects of cueing on gait 
and gait-related activities. In this chapter a part of the study on clinimetric properties 
of the tests included in the clinical test battery of Rescue is presented. The study in 
Chapter 4 presents experiments conducted in the gait laboratory of the VU University 
Medical Centre. The pre-experiment is aimed to develop guidelines on gait training by 
investigating the impact of visual flow and using different visual rhythms to optimize 
parkinsonian gait. In Chapter 5 effects of the randomized clinical trial are presented 
by using the clinical test battery of Rescue, whereas effects measured with Activity 
Monitoring are presented in Chapter 6. Subsequently, a model aimed at identifying 
factors that are associated with falls in patients with PD is presented in Chapter 7. 
Finally, Chapter 8 presents the general discussion. In this chapter the main findings 
of the previous chapters are summarized, and implications are given for optimizing 
rehabilitation services in patients with PD. In particular, future directions are given 
for research and implementation of cueing guidelines to improve gait in PD. 
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Abstract
Objective: To critically review studies evaluating the effects of external rhythmical cueing 
on gait in patients with Parkinson’s disease (PD).
Methods: Articles published from 1966 to January 2005 were searched by two 
physiotherapists in MEDLINE, PiCarta, PEDRo, Cochrane, DocOnline, CINAHL and 
SUMSEARCH. To be included, articles had to investigate the effects of external rhythmical 
cueing (i.e. auditory, visual or tactile cueing) on gait parameters in patients with idiopathic 
PD. Both controlled and non-controlled studies were included. Based on the type of design 
and methodological quality a meta-analysis or best-evidence synthesis was applied.
Results: Twenty-four studies (total number of patients = 626) out of the 159 screened 
studies were evaluated in this systematic review. Two out of 24 were randomized controlled 
trails (RCT), both of high methodological quality. One RCT did not focus specifically 
on external rhythmical cueing of individual patients with PD, but on group exercises in 
general, including walking with cues. All other studies were pre-experimental studies. 
Best-evidence synthesis showed strong evidence for improving walking speed with the 
help of auditory cues. Insufficient evidence was found for the effectiveness of visual and 
somatosensory cueing.
Conclusion: Only one high-quality study specifically focused on the effects of auditory 
rhythmical cueing, suggesting that the walking speed of patients with PD can be positively 
influenced. However, it is unclear whether positive effects identified in the laboratory 
can be generalized to improved activities of daily living (ADLs) and reduced frequency 
of falls in the community. In addition, the sustainability of a cueing training programme 
remains uncertain.
Introduction
Parkinson’s disease (PD) is a progressive neurological disorder, with a prevalence 
increasing with advancing age. In Europe, 1.8 per 100 inhabitants under the age of 
65 are diagnosed with PD, whereas in the age category of 65−69 years 2.4 per 100 
inhabitants are affected. For the age of 85−89 years, the prevalence increases up to 2.6 
per 100 inhabitants.1
The idiopathic form of PD results from a degeneration of dopamine-producing cells in 
the substantia nigra which leads to clinical symptoms such as hypokinesia, bradykinesia, 
postural instability, rigidity and tremor.2‒4 These symptoms are accompanied by 
difficulties in motor performance such as gait problems and falls.4‒7
Despite optimal medication therapy, gait problems associated with PD are often 
characterized by a decreased stride length8 and walking speed, an increased step 
frequency and double limb support,2,6 shuffling gait, gait festination and freezing.9‒11 
Physical therapy is reported to be a low-cost12‒14 treatment and an useful addition 
to standard medication.15‒19 De Goede et al.16 demonstrated small but significant 
improvements in activities of daily living (ADLs), walking speed and stride length in 
a meta-analysis on the effects of physical therapy on PD using a fixed effects model. 
Deane et al. conducted a Cochrane review15 on the effects of physical therapy on PD. 
They were not able to draw firm conclusions regarding the efficacy of physical therapy, 
because of methodological weaknesses and due to the small number of trials at the 
time of their review. Recently, Gage et al.18 reported positive effects of physical therapy 
on motor performance, gait, ADLs and cardiovascular fitness in their narrative review 
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of the effects of multidisciplinary rehabilitation on PD. All reviews included studies 
in which intervention was offered with the help of external rhythmic stimulation or 
external rhythmic cueing. 
Facilitation of gait of patients with PD with the help of cueing has been reported since 
1942.20 The first detailed analysis of external cueing on gait was performed by Martin in 
1967.21 Two non-systematic reviews by Rubinstein et al.17 and Darmon et al.22 evaluated 
the effects of external cueing on gait in PD. They concluded that external cueing can 
significantly improve gait and gait-related activities in patients with PD. 
The precise definition of a cue is problematic and intervention based on external 
rhythmical cueing has not been clearly defined. According to Cools,23 cues are 
‘contextual or spatial stimuli which are associated with behaviour to be executed, 
through past experience’. Horstink et al.24 distinguish between cues and stimuli, stating 
that ‘cues give information on how an action should be carried out and are hence more 
specific than simple stimuli’. Based on the observations of Cools23 and Horstink et 
al,24 and given the fact that parkinsonian symptoms particularly affect complex and 
sequential movements, for the purposes of this review external rhythmical cueing is 
operationally defined as ‘applying temporal (rhythmical) or spatial stimuli associated 
with the initiation and ongoing facilitation of motor activity (gait)’.25
The aim of the present systematic review is to add to the literature a systematic review 
based on (1) a qualitative synthesis method and (2) the above-mentioned, prestated 
definition of cueing.
Methods and materials 
Literature search 
Articles were compiled for this study from a number of sources. Two physical 
therapists (SB/OD) independently performed a search in the databases of MEDLINE 
(1966−2004), PiCarta, PEDro, Cochrane, DocOnline, CINAHL and SUMSEARCH 
using the following keywords and their combinations: Parkinson, Parkinson’s disease, 
Parkinson disease, cue, cueing, physical therapy, physiotherapy, exercise, locomotion, 
gait, optical flow field, visual, auditory, sensory, tactile, behavioural, external, rhythmic, 
stimulus, stimuli and walking.
Studies were accepted when: (1) they investigated the effects of external rhythmical 
cueing on gait in patients with idiopathic PD; (2) the intervention was applied to 
improve gait performance; (3) they were published in a peer-reviewed journal and 
(4) they were written in English, German, French or Dutch. Single-case studies were 
excluded. 
Intervention types
For the present review, the external rhythmical intervention was classified into four 
types of cueing: (1) auditory cueing; (2) visual cueing; (3) tactile cueing; and (4) a 
combination of above-mentioned types of cueing.
Chapter 2 
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Data analysis
If appropriate, quantitative analysis of the results was performed separately for each 
intervention and restricted to RCTs. When these RCTs were comparable in terms of 
intervention, patient characteristics and outcome measures, statistical pooling was 
considered. In case of heterogeneity, with respect to intervention and measurements 
of outcome, or lack of RCTs, a best-evidence synthesis was applied. The method for 
applying a best-evidence synthesis was based on the list proposed by Van Tulder et 
al.26 and modified by Steultjens et al.27 (See Appendix 1). The design of the studies and 
the methodological quality was taken into account when rating the levels of evidence. 
The methodological quality of all studies was evaluated by two independent reviewers 
(IL, MD). Disagreements were resolved by discussion. If no consensus was met a third 
reviewer (GK) made the final decision. A kappa statistic for inter-rater agreement was 
calculated. 
A list of methodological criteria recommended by Van Tulder et al.26 was used to rate 
the methodological quality of randomised controlled trials (RCTs). This list, containing 
all the criteria proposed by Jadad et al.28 and Verhagen et al.,29 consists of 11 criteria for 
internal validity, six for descriptive criteria and two for statistical criteria (See Appendix 
2). One modification was made regarding the specification of the eligibility criterion: 
this involved the addition of the Hoehn and Yahr stage.30 Studies were considered to 
be of high quality if at least six criteria for internal validity, three descriptive criteria, 
and one statistical criterion were met.26
To rate the methodological quality of the studies with another design than controlled 
trials (i.e. pre-experimental studies31) the same methodological scorings list was used, 
with an adaptation made by Steultjens et al.27 This adapted scorings list includes 
seven criteria for internal validity, five descriptive and two statistical criteria. A study 
with a non-controlled design was considered to be of sufficient quality if at least four 
internal validity criteria, two descriptive criteria and one statistical criterion were rated 
positively (See Appendix 2). RCTs and non-controlled studies who did not meet the 
above-stated criteria were considered to be of low quality.
Results
Overview of literature and rating of the studies
Based on abstracts and titles, a total of 159 articles was identified and 40 of these 
candidate studies investigated the effects of external rhythmical cueing. Twenty-four 
studies, with a total number of 626 patients included, matched all inclusion criteria 
and were selected for qualitative analysis.3,32‒53
General characteristics of the different studies concerning design of the study, type of 
cueing, number of subjects, characteristics of the subjects, type and dose of intervention, 
outcome measurements and ratings of results are presented in Appendix 3.
The methodological quality was assessed for two RCTs and 22 pre-experimental studies. 
None of these studies were controlled clinical trials (CCTs). One publication3 presented 
three independent studies. These studies are separately rated on methodological 
Chapter 2 
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quality. In two publications48,53 more than one study was presented. As the effects of 
cueing were investigated in only one study per publication, only those studies were 
taken into account for analysis.
The two RCTs32,33 were of high methodological quality, five pre-experimental studies 
were of sufficient methodological quality,36,41,42,47,52 and all other studies were of low 
methodological quality (Appendix 2). A kappa statistic of 0.84 was calculated for 
inter-rater agreement on scoring the list for methodological quality.27
Applying a quantitative analysis was not possible due to the lack of RCTs, therefore a 
best-evidence synthesis has been applied on all intervention types. 
Auditory cueing
Fourteen studies, two RCTs32,33 and 13 studies with a pre-experimental design37,39‒42,45-48,50,51,53 
investigated the effects of auditory cueing (music, metronome) on gait (Appendix 
3). Both RCTs were of high methodological quality and three studies with a pre-
experimental design were of sufficient methodological quality,41,42,47 all other studies 
were of low methodological quality.37,39,40,45,46,48,50,51,53
Measurement outcomes
Walking speed was measured in two RCTs32,33 and in 10 studies with a pre-experimental 
design.39,41,42,45‒47,50,51,53 Both RCTs found significant improvement on walking speed as 
an outcome measurement and therefore strong evidence was shown in a best-evidence 
synthesis. Stride length and step frequency were measured in one RCT32 and 11 pre-
experimental studies.39,41,42,45‒48,50,51,53 As significant improvements were found for stride 
length and step frequency as outcome measurements in one RCT, limited evidence was 
available for these parameters. Step length, step-extremity ratio, double support, cycle 
time and base of support41 were assessed in one pre-experimental study of sufficient 
quality. Step to step variability was assessed in one pre-experimental study of sufficient 
quality47 and in one pre-experimental study of low quality.54 Time37,40 and number of 
steps40 needed to complete a complex track with freezing-inducing elements (e.g. turns 
and doorways) were assessed in studies of low quality. Therefore, insufficient evidence 
was found for these gait parameters after applying a best-evidence synthesis.
Visual cueing
Fourteen studies3,34‒36,38,43,44,48,49,51‒53 measured the effect of visual cueing on gait in PD 
(Appendix 3), however no RCTs were found investigating the effects of visual cueing 
on gait. Two studies showed sufficient methodological quality,36,52 whereas 12 studies
3,34,35,38,43,44,48,49,51,53 were of low methodological quality.
Measurement outcomes
Ten studies3,34,35,44,48,49,51,53 investigated the effect of floor markers on walking, by using 
stripes on the floor, perpendicular to the walking direction. All but one[36] of these 
studies were of low methodological quality. Therefore, insufficient evidence was found, 
when applying a best-evidence synthesis. Stride length was measured in two studies of 
sufficient methodological quality36,52 and 10 studies of low quality.3,34,35,44,48,49,51,53 One of 
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the two studies with sufficient quality52 reported positive effects of floor markers on 
stride length. In the other studies,36 no changes were found and therefore insufficient 
evidence was shown. Insufficient evidence was found for the effect of floor markers 
on step frequency,3,34,35,44,48,49,51,53 step length, stride time, single support36 and double 
support,3,36,38 due to the low quality of the studies measuring these parameters.
Several studies investigated the effect of other visual cues than floor markers, e.g. 
(modified) walking sticks,38,43 a rhythmic flashing light, mounted to the spectacles of 
the subjects52 or a subject mounted light device.44 Insufficient evidence was found for 
all of these visual cues, applying best-evidence synthesis.
Tactile cueing
One pre-experimental study of low quality40 studied the effects of tactile cueing 
(shoulder taps) (Appendix 3). Best-evidence synthesis showed insufficient evidence 
for rhythmical shoulder taps on the time and number of steps needed to complete a 
complex track.
Combination of auditory and visual cueing
One pre-experimental study of low quality51 investigated the effects of a combination 
of auditory cueing and floor markers (Appendix 3). Insufficient evidence was found 
for this on walking speed, stride length and step frequency, applying a best-evidence 
synthesis.
Discussion
This is the first systematic review of the literature using an explicit analysis method 
that explored the effects of external cueing on the gait of patients with PD. Two RCTs 
and 24 studies with a non-controlled design were identified investigating four different 
types of cueing and 13 different measurements of outcome. Unfortunately, only one 
study investigated the effects of tactile cueing on parkinsonian gait. Strong evidence 
was found for effects with the use of auditory cueing on walking speed in PD. Limited 
evidence was available for improving stride length and step frequency with the use of 
auditory cueing, applying best-evidence synthesis. Insufficient evidence was found for 
improving gait of patients with PD with the help of visual cueing (i.e. floor markers, 
walking sticks, subject-mounted laser beams or a flashing light mounted on the 
spectacles of the subject), tactile cueing (shoulder taps) or a combination of auditory 
and visual cueing (an auditory rhythm and floor markers). 
Although external rhythmical cueing is often used in rehabilitation of patients with 
PD, only two RCTs investigated the effects of auditory cueing on gait. However, in the 
RCT of Ellis et al.33 auditory cueing was only a third part of an exercise programme 
given to patients with PD (Appendix 3). It is therefore not clear whether the improved 
walking speed was a result of external rhythmical cueing or due to other elements in 
this group exercise programme. Leaving this study out, the evidence for improving gait 
in PD with the help of auditory cueing was reduced to limited evidence for walking 
speed, stride length and step frequency. 
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Many studies have found significant improvements of gait, but evidence for this can 
not be established, due to the low methodological quality of these studies, therefore 
pooling of the studies for quantitative meta-analysis was not possible. Steultjens et al.27 
compared effect-sizes with the levels of evidence found for the different interventions 
in their study and concluded that the levels of evidence confirmed the findings found 
with a meta-analysis, underpinning the reliability of the method used in the current 
study.
Although strong evidence was found in favour of auditory cueing, the interpretation 
of reported effects on walking speed needs further consideration. Firstly, most studies 
were executed in a laboratory setting and focused on instantaneous effects only, 
whereas four intervention studies were reported in which patients were taught to 
take advantage of auditory rhythms by systematic training.32,33,37,54 In three studies an 
exercise programme was applied32,33 and in two studies the subjects were able to practise 
using the cues in their own home situation.32,37 Although these studies showed positive 
results for auditory cueing,32,33 the impact of reported effects measured in a laboratory 
setting is difficult to generalize to the home. It is known that patients with PD have 
severe problems apply the learned skills in a clinical setting to their home situation.55 
For this reason it is preferable for intervention and assessments to be carried out in 
the patient’s own home environment. 
Secondly, the impact of walking speed on ADLs and extended ADLs remains unclear. 
In particular the carry-over effects of external cues on symptoms such as freezing and 
falling needs further investigation. 
Thirdly, it is not clear how the external cues need to be presented to the patient with 
PD to obtain maximum effect. Both instantaneous effects and training effects were 
found in the current review. Future studies should focus on the best way to use the 
cues in the clinical setting.
A possible explanation for the uncertainty about the best way to present cues and to 
assess the effects on gait is the lack of a uniform definition for external cueing. For this 
review, a definition was formulated based on the descriptions of cues by Cools23 and 
Horstink.24 In addition, the mechanism behind external cueing remains unclear. 
The present study has some limitations. The review based itself on a restricted number 
of languages within a limited number of electronic databases. Some relevant studies may 
therefore have been missed. In addition, the precise way of cueing as well as appended 
instruction to the cued patient was not always clear in found studies. This might have 
resulted in misclassification of the intervention type. Further studies should evaluate 
the effects of different types of cueing on gait-related activities in patients’ own home 
situation and community, in a well-conducted RCT, including measurements related 
to ADLs, falling, freezing and perceived quality of life in general.
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Appendix 1  Best-evidence synthesis
Strong evidence Provided by consistent, statistically significant findings in outcome 
measures in at least two high-quality RCTsa
Moderate evidence Provided by consistent, statistically significant findings in outcome 
measures in at least one high-quality RCT and at least one low-quali-
ty RCT or high-quality CCTa
Limited evidence
or
Provided by consistent, statistically significant findings in outcome 
measures in at least one high-quality RCT
Provided by consistent, statistically significant findings in outcome 
measures in at least two high-quality RCTs (in absence of high-quality 
RCTs) 
Indicative findings
or
Provided by consistent, statistically significant findings in outcome 
and/or process measures in at least one high-quality CCT or low-
quality RCTa (in the absence of high-quality RCTs)
Provided by consistent, statistically significant findings in outcome 
and/or process measures in at least two non-controlled studies with 
sufficient quality (in absence of RCTs and CCTs)
No or insufficient evi-
dence
or
or
In the case that results of eligible studies do not meet the criteria for 
the above stated levels of evidence
In the case of conflicting results (statistically significant positive and 
statistically significant negative) results among RCTs and CCTs
In the case of no eligible studies
RCT, randomized controlled trial; CCT, controlled clinical trial.
aIf the number of studies that show evidence is <50% of the total number of studies found within the same 
category of methodological quality and study design (RCTs, CCTs, or non-controlled studies), no evidence will 
be stated.
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 Appendix 2  Fulfilled items of methodological quality plus quality criteria for randomized 
controlled trials (RCT) and non-controlled studies
RCT, randomized controlled trial; pre-exp, pre-experimental design; MQ, methodological quality; HQ, high 
methodological quality; SQ, sufficient methodological quality; LQ, low methodological quality. 
All studies were scored on items concerning internal validity, descriptive criteria and statistical criteria. 
a, a positive score on a description of the eligibility criteria; b1, a randomization procedure has been applied; b2, 
the treatment allocation was concealed; c, groups were similar at baseline; d, index and control interventions 
were adequately described; e, the care provider was blinded for allocation of the patients; f, co-interventions 
were avoid; g, compliance was acceptable; h, the patient was blinded for allocation; i, the assessor of the out-
come measurements was blinded for allocation; j, the outcome measures were relevant; k, adverse effects were 
described; l, withdrawal/dropout rate was described; m1, a short-term follow-up measurement was applied (at 
the end of the intervention); m2, a long-term follow-up measurement was applied (after three months or later); 
n, the timing of outcome assessments was comparable for all groups; o, the sample size for each group was 
presented at randomization and for most important outcomes assessments; p, an intention-to-treat analysis 
was applied; q, all point estimates and measures of variability were presented; −, there are no items that can be 
scored positively. Criteria b1, b2, c, e and h were not scored for non-controlled studies.
First Author Design Items positively 
scored on criteria 
for internal validity
Items positively 
scored on 
descriptive criteria 
Items positively 
scored on 
statistical criteria
MQ
Ellis33 RCT b1, b2, f, g, i, j, l, n a, c, d, c m2 o, q HQ
Thaut32 RCT  b1, g, j, l, n, p c, d, m1 o, q HQ
Azulay34 Pre-exp f, j, l, n, p d o, q LQ
Azulay35 Pre-exp f, j, l, n, p d o, q LQ
Bagley36 Pre-exp f, j, n, p d, m1 q SQ
Cubo37 Pre-exp i, j, n m1 o, q LQ
Del Olmo54 Pre-exp j a, d, m1 q LQ
Dietz38 Pre-exp j, l, p d, m1 o, q LQ
Ebersbach39 Pre-exp j, n a o, q LQ
Enzensberger40 Pre-exp j, l, n a o LQ
Freedland41 Pre-exp j, l, n, p d, m1 o, q SQ
Howe42 Pre-exp f, j, l, n, p a, d o, q SQ
Kompoliti43 Pre-exp f, j, l, n, p d o LQ
Lewis44 Pre-exp f, j, l, n, p d o, q LQ
McCoy45 Pre-exp f, j, n d q LQ
McIntosh46 Pre-exp f, j, n, p m1 − LQ
McIntosh47 Pre-exp f, j, l, n, p d, m1 o SQ
Morris49 Pre-exp f, j, n d − LQ
Morris49 Pre-exp f, j, n d q LQ
Morris, study 13 Pre-exp f, j, n d, m1 q LQ
Morris, study 23 Pre-exp f, j, n d, m1 q LQ
Morris, study 33 Pre-exp f, j, n d, m1 q LQ
Nieuwboer50 Pre-exp f, j, n − q LQ
Suteerawattananon51 Pre-exp f, j, n a, d − LQ
Van Wegen52 Pre-exp f, j, l, n, p a, d o SQ
Zijlstra53 Pre-exp j, l, n − o LQ
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Abstract
The aim of this study was to assess reliability, responsiveness and feasibility of gait and 
gait-related tests in the home of patients with Parkinson’s disease. The Unified Parkinson’s 
Disease Rating Scale, a timed walking test, the Timed Get Up and Go test, the Berg Balance 
Scale and the Functional reach test were applied by three independent observers on 26 
PD patients. Moderate to high Intraclass Correlation Coefficients were found, ranging 
from 0.74 to 0.88 and 0.64 to 0.87 for the intra- and inter-observer reliability, respectively. 
All tests showed Reliable Change Indexes under 11% and the whole test battery was 
applicable within 30 minutes.
Introduction
Parkinson’s disease (PD) is a chronic, progressive disorder characterized by movement-
related symptoms such as bradykinesia, tremor, rigidity, freezing and festination. 
Consequently patients experience problems in gait and in gait-related activities such 
as balance control and transfers.1 The consensus view is that if one wants to build 
an overall picture of the gait-related problems that patients with PD experience on a 
daily basis, a range of measurements should be used2‒5 and therefore, a comprehensive 
battery of tests is needed. Such a test battery should include measures that reflect the 
‘domain of activities’ according to the International Classification of Functioning, 
Disability and Health (ICF).6 The selection of tests should be based on methodological 
considerations regarding reliability and validity.
Performance tests to assess gait-related functioning in PD recommended in the 
literature include: the Unified Parkinson’s Disease Rating Scale‒motor examination 
section (UPDRS III),7,8 the Timed Get Up and Go test (TGUG),9 the Berg Balance Scale 
(BBS),10 the Functional reach test (Fr)10 and timed walking tests.11,12 The full UPDRS 
is recommended to assess disease severity.2,3,13‒15 It has been suggested that patients 
with PD should preferably be treated and tested in their own home situation.16,17 
However, the reliability of these tests aimed at assessing gait and balance control has 
never been established in the patients’ own home situation, where the circumstances 
are less optimal for standardization compared to a clinical setting. Therefore, the aim 
of the present study was to assess the reproducibility, responsiveness and feasibility 
of performance tests used to measure gait and gait-related problems in the patients’ 
own home environment. A gait-related test battery was compiled for patients with 
PD in collaboration with three different countries within Europe. This test battery 
will be used in a large randomised multicenter trial (RCT) aimed at investigating 
the effects of cueing strategies on gait and gait-related activities in the patients’ own 
home situation.18
Methods
Patient selection
Twenty-six subjects (15 male, 11 female) with a diagnosis of idiopathic PD were 
included in the study. The average age was 62.5 years (range 44‒80 years) and average 
duration of symptoms was 6.5 years (range 1‒20 year). Inclusion criteria were: (1) a 
Hoehn and Yahr19 stage ranging from 1 to 3; (2) a stable medication regime; (3) ability 
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to walk independently without a walking device; (4) absence of co-morbidity that 
may influence mobility; (5) an age under 80 years; (5) sufficient orientation in time 
and place (Mini Mental State Examination, MMSE, ≥2420) and (6) completion of an 
informed consent for participation.
All PD patients were recruited from the VU University Medical Center (VUmc) and 
lived in a geographically defined district around Amsterdam. The study was approved 
by the ethics committee of the VUmc.
Measurements
The test battery was compiled to assess severity of PD and gait-related functioning. 
The test battery consisted of the UPDRS, including the motor examination section 
(UPDRS III),2 the TGUG test,21 the timed 10 m walk test, the BBS22 and the Fr test.23 
In order to obtain uniformity of assessment practical guidelines were developed which 
included instructions on how to deal with specific difficulties inherent to testing in 
patients’ homes, such as lack of space and obstacles that could impede proper gait and 
balance assessment.
Observers
Three physical therapists were employed to perform the assessments. Prior to testing, 
the observers were trained to apply the test battery in a uniform way in three healthy 
subjects and one patient with PD. In addition, they were instructed on how to use 
the practical guidelines. The training of the three observers was conducted by two 
coaches (i.e., a physical therapist (CG) and a human movement scientist (EW)) who 
were experienced in clinical research in PD. 
Design
Patients were assessed by the three independent observers during two consecutive 
visits to the patient’s home. All subjects were visited at approximately the same time 
of the day (maximum difference in time was about 1 h) to minimize existing circadian 
fluctuations. All patients were measured in the ‘on-phase’ about 1 hour after medication 
intake. Before assessment, randomisation was applied for the sequence of the tests as 
well as for the sequence in which the three observers assessed the patient.
Data analysis and statistics
The inter-observer reliability for the three observers was calculated using Intraclass 
Correlation Coefficients (ICC) using a two-way random effects model with an absolute 
agreement definition.24 Similarly, the intra-observer reliability for one of the three 
assessors was determined by applying a two-way mixed effects model for absolute 
agreement24 and by using the Bland and Altman method.25 ICCs were preferred because 
this statistic is able to deal with dichotomous outcomes, corrects for systematic errors 
and can be used for more than two observers.24 The use of ICCs and the Bland and 
Altman method gives complementary information as shown by Rankin and Stokes.26 
For the Bland and Altman method the ‘limits of agreement’ were computed, defined as 
± 1.96  standard deviation of the difference score. Assuming a normal distribution 
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of the found differences, only 95% of the differences between two measurements per 
individual in a stable population will be between the limits of agreement.25
The responsiveness of the tests was determined using the Smallest Detectable Difference 
(SDD), the SDD was calculated on the basis of the standard error of measurement27 
(see Eq. (1)), assuming that the measurement errors were constant across the range 
of possible scores.28
Chapter 3 
a Mean, SD standard deviation (between brackets). b Number of patients. c Posture and Gait, item 1: score ≥1.      
d Freezing of Gait Questionnaire, item 3: score ≥2. e Unified Parkinson’s Disease Rating Scale, item 30. M, male; F, 
female; Y, yes; N, no; H-Y, Hoehn and Yahr Scale.
Variable Mean (SD) Range
Age (years)a 62.5 (8.2) 44−80
Disease duration (years)a 6.5 (4.2) 1−20
Gender (M/F)b 15/11
Medicationb
None 4
Levodopa (in combination with benzeraside or carbidopa) 14
Dopamine agonists 18
Selegiline 4
Parasympathicoliticum 1
Other 2 (amantadine)
Partner (Y/N) 21/5
Modified H-Y stageb
Stage 1 9 
Stage 1.5 4
Stage 2 8
Stage 2.5 3
Stage 3 1
Stage 4 0
Stage 5 0
Fallersb,c 7
Freezersb,d 16 
UPDRS scorea 41.19 (44.15) 15−71
UPDRS IIIa 23.27 (9.64) 8−39
Retropulsion test scorea,e
0=normal 22
1=retropulsion, but recovers unaided 2
2=absence of postural response; would fall if not caught by examiner 2
3=very unstable, tends to lose balance spontaneously 0
4=unable to stand without assistance 0
BBS scorea 53.77 (1.99) 46−56
Functional reacha (cm) 33.54 (7.36) 22−50
PGa 2.15 (2.15) 0−9
Table 1  Patient characteristics
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SDD=SEM1.96√2                  (Eq. 1)
where SDD is smallest detectable difference, and
SEM, standard error of measurement.
In order to allow comparison of responsiveness between the tests, the Reliable Change 
Index (RCI) was determined for each measurement by calculating the SDD as the 
percentage of the maximal feasible score. Each hypothesis was tested with a two-tailed 
analysis with 0.05 as the level of significance.
Feasibility was determined by measuring the time needed to apply the whole test 
battery, including the time needed to adapt the home environment for assessments 
(e.g., moving furniture).
Results
The patients in this study had a H-Y score ranging from 1 to 3. Patient characteristics 
are shown in Table 1. The duration of the first visit was approximately 45 minutes, 
whereas the duration of the second visit ranged from 30 to 35 minutes. The median 
number of days between two test sessions of the same observer was 7 (inter quartile 
range 3 days).
Inter- and intra-observer reliability
Table 2 shows the reliability between and within observers. ICCs for inter-observer 
reliability ranged from 0.64 for the Fr test to 0.91 for the TGUG. ICCs for intra-
observer reliability ranged from 0.74 for the UPDRS III and the Fr test to 0.93 for the 
TGUG (Table 2). Bland Altman plots are displayed in Figure 1, with the dashed and 
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Table 2  Intraclass Correlation Coefficients for inter-observer reliability and intra-observer 
reliability, smallest detectable difference and reliable change index (N=26)
Test Inter-observer 
reliability
Intra-observer 
reliability
SDD RCI (%)
UPDRS 0.78* 0.84* 15 10
UPDRS III 0.68* 0.74* 13 11
TGUG (s) 0.91* 0.93* 1.57
10 m walk test 1
walking speed (m/s) 0.87* 0.81* 0.19
step frequency (steps/min) 0.80* 0.88* 10
BBS 0.74* 0.87* 2.84 5
Fr (cm) 0.64* 0.74* 11.5
SDD, Smallest detectable difference; RCI, Reliable change index; UPDRS, Unified Parkinson’s Disease Ratio Scale; 
III, motor examination section; TGUG, Timed Get Up and Go test; PG, Posture and Gait score; BBS, Berg Balance 
Scale; Fr, Functional reach test. * p<0.01.
a The 10 m walk test was performed at comfortable walking speed.
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bold line representing the mean difference score between the two assessments and 
the two dashed lines are representing the limits of agreement. The analysis showed 
homogenous distribution of differences for all tests. No systematic differences (p<0.5) 
are found between the test and retest, except for the step frequency in the 10 m walk 
test. A mean systematic difference of 2.32 steps/minute was observed (p=0.06).
Responsiveness
Table 2 illustrates the SDDs for the five performance tests. Responsiveness ranged 
from three points on the BBS to 13 points on the UPDRS III, reflecting a RCI of 5% 
for the BBS up to 11% for the UPDRS III (Table 2).
Chapter 3 
Figure 1  Agreement of the 5 tests: graphic representation according to the Bland and 
Altman technique. UPDRS, Unified Parkinson’s Disease Ratio Scale; III, motor examination 
section. Dashed bold lines represent the mean difference score, dashed lines represent the 
limits of agreement, defined as the mean ±1.96the standard deviation of the difference 
score.
mean of the two assessments (score) mean of the two assessments (score)
UPDRS UPDRS III
10 meter walking test, step frequency10 meter walking test, walking speed
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Feasibility
The duration of applying the test battery ranged from 20 to 30 minutes at the first 
assessment, whereas the duration of the second assessment ranged from 20 to 25 
minutes.
Discussion
In the present study, tests were evaluated in terms of reliability and responsiveness by 
three independent observers in the home environment of PD patients. In general the 
test battery shows moderate to excellent inter-observer reliability (ICC=0.64‒0.87), 
and moderate to excellent intra-observer reliability (ICC=0.74‒0.88) according to the 
classification of ICCs of Fleiss.29 Good reliability was obtained regardless of the fact 
that the tests could not be completely standardised, due to the different interiors of 
the subjects’ homes. Interestingly, despite the lack of observer experience with using 
the test battery in PD patients, inter- and intra-observer reliability was moderate to 
excellent. These findings underpin the robustness of the tests included in this battery. 
In addition, the average time needed to apply the whole test battery was about 25 
minutes, ensuring its feasibility.
Our findings on reliability are comparable with the literature with respect to tests 
such as the UPDRS,7,13,15 TGUG,9 and 10 m walk test.11,12 For the Fr test a higher ICC 
for intra-observer reliability was observed (ICC=0.64) compared to the ICC (0.42) 
found by Smithson et al.10 for PD patients without a history of falls. The ICC found by 
Smithson et al.10 for PD patients with a history of falls was higher (ICC=0.93) compared 
to the ICC found for non-fallers.10 Although no explanation is given by Smithson and 
colleagues, differences in ICCs may be due to the larger between-subject variability 
in executing the Fr test in the population of fallers when compared to non-fallers. 
The PD patients in the current study were non-fallers (n=19) and fallers (n=7) which 
might have influenced the intra-observer reliability. 
Due the lack of consensus regarding methods of measuring responsiveness in the 
literature,30−32 SDDs in this study can not directly be compared with earlier reported 
SDDs for the tests used in the current study. In most studies responsiveness was 
defined as the average changes in scores relative to baseline in self-rated clinically stable 
and improved patients.2,33 Two studies were found that applied the same method for 
determining responsiveness on some of the tests used in the present study.34,35 In these 
studies where the BBS and the timed 10 m walk test were applied, the SDDs for both 
tests were 6 points34 and 0.16 m/s,35 respectively. However, these tests were investigated 
in patients with stroke and therefore difficult to generalize to the PD patients in the 
present study. Unfortunately, general accepted criteria to judge the responsiveness 
of these tests do not exist. Therefore, in order to interpret the calculated scores, we 
compared the RCIs with each other. All RCIs were 11% or less, which is in our opinion 
acceptable for clinical use. In particular, realizing that assessments in patients’ own 
home environment is accompanied with a decreased ability to standardize the execution 
of measurements and with that higher error rates.
A limitation of the present study was that only subjects with mild to moderate disease 
severity were included (H-Y score ranging from 1 to 3). The battery was composed 
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for those who were independent in ADL and were able to perform the tests without 
the use of a balance or walking aid. This limits the generalisation of present findings 
to the population of PD patients in general. In addition, all patients were tested in the 
on-phase and each patient was assessed at approximately the same time of the day, 
however, differences in time of assessment relative to moment of medication intake 
could have influenced the present findings.
Conclusion
The test battery was shown to have moderate to excellent reliability, despite limited 
clinical experience of the observers in assessing PD patients. Agreement on practical 
guidelines is necessary to standardize assessments as much as possible under less 
optimal circumstances, such as the home situation.
Since there appears to be a lack of consensus on how to quantify responsiveness,32 strict 
comparison with the literature is difficult. However, the results from the current study 
can be applied as indicators for an approximate threshold in the utility of the tests as 
outcome measures in a larger clinical trial.
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Abstract
This study was aimed at determining the effects of rhythmic visual cueing under changing 
visual conditions on stride frequency in patients with Parkinson’s disease (PD; n=21) 
and healthy age matched controls (n=7) while walking at different speeds on a treadmill. 
Stride frequency and stride length in patients with PD as well as controls were not rigidly 
coupled to walking speed and could be manipulated with walking speed as well as by 
using spatial and temporal rhythmic visual cues.
Introduction
It has been well established that patients with Parkinson’s disease (PD) exhibit specific 
changes in gait patterns during walking. Patients with PD walk at a reduced overall 
speed with a shorter stride length in comparison with healthy age matched control 
subjects.1 Step frequency (i.e. number of steps made in 1 minute) may be normal, but 
is often elevated when speed of walking is taken into account. This increased step 
frequency appears to be a compensation for the reduced stride length.2 Several studies 
suggest that step frequency control is still intact and can be modulated for a variety of 
conditions.1,3,4 On the other hand patients with PD seem to have particular difficulty 
with the internal regulation of stride length.2,3,5–7
In addition to changes in stride parameters, changes in foot fall patterns, trunk position 
as well as reduced trunk rotation and absence of arm swing have been observed.8–11 
Even with an ‘optimal’ medication regimen gait-related movement problems persist and 
could be related to the occurrence of falling.12–14 Taken together, the mobility problems 
can have a large impact on activities of daily living in PD patients.15–17
In many observational studies, gait changes are investigated during tests at the 
preferred walking speed during over ground walking. However, since variables such 
as stride length and stride frequency tend to change as a function of walking speed, 
same-speed comparisons need to be undertaken in order to eliminate the effects of 
speed on stride parameters.11,18 At a fixed speed, the shorter stride length in PD may 
be compensated for by an elevated step frequency.2 Thus, when controlling for speed, 
adaptation of step frequency by an external rhythm might offer a possible strategy to 
indirectly influence stride length regulation.
Several studies have shown that auditory rhythms can positively influence stride 
characteristics of gait in PD, presumably by compensating for basal ganglia disease 
causing an inability to internally generate rhythmic movements.9,19–22 Such external cues 
can be defined as providing temporal or spatial stimuli associated with the initiation 
and ongoing facilitation of motor activity such as gait.23
An alternative way to apply external rhythmic cueing in patients with hearing problems 
could be the provision of a visual cueing rhythm by means of a rhythmically flashing 
light attached to a pair of spectacles. However, to our knowledge this has not been 
investigated to date.
While some visual environmental stimuli such as parallel lines on the floor or lines 
on the pavement can elicit a more normal walking pattern in PD,1,2,8,24,25 other visually 
perceived features of the environment such as thresholds, confined spaces, furniture, 
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narrow doorways or moving surfaces such as elevators and escalators tend to predispose 
patients with PD to slowing gait and/or motor blocks.26 In the case of visual rhythmic 
cueing this could pose an additional problem, since multiple visual inputs (i.e. optic 
flow from the environment generated through walking as well as the visual rhythm) 
need to be accommodated.
The main purpose of the current investigation was to study the effects of rhythmic 
visual cueing under changing visual conditions on the stride pattern of patients with 
PD. Cueing consisted of a flashing light or transverse lines. The possible suppressive 
influences of a moving environment containing objects (doorways and thresholds in 
a projection of a moving virtual corridor) during cued and uncued gait was studied. 
In a controlled laboratory environment, kinematic gait patterns of patients with PD 
and healthy controls were studied during treadmill walking under baseline conditions 
(absence of virtual environment, no virtual corridor projection) and under optic flow 
conditions (projection of virtual corridor with doorways and thresholds). In addition, 
the effects of virtual optic flow on the use of visual rhythmic cueing were examined. 
So-called ‘walking velocity manipulations’ were performed to study the differential 
effects of walking speed on the influence of virtual objects during walking. It was 
hypothesized that using visual rhythmic cueing (i.e. a flashing light or transverse lines) 
it would be possible to regulate the stride frequency. Specifically, a cueing frequency 
lower than baseline as well as transverse lines would result in lower stride frequencies 
and thus larger stride lengths at the same speed. Stride parameters were expected to 
systematically change with walking speed. Lastly, it was expected that virtual optic flow 
would negatively influence this effect due to a suppressive interference effect.
Methods
Subjects
Three groups of subjects participated in the study, one group consisting of age and 
sex matched healthy adults (n=7), one group of non-medicated (i.e. drug-naïve) 
patients with PD (n=8) and a group of medicated patients with PD (n=13). Patients 
with idiopathic PD27 were screened for inclusion into the study and admitted when 
they are on a stable medication regime (for the medicated group), without acute co-
morbidity influencing mobility, under 75 years of age, free of signs of dementia (Mini 
Mental State Examination score > 24) and willing and able to sign a consent form for 
participation. Patients with mild to moderate disease severity (Hoehn-Yahr 1.5–3) were 
recruited. Additionally, patients who were included in the study had to (1) be able to 
walk independently at a walking speed of at least 3.8 km/h, (2) have a minimal score 
of 2 for at least at one of the items: tremor, rigidity, bradykinesia and hypokinesia on 
the Unified Parkinson’s Disease Rating Scale (UPDRS), (3) be non-institutionalised 
and (4) be without severe visual deficits based on self report. Patients were recruited 
by phone, based on an existing database as well as referrals from several neurologists. 
Control subjects were recruited from the community; in addition spouses from the 
patient groups participated. Prior to their arrival at the hospital, subjects were informed 
about the study by way of an information packet. All participants signed an approved 
informed consent form. The Human Subjects Review Committee of the VU University 
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Medical Center approved the project.
Protocol
Subjects were asked to come to the Outpatient Department for an experimental session 
that would take between 2.5 and 3.5 hours. The session was divided into two separate 
sections: (1) clinical tests, and (2) a treadmill protocol. All patients were tested in the 
on-phase, approximately 1 hour after taking their regular medication.
Clinical tests
Prior to testing on the treadmill, subjects performed a 10 m walk test, a Timed Get 
Up and Go test (TGUG),28 and a Berg Balance Scale (BBS)29 to evaluate walking and 
balance performance.
Treadmill protocol
Before the protocol, subjects were fitted out with butterfly-shaped Light Emitting 
Diodes (LEDs, see Materials section). A harness attached to the ceiling via a rope was 
used for safety. Subjects subsequently were asked to walk on the treadmill. Before the 
actual treadmill protocol began, the comfortable as well as maximal walking speed was 
determined after extensive habituation. During the treadmill protocol the following 
variables were manipulated: visual flow, rhythmic visual cueing and walking speed.
Manipulation of visual conditions
Visual flow was manipulated by means of a 22 m rear projection screen positioned 
75 cm in front of the treadmill: in conditions where visual flow was offered a ‘virtual’ 
corridor was projected that ‘moved’ at the speed of the treadmill, providing the illusion 
that the subject walks through the corridor. The virtual corridor contained several 
thresholds and doorways to mimic narrowing of the passageway, known causes of 
gait disturbance in PD. Visual cueing was manipulated by means of a light flash from 
a LED attached to a pair of glasses (rhythmic temporal cueing) as well as through 
transverse lines projected 60 cm apart on the floor of a virtual corridor (rhythmic 
spatial cueing). Consequently, subjects walked on the treadmill under the following 
five conditions, offered in random order:
(1) Blank screen, no projection of virtual corridor
(2) Projection of virtual corridor 
(3) Projection of virtual corridor with rhythmic spatial cueing (the transverse 
lines)
(4) Blank screen with rhythmic temporal cueing (the flashing light)
(5) Projection of virtual corridor with rhythmic temporal cueing (the flashing 
light)
To promote larger stride lengths at fixed speeds, the flash-frequency of the LED on 
the glasses for the conditions 4 and 5, was set after subtracting ten percent from the 
baseline stride frequency determined previously (cf. Howe et al.22 and Van Wegen et 
al.30). For rhythmic temporal cueing the subjects were given the instruction to ‘step 
with your right foot in front when the light on the side of your glasses flashes’. For 
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rhythmic spatial cueing the subjects were given the instruction to ‘step on or over the 
approaching lines’. 
Manipulation of speed
Within each condition, the speed of the treadmill was systematically increased from 
0.6 to 3.8 km/h in steps of 0.8 km/h and subsequently reduced with the same steps 
(see Figure 1). Thus, subjects completed nine speed levels. Treadmill and flow speed 
were synchronized in conditions 2, 3 and 4. Each speed level lasted about 1 minute, 
of which the last 30 seconds were used to collect kinematic data.
Material
The experiment was performed on a treadmill (Biometrics Europe BV, Almere, The 
Netherlands) with a 1.2 m  2.0 m belt. A 3D kinematic motion analysis system 
(Optotrak (OT), Northern Digital Inc., Canada) was used to collect position data of 
the extremities. Two camera units placed diagonally behind the treadmill at a distance 
of about 3 m were used at a sample frequency of 60 Hz. Motion was tracked from 24 
infrared-light emitting diodes, attached in triads of three on eight butterfly shaped 
marker sets, which were placed bilaterally and on the backside of the body on the 
upper arm, lower arm, upper leg and the lower leg.
The virtual corridor was generated on a Silicon Graphics Workstation (Octane) 
and projected on a custom-made rear-projection screen by a RGB color projector 
(Kindermann Omega Sx 1280c).
Data analysis
Segmental angles for the extremities were calculated for the frontal, transverse and 
sagittal planes, using custom software. From the sagittal plane segmental angles, the 
stride frequency was determined using a count of the number of peaks in the thigh angle 
~ 10 minutes
30 sec 
measurement
1 minute
0,6 km/h
4.6
3.8
3.0
2.2
1.4
5.4
3.8
3.0
2.2
1.4
0.6
Figure 1  Systematic speed manipulation.
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trajectories during a 30 seconds data collection. The obtained frequency was compared 
with an estimation of the dominant peak power frequency using a standard Fast Fourier 
Transform and results proved to be identical, with average variation <0.9%.
Statistical analysis
A one-way ANOVA was applied to test for group differences on the clinical tests and 
subject characteristics. A general linear model for repeated measures was applied 
with group (3 levels, medicated PD patients, non-medicated PD patients and healthy 
controls), condition (5 levels, see under treadmill protocol) and velocity (9 levels, 
0.6, 1.4, 2.2, 3.0, 3.8, 3.0, 2.2, 1.4 and 0.6 km/h) as factors. When significant effects 
were found, planned comparisons were performed to determine the location of the 
effect. Each hypothesis was tested with a two-tailed analysis and 0.05 as the level of 
significance.
Results
Since stride frequency was manipulated and correlated in a fixed manner to stride 
length at a constant speed only the effects on stride frequency will be discussed. 
Subject characteristics
Table 1 shows subject group data. The groups did not differ with regard to age, height 
and weight. Although the non-medicated PD patients had lower average Hoehn 
and Yahr scores and lower average scores on the Mini Mental State Examination 
(MMSE), these were not statistically significant (p>0.05). The UPDRS score for the 
non-medicated patients was lower than the medicated patients (p<0.05). Since all non-
medicated subjects were recently diagnosed within the last 3 years, except 1 patient who 
was diagnosed 5 years prior, the disease duration as well as the duration of medication 
usage were lower in the non-medicated group (p<0.05). On the clinical tests, the PD 
groups did not differ significantly from each other, but the medicated group performed 
Med, medicated; nonmed, non-medicated; PD, Parkinson’s disease; HY, Hoehn Yahr; UPDRS, Unified PD Rating 
Scale; MMSE, Mini Mental Status Exam; m, meters; kg, kilogram; 10m, 10 meter walk test comfortable speed; 
TUG, Timed Up and Go test; s, seconds; BBS, Berg Balance Scale. Mean values are reported followed by brack-
eted standard deviation. *Significantly different from group 1; p<0.05.
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Table 1  Subject characteristics
Group Age Weight 
(kg)
Height 
(m)
Years 
PD
HY UPDRS MMSE 10m 
(km/h)
TUG (s) BBS N
PD med 62.3 
(9.8)
82.4 
(15.3)
1.79 
(0.08)
5.5 
(3.5)
2.3 
(0.5)
52.9 
(11.1)
27.8 
(1.5)
3.8 
(0.5)
10.3 
(3.5)
52.6 
(2.7)
13
PD 
nonmed
56.7 
(9.4)
77.4 
(12.0)
1.78 
(0.10)
2.1 
(2.2)*
2.1 
(0.7)
38.4 
(18.2)*
29.1 
(1.4)
4.0 
(0.7)
10.1 
(2.8)
54.2 
(2.5)
8
Controls 59.2 
(10.2)
80.2 
(9.4)
1.77 
(0.07)
  < 5 29.3 
(1.3)
4.8 
(0.3)*
8.1 
(0.4)*
55.8 
(0.4)*
7
53
Rhythm
ic visual cueing in Parkinson’s disease
Chapter 4 
worse on all tests as compared to the control group (p values < 0.05).
With regard to the treadmill protocol, a significant (‘Group’  ‘Speed’) interaction 
effect was found for stride frequency (p<0.01), indicating a speed dependent difference 
between the groups. Specifically, the control group walked at significantly lower stride 
frequencies at 2.2, 3.0 and 3.8 km/h as compared to both PD groups (p values < 0.05, 
Figure 2).
Effects of walking speed
Stride frequency increased significantly with increasing speed (p<0.01). The absence 
of a significant (‘condition’  ‘speed’) interaction effect (p=0.96) indicates that this 
applies to all conditions. Post hoc analysis showed that at all speeds except at 0.6 km/h 
the stride frequency in the decreasing speed range was significantly lower compared 
to the stride frequency for corresponding speeds in the increasing speed range (p 
values < 0.05).
Effects of visual conditions
Stride frequency was significantly lowered (and thus stride length enlarged) in the 
rhythmic cueing conditions compared to corresponding speeds in the baseline 
condition (conditions 3, 4, and 5 < condition 1; p<0.05; Figure 3). No significant (‘group’ 
 ‘condition’) interaction effect was found (p=0.99) and the reduction occurred in all 
groups. No difference was found between conditions 3 (virtual corridor projected with 
stripes), 4 (flashing light, virtual corridor not projected on screen) and 5 (flashing light, 
virtual corridor projected) (p>0.05). In addition, stride frequency between conditions 
1 and 2 did not differ (p>0.05).
Figure 2  Stride frequency, averaged across speeds 2.2, 3.0 and 3.8 km/h (i.e. pooled). Med, 
medicated PD patients (n=13); nonmed, non-medicated PD patients (n=8); controls, healthy 
older adults (n=7). * significantly different at p<0.05.
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Discussion
The aim of this study was to examine the effects of temporal and spatial visual rhythms 
as external cues on the stride pattern of patients with Parkinson’s disease. The main 
finding was that both transverse stripes projected in a virtual corridor as well as a 
flashing light attached to a pair of spectacles can be used to lower the stride frequency 
while maintaining walking speed. This effect occurred in both PD patients and controls. 
The results also suggest that optic flow information during walking does not impair 
nor facilitate the use of a rhythmic flashing light to manipulate stride frequency. In 
addition, it was shown that the stride frequency obtained at higher speeds is maintained 
during subsequent lowering of walking speed.
The results confirm that PD patients walk with smaller steps when controlling for 
walking speed, which is consistent with the literature.1–3,6,7,31 However, in the current 
experiment this effect is speed dependent, since there was no difference at 0.6 and 1.4 
km/h. Although the same subjects were not compared on and off medication, the fact 
that the stride frequency in the medicated patients tended to be less elevated compared 
to the non-medicated patients does suggest that dopamine (replacement) therapy can 
improve stride frequency to a certain extent.
Chapter 4 
Figure 3  Stride frequency (normalized for leg length) as a function of condition in the three 
groups. Means and between subjects standard deviations are shown. Med, medicated PD 
patients (n=13); nonmed, non-medicated PD patients (n=8); controls, healthy older adults 
(n=7). c1, blank screen, no projection of virtual corridor; c2, projection of virtual corridor; 
c3, projection of virtual corridor with transverse lines on the floor; c4, blank screen with 
rhythmic visual cueing; c5, projection of virtual corridor with rhythmic visual cueing.
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The current study also confirms results from earlier studies that have found positive 
effects of transverse stripes on parkinsonian gait.1,2,8,24–26,32,33 To our knowledge this is 
the first study that has used projected transverse stripes in a virtual corridor while 
walking on a treadmill, where walking speed was kept constant at each speed level. 
Azulay et al. have suggested that the effect is caused by the fact that the approaching 
stripes have certain dynamic properties that encourage stepping over or on the stripes, 
perhaps through alternative visuo-motor circuits.24 Alternatively, the stripes could 
simply attract attention to the walking pattern itself, relieving emphasis on automatic 
motor function.1,26
Several studies have shown positive effects of external (auditory) rhythms on stride 
characteristics of gait in PD (a form of temporal cueing). It is suggested that the external 
cues compensate for the inability to internally generate cued rhythmic movements 
caused by basal ganglia disease resulting in disturbed relay of information to the 
supplementary motor area (SMA).9,19–22 In the current study an alternative method 
of external temporal cueing was investigated, namely by means of a flashing light. 
The results show that this is a viable and relatively simple alternative: at comparable 
speeds the stride frequency was systematically lower when subjects were cued at 10% 
below their baseline stride frequency. Since walking speed was constant within each 
speed level, the slower rhythm resulted in larger strides. This result confirms that PD 
patients (as well as healthy controls) are able to adjust their walking patterns flexibly 
using an external visual rhythm without changing walking speed. Howe et al. have used 
auditory cueing at 85% of baseline frequency and found a slowing of walking speed 
and the stepping rhythm.22 A slower walking speed could however be an undesirable 
effect of cueing since the characteristic pattern of small steps does not change. 
The mechanism for bypassing the defective pallidocortical projections with a visual 
rhythm could be similar to that for auditory cueing (cf. McIntosh et al.20). Connections 
from the visual system project via the lateral geniculate nucleus of the thalamus to the 
visual cortex and lateral pre-motorcortex, where sensory information is received for 
externally guided movements.34,35 Additionally, alternative sensory visuo-motor circuits 
passing to the cerebellum and in particular the dentate nucleus, may also be involved 
in the generation and/or guidance of movement based on visual cues.36,37
The phenomenon that stride frequency was lower at the decreasing speeds compared 
to the same speed levels in the increasing speed range is known as ‘hysteresis’ in (bio)
physics. As with the frequency manipulations, this hysteresis effect was not group-
specific, indicating that it may be a more general phenomenon. Hysteresis-effects under 
systematic walking speed manipulations have been observed in previous studies in 
stride parameters and trunk rotation in healthy subjects,38 patients with PD39 and 
stroke.40 Apparently an initial increase in walking speed has in itself a positive effect 
on the gait pattern during subsequent lowering of speed, confirming that the stride 
frequency is not coupled to walking speed in a fixed manner. The hysteresis-effect could 
be viewed as emerging from an after-effect, where the kinematic changes accompanying 
higher speeds are maintained during subsequent lower speed levels. Simply performing 
such a walking speed manipulation could be an effective and easy method to influence 
and perhaps normalize the pathologic gait pattern of patients with PD.
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Small spaces, moving surfaces such as escalators and elevators as well as discontinuities 
in the floor surface such as thresholds, furniture or narrow doorways can lead to 
unwanted stagnation or even freezing of the gait of patients with PD. The current 
results confirm that simultaneous presentation of transverse stripes on the floor of a 
virtual corridor containing thresholds and doorways can enhance the stride pattern 
of PD patients.24,41 In combination with the explicit control of walking speed on a 
treadmill, the current approach to facilitate locomotor function could prove to be a 
useful treatment option for PD.
Interestingly, the presentation of the virtual corridor containing thresholds and 
doorways did not have a noticeable effect on the average stride frequency since there 
was no difference between condition 1 (baseline) and condition 2 (virtual corridor, no 
cueing). While it is possible that the projected environment was not convincing enough, 
almost all subjects felt that they were really walking through the corridor. It is possible 
that the average stride frequency did not change due to the fact that the doorways 
and thresholds were relatively far apart. There could have been a more instantaneous 
effect, influencing the consistency (i.e. the variability) of the stride pattern. Prokop 
et al. found an elevated stride length variability and slower walking speed in healthy 
subjects during presentation of an optic flow field during treadmill walking.41 Studies 
suggest that increased stride variability is related to susceptibility to falls in patients with 
PD, and that stride variability may be responsive to dopamine therapy.42,43 Although 
subtle effects on stride variability cannot be ruled out, our PD groups were relatively 
young and had moderately low disease severity. Therefore stride variability may not 
have been very much affected; however, this requires further investigation.
The third research question concerned the possibility that presentation of the virtual 
corridor would suppress the effect of visual rhythmic cueing using the flashing light, as 
Parkinson patients may be more dependent on visual information for locomotion.24 
The results showed no effect of projected optic flow on the stride parameters: the stride 
frequency in condition 4 was significantly lowered compared to condition 1 (baseline) 
and 2 (virtual corridor, no cueing) and there was no difference between conditions 
4 (cueing with flash, with virtual corridor) and 5 (cueing with flash, without virtual 
corridor). This suggests that a moving visual surround, which also occurs during 
normal walking through the environment, does not impede the use of the flashing 
cue-light, which is consistent with observations in our clinic. A possible explanation 
for the absence of a suppressive effect during cued conditions, which was supported 
by subjective comments from the patients, is that focal attention is drawn away from 
the possibly destabilizing visual stimuli in the environment, allowing gait to proceed 
undisturbed under the guidance of the visual rhythm.
Conclusion
The current experiment shows that the stride pattern of patients with PD is not rigidly 
coupled to walking speed and can be manipulated with visual cueing techniques as well 
as with a systematic manipulation of walking speed. It was shown that a rhythmically 
flashing light as well as projection of virtual stripes can be used to enhance the stride 
length of patients with Parkinson’s disease. This indicates that pathological gait can be 
influenced by visual rhythmic entrainment strategies using alternate sensory motor 
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pathways in the presence of basal ganglia dysfunction. This cueing-method could 
therefore be a useful alternative for patients who cannot or will not use auditory cues. 
Additionally, the used protocol provides an excellent way to control walking speed at 
the same time.
Obviously, the transfer to and implementation in every day activities of this cueing 
method needs to be further investigated. In addition, the effects of cueing-therapy have 
not been systematically investigated in the home environment of patients with PD. 
The European project Rescue is directed at investigating these issues in a randomized 
controlled trial.
Acknowledgements
This study was supported by a grant from the European Committee (The Rescue 
project, grant number QLK6-CT-2001-00120). We would like to thank all participants 
for their contribution and A. Nanne and I. Wijbrands for their assistance in data 
collection.
References
(1) Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson’s disease: the use of extrinsic, 
visual cues. Brain 2000; 123: 2077-2090.
(2) Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in 
Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 1994; 57: 1532-1534.
(3) Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson’s disease. 
Normalization strategies and underlying mechanisms. Brain 1996; 119: 551-568.
(4) Morris M, Iansek R, Matyas T, Summers J. Abnormalities in the stride length-cadence relation in 
parkinsonian gait. Movement Disorders 1998; 13: 61-69.
(5) Carr JH, Shepherd R. Fysiotherapie bij hersenaandoeningen. Lochem-Poperinge: de Tijdstroom; 
1982.
(6) Knutsson E. An analysis of Parkinsonian gait. Brain 1972; 95: 475-486.
(7) Blin O, Ferrandez AM, Serratrice G. Quantitative analysis of gait in Parkinson patients: increased 
variability of stride length. Journal of Neurological Science 1990; 98: 91-97.
(8) Martin JP. The Parkinson’s Handbook. London: Pitmal Medical; 1967.
(9) McCoy RW, Kohl RM. The impact of auditory cues on gait control of individuals with Parkinson’s 
Disease. Journal of Human Movement Studies 2002; 42: 229-236.
(10) Morris M, McGinley J, Huxham F, Collier J, Iansek R. Constraints on the kinetic, kinematic and 
spatiotemporal parameters of gait in Parkinson’s disease. Human Movement Science 1999; 18: 461-483.
(11) Van Emmerik RE, Wagenaar RC, Winogrodzka A, Wolters EC. Identification of axial rigidity during 
locomotion in Parkinson disease. Archives of Physical Medicine and Rehabilitation 1999; 80: 186-191.
(12) Bloem BR, Van Vugt JP, Beckley DJ. Postural instability and falls in Parkinson’s disease. Advances 
in Neurology 2001; 87: 209-223.
58
 
(13) Hamani C, Lozano AM. Physiology and pathophysiology of Parkinson’s disease. Annals of the New 
York Academy of Sciences 2003; 991: 15-21.
(14) Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Archives of Neurology 2001; 58: 
1611-1615.
(15) Ashburn A, Stack E, Pickering RM, Ward CD. A community-dwelling sample of people with 
Parkinson’s disease: characteristics of fallers and nonfallers. Age and Ageing 2001; 30: 47-52.
(16) Gray P, Hildebrand K. Fall risk factors in Parkinson’s disease. Journal of Neuroscience Nursing 2000; 
32: 222-228.
(17) Playfer JR. Falls and Parkinson’s disease. Age and Ageing 2001; 30: 3-4.
(18) Zijlstra W, Rutgers AW, Van Weerden TW. Voluntary and involuntary adaptation of gait in Parkinson’s 
disease. Gait & Posture 1998; 7: 53-63.
(19) Thaut MH, McIntosh GC, Rice RR, Miller RA, Rathbun J, Brault JM. Rhythmic auditory stimulation 
in gait training for Parkinson’s disease patients. Movement Disorders 1996; 11: 193-200.
(20) McIntosh GC, Brown SH, Rice RR, Thaut MH. Rhythmic auditory-motor facilitation of gait patterns 
in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 1997; 62: 22-26.
(21) Thaut MH, McIntosh KW, McIntosh GC, Hoemberg V. Auditory rhythmicity enhances movement 
and speech motor control in patients with Parkinson’s disease. Functional Neurology 2001; 16: 163-172.
(22) Howe TE, Lovgreen B, Cody FW, Ashton VJ, Oldham JA. Auditory cues can modify the gait of 
persons with early-stage Parkinson’s disease: a method for enhancing parkinsonian walking performance? 
Clinical Rehabilitation 2003; 17: 363-367.
(23) Lim LIIK, Van Wegen EEH, Deutekom M, Jones D, Rochester L, Nieuwboer A, Kwakkel G. Effects 
of external rhythmical cueing on gait in patients with Parkinson’s disease: a systematic review. Clinical 
Rehabilitation 2005; 19(7), 695-713.
(24) Azulay JP, Mesure S, Amblard B, Blin O, Sangla I, Pouget J. Visual control of locomotion in Parkinson’s 
disease. Brain 1999; 122(1): 111-120.
(25) Bagley S, Kelly B, Tunnicliffe N, Turnbull G, Walker JM. The effect of visual cues on the gait of 
independently mobile Parkinson’s Disease patients. Physiotherapy 1991; 77: 415-420.
(26) Morris M, Iansek R, Summers J, Matyas T. Motor Control Considerations for the rehabilitation of 
gait in Parkinson’s Disease. In: Glencross DJ, Piek JP, eds. Motor control and sensory integration: Issues 
and directions. Elsevier Science B.V.; 1995. pp 61-93.
(27) Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s 
disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery & Psychiatry 1992; 
55: 181-184.
(28) Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Archives of Physical 
Medicine and Rehabilitation 1986; 67: 387-389.
(29) Berg KO, Maki BE, Williams JI, Holliday PJ, Wood-Dauphinee SL. Clinical and laboratory measures 
of postural balance in an elderly population. Archives of Physical Medicine and Rehabilitation 1992; 73: 
1073-1080.
Rhythmic visual cueing in Parkinson’s diseaseChapter 4 
59
 (30) Van Wegen EEH, De Goede CJT, Lim I, Jones D, Rochester L, Nieuwboer A, Willems A, Kwakkel 
G. Effecten van externe visuele ritmen op het looppatroon van patienten met de ziekte van Parkinson. 
Nederlands Tijdschrift voor Fysiotherapie 2004; 114: 83-87.
(31) Forssberg H, Johnels B, Steg G. Is parkinsonian gait caused by a regression to an immature walking 
pattern? Advances in Neurology 1984; 40: 375-379.
(32) Azulay JP, Van Den BC, Mestre D, Blin O, Sangla I, Pouget J, Serratrice G. [Automatic motion 
analysis of gait in patients with Parkinson disease: effects of levodopa and visual stimulations]. Revue 
Neurologique (Paris) 1996; 152: 128-134.
(33) Hanakawa T, Fukuyama H, Katsumi Y, Honda M, Shibasaki H. Enhanced lateral premotor activity 
during paradoxical gait in Parkinson’s disease. Annals of Neurology 1999; 45: 329-336.
(34) Halsband U, Matsuzaka Y, Tanji J. Neuronal activity in the primate supplementary, pre-supplementary 
and premotor cortex during externally and internally instructed sequential movements. Neuroscience 
Research 1994; 20: 149-155.
(35) Mushiake H, Inase M, Tanji J. Neuronal activity in the primate premotor, supplementary, and 
precentral motor cortex during visually guided and internally determined sequential movements. Journal 
of Neurophysiology 1991; 66: 705-718.
(36) Kandel ER, Schwartz JH. Principles of Neural Sciences. New York: Elsevier Science Publishing Co., 
Inc.; 1985.
(37) Mushiake H, Strick PL. Preferential activity of dentate neurons during limb movements guided by 
vision. Journal of Neurophysiology 1993; 70: 2660-2664.
(38) Van Emmerik RE, Wagenaar RC. Dynamics of movement coordination and tremor during gait in 
Parkinson’s disease. Human Movement Science 1996; 15: 203-235.
(39) Van Emmerik REA, Wagenaar RC, Wolters EC. Dynamics of movement coordination in Parkinson’s 
disease. In: Wolters EC, Scheltens P, eds. Mental Dysfunction in Parkinson’s Disease. Dordrecht: ICG 
Printing; 1993. pp 69-91.
(40) Wagenaar RC, Beek WJ. Hemiplegic gait: a kinematic analysis using walking speed as a basis. Journal 
of Biomechanics 1992; 25: 1007-1015.
(41) Prokop T, Schubert M, Berger W. Visual influence on human locomotion. Modulation to changes 
in optic flow. Experimental Brain Research 1997; 114: 63-70.
(42) Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia 
disorders: stride-to-stride variations of gait cycle timing in Parkinson’s disease and Huntington’s disease. 
Movement Disorders 1998; 13: 428-437.
(43) Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson’s 
disease: relationship to Parkinsonian features, falls and response to levodopa. Journal of the Neurological 
Sciences 2003; 212: 47-53.
Chapter 4 
Rhythm
ic visual cueing in Parkinson’s disease
60
 Rhythmic visual cueing in Parkinson’s diseaseChapter 4 
Journal of Neurology, 
Neurosurgery, and Psychiatry 
2007; 78: 134-140
5
Cueing training in the home 
improves gait-related mobility 
in Parkinson’s disease: 
The Rescue trial
A. Nieuwboer, G. Kwakkel, L. Rochester, D. Jones, 
E. van Wegen, A. Willems, F. Chavret, 
V. Hetherington, K. Baker, I. Lim 
62
Chapter 5 The Rescue trial
Abstract
Objectives: Gait and mobility problems remain difficult to treat in people with Parkinson’s 
disease (PD). The Rescue trial investigated the effects of a home physical therapy 
programme based on rhythmical cueing on gait and gait-related activity.
Methods: A single-blind randomized crossover trial was set up, including 153 patients with 
PD aged between 41 and 80 years and in Hoehn & Yahr stage II to IV. Subjects allocated 
to early intervention (n=76) received a three-week home cueing programme using a 
prototype cueing device followed by three weeks without training. Patients allocated to 
late intervention (n=77) underwent the same intervention and control period in reverse 
order. After the initial 6 weeks, both groups had a 6 week follow-up without training. 
Posture and Gait scores (PG scores) measured at 3, 67, and 12 weeks by blind testers were 
the primary outcome measure. Secondary outcomes included specific measures on gait, 
freezing and balance, functional activities, quality of life and carer strain.
Results: Small but significant improvements were found after intervention of 4.2% 
on the PG scores (p=0.005). Severity of freezing was reduced by 5.5% as measured in 
freezers only (p=0.007). Gait speed (p=0.005), step length (p<.0001) and timed balance 
tests (p=0.003) improved in the full cohort. Other than a greater confidence to carry out 
functional activities (Falls Efficacy Scale, p=0.04), no carry-over effects were observed 
in functional and quality of life domains. Effects of intervention reduced significantly 
at 6 week follow-up.
Conclusions: Cueing training in the home has specific effects on gait, freezing and 
balance. The wearing-off of intervention effects underscores the need for permanent 
cueing devices and follow-up treatment. Cueing training may be a useful therapeutic 
adjunct to the overall management of gait disturbance in PD.   
Introduction
In neurological patients, Parkinson’s disease (PD) is the most common disorder 
leading to gait disturbance and falls.1 Despite advances in pharmacological therapies 
and surgical techniques, gait and balance deficits still persist and are associated with 
loss of independence, immobility and high cost for health care systems.2 Therefore, 
the development of rehabilitation approaches that work in conjunction with current 
treatment is important to manage these problems.
Recent systematic reviews concluded that there was insufficient evidence to support 
or refute the efficacy of physical therapy in PD, or to support the use of one form of 
physical therapy over another.3,4 Studies suffered from methodological problems. 
However, reviewers did comment that the efficacy of physical therapy had improved 
through the addition of cueing techniques. Cueing is defined as using external 
temporal or spatial stimuli to facilitate movement (gait) initiation and continuation. 
Recent reviews into cueing suggest that it can have an immediate and powerful effect 
on gait performance in people with PD, indicating improvements in walking speed, 
step length and step frequency.5,6 The influence of cueing has mainly been studied in 
single session experiments in laboratory settings.7-11 Results demonstrate a short-term 
correction of gait and gait initiation and suggest that carry-over to uncued performance 
and its generalization to activities of daily living (ADL) is limited. Using cues in a 
therapeutic setting is more complex as the ‘modality’ of cue delivery (visual, auditory or 
somatosensory) and the cue ‘parameter’ selected for movement correction (frequency 
or size of step) have to be adapted to the needs of the patient. Apart from two limited 
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studies into the retention effects of cues, to date no work has evaluated the clinical 
application and prolonged training effects of cues in the home to improve walking 
in a functional context.12,13 Furthermore, improved mobility with cues may have an 
adverse effect and distract attention, increasing the risk of falling.14,15 
The primary objective of this study was to investigate the efficacy of a home-based 
cueing programme on parameters of gait, gait-related activity and health-related quality 
of life in people with PD. We hypothesized that a three-week period of home-based 
cueing training would result in measurable improvements of selected gait parameters 
immediately after treatment, but that these effects might decrease after 6 weeks without 
cueing.
Methods
Study population
We recruited 153 patients with idiopathic PD from three European centres, 
Northumbria University, Newcastle upon Tyne (UK), Katholieke Universiteit of 
Leuven (B) and the Vrije Universiteit Medical Centre of Amsterdam (NL). The study 
was approved by the ethics committee of each participating centre. All patients gave 
informed written consent to the study. Eligibility criteria were (1) showing mild to 
severe gait disturbance with score >1 on the Unified Parkinson’s Disease Rating Scale 
(UPDRS; item 29);16 (2) diagnosis of idiopathic PD, defined by the UK Brain Bank 
Criteria);17 (3) stable medication usage; (4) Hoehn & Yahr stage II−IV; and (5) age 18−80 
years. Patients were excluded if they had (1) undergone deep brain stimulation or other 
stereotactic neurosurgery; (2) a cognitive impairment (Mini Mental State Examination 
scores <24);18 (3) disorders interfering with participation in cueing training, including 
neurological (stroke, MS, tumour), cardiopulmonary (chronic obstructive disorders, 
angina pectoris) and orthopaedic (osteoarthritis, rheumatoid arthritis and back pain) 
conditions; (4) unpredictable and long lasting off-periods (score=1 item 37 and score 
>2 on item 39 of the UPDRS);16 and (5) participated in a physical therapy programme 
two months prior to commencing the trial. 
Design and procedures
The present study was a single blind, randomized, clinical trial with a crossover design 
with no wash-out period. The choice of design was based upon previous evidence 
of the short-lasting effects of cueing,5,6 the advantage of providing treatment for all 
participants, and increasing the statistical power within the constraints of research 
funding. In each centre patients were randomly allocated in permuted blocks of six to 
an early or late intervention group by an independent investigator not involved in data 
analysis. Allocation was concealed by the use of opaque sealed envelopes. The early 
group received a cueing programme delivered in nine treatment sessions for 30 minutes 
over 3 weeks, immediately followed by 3 weeks in which no training was received. 
Subjects in the late group were put on a three-week waiting list, immediately followed 
by 3 weeks of cueing training. Both treatment arms underwent a follow-up period of 
6 weeks without training. Medical treatment continued unchanged throughout the 
study. Prior to the trial, Rescue therapists and testers underwent separate training 
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sessions lasting a full week to standardize procedures in all centres.
Intervention
Cueing training was delivered in the home by one therapist in each country. A prototype 
cueing device, specifically developed for the study, provided three rhythmical cueing 
modalities: (1) auditory (a beep delivered through an earpiece); (2) visual (light 
flashes delivered through a Light Emitting Diode attached to a pair of glasses); and 
(3) somatosensory (pulsed vibrations delivered by a miniature cylinder worn under 
a wristband). Patients tried all cueing modalities in the first week but trained with 
their preferred modality. Through addressing the temporal aspects of gait, cueing 
training aimed to improve step length and walking speed, prevent freezing episodes 
and improve balance.
Cued practice was applied during a variety of tasks and environmental situations 
and consisted of the following components: gait initiation and termination,10,11 heel 
strike and push-off, sideways and backwards stepping, walking while dual tasking19 
and walking over various surfaces and long distances.8 For freezers, cues were applied 
to facilitate continuation of gait during turns and manoeuvres in tight places and 
doorways. Based on previous experiments undertaken by the Rescue consortium19-
22 and the literature,5,6 evidence-based cueing guidelines were drawn up, specifying 
the cueing parameters and instructions for different profiles of patients (available on 
CD-Rom http://www.rescueproject.org/). Cues were generally delivered at patients’ 
preferred frequency (determined for an indoor and outdoor environment) and adjusted 
to increase step length and walking speed, depending on aims of therapy. In case 
patients had freezing, cueing frequency was started at preferred rhythm and adjusted to 
lower rhythms to avoid hastened stepping if needed.22 Chiefly, patients were instructed 
to match their heel strike with the cueing rhythm and keep on stepping through turns 
or during other manoeuvres. Specific instructions to maintain or enlarge step length 
or heel strike with every cue were added if and when required. Therapists recorded 
the content and amount of therapy in a diary in 15 minute units.
Outcome measures
As this study wanted to measure the training effects, and not the immediate effects 
of cueing, outcome measures were tested without the cueing device. Most outcomes 
described below were tested for reliability and validity in the home prior to the trial 
by three testers and during two consecutive visits. Part of this study, including the 
full methodology, was published elsewhere.23 As the Rescue trial included repeated 
measures carried out by the same tester, the intraclass correlation coefficients (ICC) 
for within raters of each outcome are described in the following sections: 
(1) The primary outcome measure was the PG score, a composite score 
of gait and balance UPDRS items (13−15 and 29−30), reflecting 
the main aims of cueing training (ICC=0.79).
(2) To explore the specific effects of cueing training secondary outcome 
measures consisted of:
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(a) Gait and balance measures: 10m walk test at the person’s preferred 
walking speed using a stopwatch to calculate gait speed (m/s) 
(ICC=0.81), step length (m) and step frequency (steps/min); 
Functional reach24 (Fr; ICC=0.74); timed single leg and tandem 
stance until subjects reached a maximum of 30 s; Freezing of Gait 
Questionnaire25 (FOGQ; ICC=0.84); and Timed Get Up and Go 
Test26 (TGUG; ICC=0.88). Timed walking and Get Up and Go tests 
were standardized for each patient’s home. 
(b) Activity measures: Nottingham Extended Activities of Daily Living 
Index27 (NEADL; ICC=0.93) and Falls Efficacy Scale28 (FES; 
ICC=0.88). 
(c) Participation measures: Parkinson’s Disease Questionnaire-3929 
(PDQ-39; ICC=0.79) and Carer Strain Index30 (CSI; ICC=0.85).
A falls diary was left in the patient’s home during the trial period to indicate the 
number of falls as a measure of possible adverse cueing effects. A dichotomized score 
was derived (falls=1 or no falls=0) at crossover and at the end of therapy from the 
recorded number of falls during the previous three-week periods and at follow-up for 
the previous 6 weeks. At test1, the dichotomized score was calculated from the number 
of falls during the previous 3 months. 
Descriptive measures included the Mini Mental State Exam (MMSE),13 the Brixton Test31 
for executive function and the Hospital Anxiety and Depression Scale (HADS).32 
Assessment Protocol
All outcome measures were assessed immediately prior to randomization (test1) 
and at 3 (test2), 6 (test3), and 12 weeks (test4). One trained tester in each centre, not 
involved in training and blind to group allocation, performed all assessments in the 
patient’s home. Each patient was assessed at the same time of day in the on-phase, 
approximately 1 hour after medication intake, in order to control for variations due 
to the medication cycle. The order of tests was randomized for each patient. Testers 
verified that patients had taken their medication and the efficacy of medication was 
checked at each assessment.
Statistical analysis
Power analysis prior to the trial indicated that 150 patients were required for a 10% 
change relative to baseline values on the PG score (0.6 points) with a power of 80% 
and a critical value of 5% for statistical significance, allowing a drop-out of 10%. 
The success of blinding and randomization procedures was explored by comparing 
early and late groups using Wilcoxon-Mann-Whitney U tests, Chi-square tests and 
unpaired t tests. 
Exploratory analysis revealed carry-over effects of treatment in the control period 
(test3-test2) in the early group. Hence, intervention effects were estimated using the 
first three assessments (test1,2,3) with multiple linear regression models accounting for 
repeated measures. Where appropriate a linear, logistic or Cox regression model was 
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fitted for each outcome with PROC MIXED and PROC GENMOD in SAS (version 
8.2). In each model the same predictors were adopted, including indicators to represent 
time, intervention and carry-over. A logistic regression model with generalized 
estimating equations (GEE) evaluated the effect of intervention on the risk of falling. 
A Cox regression model with frailty term verified the impact of intervention on the 
hazard of failing the timed balance tests (inability to remain standing for a maximum 
30 s), using the coxph function in Splus 2000. To explore whether cueing had an effect 
on movements which were not targeted by training, upper limb repetitive movement 
scores (UPDRS items 23−25) were analyzed. 
Change at follow-up was assessed by comparing the change between test3 and test4 using 
a model with two factors (time and group) fitted onto outcomes of test1,2,3,4 for early and 
late groups taken together. For continuous outcomes a trivariate normal distribution 
for error components was assumed. Data were transformed where necessary to meet 
normality assumptions and baseline values were reported as medians and interquartile 
ranges. 
Two-tailed analysis was performed on all tests with a significance level of 5%. Given the 
exploratory nature of the secondary outcomes analysis, no Bonferroni correction was 
applied. Intervention effects are reported as β estimates and standard errors (SE) for 
the linear regression models. Odds and hazard ratios (=exp(β)) with 95% confidence 
intervals are presented for the logistic and Cox regression models. 
The statistical models adopted in this study assumed that missing values occur 
randomly, using the remaining information even if occasional missing values are 
present. Missing values occurred in 1.7% of all outcomes over the four time points 
and 1.3% over the three time points. As all patients received treatment 
Results
Trial profile
The trial flow chart (Figure 1) shows that out of 289 potential candidates, 153 patients 
(53%) were eligible for inclusion into the study. Patients were mostly excluded because of 
gait being insufficiently impaired (n=44), co-morbidity (n=25), deep brain stimulation 
(n=15) and an inability to commit time (n=15). Suitable patients were randomly 
allocated to the early (n=76) or late intervention group (n=77). One patient dropped 
out 3 weeks after randomization due to a necessary alteration of medication. In total 605 
(99%) of the planned 612 measurements were performed. Medication intake remained 
stable throughout the trial. Comparison between the observers’ guess of allocation 
(early or late) and the actual patient assignment indicated that the blinding procedure 
was successful as 56.1% (n=87) was allocated correctly and 43.1% (n=66) incorrectly 
(Chi-square=2.94, p=0.09). 
Comparison of early and late intervention
Patients received equal amounts of therapy in the early (271.8 minutes) and late groups 
(270.4 minutes) (t=0.27; p=0.79). 
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Figure 1  Trial flow chart.
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Due to medication change
Discontinued intervention (n=0)
Allocated to early intervention    
(n=76)
Received allocated intervention  
(n=76)
Did not receive allocated intervention 
(n=0)
Allocated to late intervention      
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M/F, male and female; H&Y (on), Hoehn &Yahr stages during on; H&Y II/III/IV, Hoehn &Yahr stages II, II, IV during 
on; UPDRS, Unified Parkinson’s Disease Rating Scale part I, II, III, IV and total score; MMSE, Mini Mental State 
Examination; HADS, Hospital Anxiety and Depression Scale; Q1−Q3, Interquartile Range. a Expressed as number 
of patients and p value based on Chi-square test.
Early n=76
Median (Q1−Q3)
Late n=77
Median (Q1−Q3)
p value
Demography
M/Fa 48/28 40/37 0.16
Age 67.5 (61.5−72) 69 (62.5−73) 0.7
PD characteristics
Disease duration 7 (4−11) 8 (4−12) 0.59
H&Y (on) 2.5 (2.5−3) 3 (2.5−3) 0.56
H&Y II/III/IVa 39/29/8 32/35/10 0.48
Freezers/Non-freezersa 31/45 32/45 0.92
Clinical data
UPDRS total (on) 54 (46−65.5) 56 (49−63) 0.62
UPDRS I (on) 4 (2−5) 3 (2−4) 0.1
UPDRS II (on) 16 (12−19.5) 16 (12−20) 0.67
UPDRS III (on) 31 (25−37) 34 (28−41) 0.32
UPDRS IV (on) 3 (1−5) 2 (1−5) 0.43
Levodopa (mg) 500 (300−700) 350 (200−550) 0.07
MMSE 28.5 (27−30) 29 (27−30) 0.99
Brixton 4 (2−6) 4.0 (2−6) 0.45
HADS anxiety 6.5 (4−10) 6 (4−10) 0.97
HADS depression 7.5 (5−10) 6 (4.5−9) 0.45
Table 1  Comparison between early and late allocation groups
There were no important differences between the clinical profiles of the two intervention 
groups (see Table 1). Most patients had mild to moderate disease severity as 46.4% of 
patients (n=71) were in Hoehn & Yahr stage II, 41.8% (n=64) in stage III and 11.8% 
(n=18) in stage IV. Both early and late groups included similar numbers of freezers 
defined as having at least weekly freezing episodes (n=31 [20.3%] in early and n=32 
[20.9%] in late), as defined by a score >1 on item 3 of the Freezing of Gait Questionnaire. 
Table 2 shows the median and interquartile ranges of all outcomes at tests 1−4. No 
significant group differences were found for primary and secondary outcomes at test1, 
confirming the success of the randomization procedure. Table 2 shows that 41% in the 
early and 39% in late group reported at least one episode of falling in the 3 months 
prior to trial onset. 
Treatment effects
Table 3 shows the estimated intervention effects corrected for time and carry-over. The 
primary outcome, the PG score, improved by 4.2% after intervention (p=0.005). As for 
the secondary outcomes, gait speed (p=0.005) and step length (p<0.0001) improved by 
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PG score, Posture and Gait score; FOGQ, Freezing of Gait Questionnaire; FES, Falls Efficacy Scale; TGUG, Timed 
Get Up and Go test; NEADL, Nottingham Extended ADL Index; PDQ-39, Parkinson’s Disease Questionnaire; CSI, 
Carer Strain Index.
a Falling, time periods of falls diary at each test period differ (test1=3 months, test2=3 weeks, test3=3 weeks, 
test4=6 weeks). Figures represent numbers of patients who fell. One missing value was obtained at test1 in the 
early group and at test3 and test4 due to drop-out.
Table 2  Medians and interquartile ranges of the outcomes in early and late intervention 
groups at test1−test4
test1
Median (Q1−Q3)
test2
Median (Q1−Q3)
test3 
Median (Q1−Q3)
test4
Median (Q1−Q3)
Primary Outcome
PG score (0−20)
Early 6.0 (4.0−8.0) 4.0 (3.0−7.0) 4.0 (3.0−6.0) 4.0 (3.0−7.0)
Late 7.0 (5.0−8.5) 6.0 (4.0−8.0) 4.0 (3.0−6.0) 5.0 (3.0−7.0)
Secondary Outcomes
Walking speed (m/s)
Early 0.86 (0.73−0.98) 0.94 (0.80−1.1) 0.94 (0.80−1.1) 0.92 (0.81−1.1)
Late 0.83 (0.68−0.98) 0.83 (0.72−1) 0.93 (0.77−1.1) 0.94 (0.76−1.1)
Step length (m)
Early 0.51 (0.44−0.58) 0.55 (0.48−0.63) 0.56 (0.47−0.62) 0.54 (0.46−0.60)
Late 0.50 (0.43−0.56) 0.51 (0.43−0.58) 0.55 (0.47−0.62) 0.55 (0.48−0.60)
Step Freq (steps/min)
Early 101.6 (92.5−110) 102 (89.4−108.1) 102.2 (92.5−109.2) 102.2 (95.2−111)
Late 99 (91.6−109.6) 102.5 (94.3−112.6) 101 (94−108.6) 104.2 (97.2−112)
Functional reach (cm)
Early 25.9 (20.9−31) 26.3 (23−30.5) 27.5 (20.3−33) 26.9 (23−31.4)
Late 25.2 (20.2−30.5) 25.5 (19.8−30.7) 28.6 (21.6−34.3) 26.5 (19−31)
Single stance (s)
Early 9 (3.8−20.9) 11.2 (5.3−24.4) 12 (5.5−23.2) 11 (5.2−22.1)
Late 9.1 (3.9−21) 9.5 (3.6−19.3) 14.2 (6.3−24) 12.6 (4.2−21.8)
Tandem stance (s)
Early 22 (9.3−30) 26.7 (14.3−30) 22.0 (11.1−30) 23.1 (10.4−30)
Late 23.1 (8.0−30) 20.7 (8.6−30) 24.6 (11.1−30) 22.1 (10.2−30)
TGUG (s)
Early 13.2 (10.9−17.7) 12.3 (10.8−15) 11.8 (10.7−15.7) 12.2 (11.0−15.6)
Late 13.9 (12.0−17.9) 12.7 (11.1−15.7) 12.1 (10.6−15.1) 12.2 (10.7−15.5)
FOGQ (0−24)
Early 8 (4−14) 8 (3−12) 7 (3−11.5) 7 (3−12.5)
Late 8 (4.5−12) 9 (4−12) 8 (3−11) 8 (4−12)
NEADL (0−66)
Early 41 (32−53.8) 42 (33−51) 42.5 (36.3−53.5) 46 (35.8−53.3)
Late 40 (35−51) 42.5 (23.3−54) 46 (34−51) 43.5 (35−51)
FES (0−130)
Early 85 (65.3−107.8) 91 (71−111) 94 (66−110) 90 (65.5−111.5)
Late 78 (57−99.5) 82 (54−104) 85 (70−108.3) 81 (57.5−105.5)
PDQ-39 (total %)
Early 35.4 (22.7−42.6) 31.3 (22.2−40.9) 30.9 (20−42.3) 34.2 (21.8−40.8)
Late 37.8 (27.6−45.9) 37.2 (25.9−42.7) 32.3 (20.7−41.4) 35.6 (22.8−43.5)
CSI (0−13)
Early 4 (1−5.8) 3 (1−4) 3.0 (1−6) 1 (0−3)
Late 2 (1−5) 4 (1−5.5) 3.0 (0−5) 1.5 (0−3.3)
Falling (yes/no, % yes)a
Early 31/44 (41%) 18/58 (24%) 8/67 (11%) 16/59 (21%)
Late 30/47 (39%) 14/63 (18%) 10/67 (13%) 13/64 (17%)
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PG score, Posture and Gait score; FOGQ, Freezing of Gait Questionnaire; TGUG, Timed Get Up and Go test; 
NEADL, Nottingham Extended ADL Index; FES, Falls Efficacy Scale; PDQ-39, Parkinson’s Disease Questionnaire; 
CSI, Carer Strain Index.
a Change expressed in measured units, positive figures represent an improvement
b Change expressed in % of the scoring range, positive figures represent an improvement
c After transformation 
↑ estimate represents change in direction of improvement
↓ estimate represents change in direction of deterioration
Intervention 
ß estimate (SE)
Change
in unitsa
% rangeb
p value Follow-up
ß estimate (SE)
test4−test3 
p value
Primary outcomes 
PG score (0−20) −0.85 (0.3) 4.2 % 0.005 0.582 (0.14) <0.0001
Secondary outcomes
Gait & balance
Speed (m/s)
Step length (m)
Step frequency (steps/min)
Functional reach (cm)
Tandem stance (s)
Single leg stance (s)
TGUG (s)
FOGQ (0−24)
0.05 (0.02) ↑
0.04 (0.009) ↑
−2.1 (1.19) ↑
1.3 (0.97) ↑
−
−
−0.002 (0.73) ↑
−0.86 (0.44) ↑
5.0 cm/sa
4.0 cma
−2.1 step/mina
1.3 cma
−
−
2 ms
3.6%b
0.005
0.0001
0.08
0.18
−
−
0.6
0.25c 
−0.02 (0.007 ↓
−0.02 (0.004)↓
1.24 (0.56) ↓
−1.08 (0.46) ↓
−
−
0.14 (0.2) ↓
0.8 (0.21) ↓
0.03
<0.0001
0.03
0.02
−
−
0.47
0.0002
Activity
NEADL (0−66)
FES (0−130)
1.71 (0.94) ↑
4.77 (2.29) ↑
2.6%b
3.7%b
0.07
0.04
−0.65 (0.5) ↓
−2.92 (1.22)↓
0.2
0.02
Participation
PDQ-39 (total %)
CSI (0−13)
−1.36 (1.14) ↑
−0.76 (0.32) ↑ 
1.4%
5.8%b
0.23
0.14c
0.99 (0.52) ↓
0.15 (0.18) ↓
0.06
0.42
Table 3  Intervention effects and change at follow-up (difference test4−test3)
5 cm/s and 4 cm, respectively. No significant change in step frequency was observed 
(p=0.08). The Fr test did not show an intervention effect (p=0.18). However, the 
clustered tandem and one leg standing tests showed that the chance of failing these tests 
was decreased by 36% following intervention (hazard ratio=0.64; 95 CI%: 0.48−0.87; 
p=0.003). The TGUG did not show improvement after intervention. As for the severity 
of freezing, the FOGQ scores were not significantly affected by cueing therapy (p=0.25) 
after transformation. Data revealed a bimodal distribution indicating a group with 
low scores (non-freezers) and one with high scores (freezers). When the FOGQ scores 
were re-analysed on freezers only (n=63), defined as having at least a weekly freezing 
frequency, a significant reduction of 5.5% of freezing severity was found (ß estimate 
=−1.33±0.48, p=0.007). 
Intervention effects presented in Table 3 are smaller compared with the change in 
median values before and after intervention for the early and late groups in Table 2 as 
a result of the statistical control for time and carry-over effects. For example, the PG 
score improved from a median of 6 to 4 after treatment, suggesting a 10% rather than 
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a 4.2% change of the scoring range. Overall, carry-over effects were only statistically 
significant for step length in the early group at test3 (p=0.014). Time effects showed 
significant improvements for the PG score (p=0.03), gait speed (p=0.04) and the TGUG 
(p=0.004). 
For the secondary outcomes in the activity domain improvements were found on the 
FES (p=0.03), indicating that patients felt more confident during gait-related activities. 
ADL function as measured by the NEADL was not significantly altered (p=0.07). The 
PDQ-39 scores (p=0.23) and the CSI were not significantly changed after intervention 
(p=0.14). The GEE model showed no significant increase or decrease for the probability 
of falling as a result of treatment (odds ratio=1.4; 95 CI%: 0.63−3.1; p=0.4). Separate 
analysis of the upper limb repetitive movement scores of the UPDRS (III) showed no 
significant treatment effect (ß=−1.1±0.62; p=0.08). Most patients (n=95, 67%) chose 
auditory cueing as their preferred cueing modality, while 57 patients (n=58, 33%) 
favoured somatosensory cueing. 
Follow-up (test4−test3)
Table 3 also shows the change at follow-up. Most intervention effects in the gait and 
balance domains declined significantly from 6 to 12 weeks. Secondary outcomes at 
activity and participation levels also tended to decline at test4, a pattern which was 
significant for the FES. The chance of failing the balance tests at test4 was increased as 
compared with test3 (HR=1.12; 95 CI%: 0.96−1.32) but this difference was not significant 
(p=0.15). Table 2 shows that more patients reported a fall at test4 compared with test3, 
but this may reflect the fact that at test4 a period of 6 weeks was assessed as opposed 
to 3 weeks at test3.
Discussion 
This is the first large scale randomized clinical trial investigating the effects of a cueing 
training programme delivered at home using a multi-modality cueing device. The 
main findings indicate that nine sessions of cueing training demonstrated a significant 
improvement in gait and gait-related mobility in people with PD, but that these effects 
were small and specific. The cueing method was widely accepted and well-tolerated 
in a wide range of patients ranging from Hoehn & Yahr stages II−IV, as evidenced by 
only one drop-out. 
The present findings showed that a period of training with cues in the homes of people 
with PD resulted in improvement of gait immediately after intervention. We found a 
significant increase in walking speed and step amplitude accompanied by a tendency 
to reduce step frequency. This finding is in agreement with earlier work, showing 
that the potential to generate a more normal gait pattern can be tapped in PD.7 When 
looking at freezers separately, a significant change on the FOGQ after intervention 
was found, signifying a reduction of freezing severity. This is an important finding, as 
freezing is particularly resistant to drug treatment and often associated with falling.33 
This result contradicts earlier work, in which freezers were provided with a metronome 
for one week at home without clear benefits.34 In contrast, during the Rescue trial 
cueing therapy was provided by therapists, who used specific guidelines to set the 
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cueing frequency to the needs of freezers and instructed patients on how to prevent 
and overcome freezing in their daily environment for a three-week period.22
Increased rates of falls in people with PD are well documented and have been attributed 
to preserved mobility in this population.2,35 We were, therefore, concerned that any 
improvements in mobility due to therapeutic cueing could have resulted in an increased 
risk of falls. Our results, however, showed no evidence for this but rather an improved 
balance and increased confidence not to fall. Given the limited power to detect changes 
in fall rates using a fall diary methodology over a short time span, the present results 
need cautious interpretation.
Subjects were trained for three weeks with cues and were evaluated without wearing the 
device to see if the effects were maintained. The present results showed training effects 
in the absence of cues, indicating that some degree of motor learning is preserved in 
PD. Whereas most studies investigated the immediate benefits of cued performance, 
our findings confirm the limited evidence available of improved uncued performance 
after training with cues.6,8,12
The effects found in this study can be considered robust and not attributable to 
measurement error or learning effects. All but three outcome measures had established 
test retest reliability in the home situation23 and the order of testing was randomized. 
In order to estimate the effects of intervention separately from carry-over and time 
effects, the statistical analysis controlled for these factors, providing a conservative 
estimation of treatment effects. 
The fact that intervention effects were small could reflect a limitation of cueing 
training in the home setting. However, current effects sizes are in line with those 
observed in recent meta-analyses on physical therapy in PD3,4 and in other conditions 
such as stroke.36,37 The limited effects may also be explained by the relatively short 
training duration. Training intensity rather than content was found to be a key factor 
in stroke research and may be equally crucial in PD.37 In this study training intensity 
was stipulated by the maximum number of physical therapy sessions at home allowed 
for reimbursement according to existing health care policies. This raises the question 
of what the optimal duration and intensity of cueing training is and how this should 
be delivered over time.
What actually constitutes clinically relevant results in rehabilitation of a chronic 
degenerative disorder is still unclear at this point. Possibly the improvements of gait and 
balance were too small to carry-over to ADL and perceived quality of life. Alternatively, 
the narrow focus of the intervention may have led to specific effects, as we showed 
that repetitive upper limb movements were not affected by cueing therapy. Equally, in 
other fields of rehabilitation lack of generalization is a common feature.36,37 
Training effects were not sustained at 6 week follow-up as a significant reduction 
in most outcomes was apparent. Similarly, Nieuwboer et al.38 showed a significant 
deterioration at 12 weeks after training with cues, and Thaut et al.39 found a declining 
slope from 4 to 6 week follow-up. Other authors reported negligible reductions at 4 
to 6 weeks after cueing training.12,40 
The impact of placebo effects as a result of increased attention during therapy was not 
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 controlled for, which is a limitation of this study. Although the specificity of the results 
argues against a general effect of increased attention, effects of gait-related attention 
rather than cueing cannot be ruled out. Previously, it was shown that gait training with 
auditory cues was more effective than training without cues and no training.8
Lack of Bonferroni correction and the fact that at test3 and test4 testers were aware 
of patients having received therapy, inherent to a repeated measures design, warrant 
careful interpretation of the results. However, testers were not unblinded to treatment 
allocation at any time point. 
The findings of this study cannot be generalized to people with PD who have significant 
cognitive decline and other co-morbidities. Especially in the later disease stages, cues 
may overburden cognitive resources and increase fall risk.14 Future work should focus 
on determining such at-risk patients. Equally, the possibility that cues may actually 
reduce attentional cost in patients who are not at risk requires further investigation. 
Recently, we found that during cued performance of dual tasks, gait parameters 
improved rather than deteriorated.19 Future studies, assessing cueing effects over a 
longer period of time, will be able to determine whether habituation occurs to the 
stimulus of the cue and verify our findings on fall risk associated with cueing over 
longer periods. In addition, the cost-effectiveness of an extended therapeutic cueing 
programme possibly supplemented with a permanent cueing device needs further 
investigation. Although most patients preferred the auditory cueing modality (67%), 
a large number (33%) perceived somatosensory cueing as a well-tolerated and discrete 
alternative. At present, auditory cueing alone can be provided at relatively low cost 
using metronomes with earphones or via digital music players.
We conclude that cueing training in the home situation has a small and specific benefit 
for managing gait and freezing in patients with Parkinson’s disease. In addition, this 
study has highlighted important questions on how to deliver cueing training in the 
most optimal way. 
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Abstract
Objectives: To investigate the effects of a home cueing training programme on func-
tional walking activity in patients with Parkinson’s disease (PD).
Design and procedures: In a single-blind, randomized crossover trial, PD patients allo-
cated to early intervention received cueing training for 3 weeks. Patients allocated to late 
intervention received training in the following 3 weeks. Training was applied at home, 
using a prototype cueing device.
Measurements: Activity monitoring (AM) was applied at baseline, 3, 6, and 12 weeks in 
the patient’s home, to record body movements.
Data analysis: Postures and motions were classified as percentage of total time spent on 
(1) static activity, further specified as % sitting and % standing, and (2) dynamic activity, 
further specified as % walking, % walking periods exceeding 5 sec (W>5s), and % walk-
ing periods exceeding 10 sec (W>10s).
Statistics: Random coefficient analysis was used for all variables.
Results: 153 patients participated in this trial. Significant improvements were found for 
dynamic activity (+4%, p<0.01), static activity (-3%, p<0.01), walking (+4%, p<0.01), 
W>5s (+3%, p<0.05) and W>10s (+3%, p<0.01). All intervention effects declined sig-
nificantly at 6 weeks follow-up.
Conclusion: Cueing training in PD patients’ own home significantly improves the 
amount of walking as recorded by AM. Treatment effects significantly reduced after the 
intervention period, pointing to the need for permanent cueing devices and follow-up 
cueing training.
Introduction
Parkinson’s disease (PD) is one of the most common neurological disorders in elderly 
people.1 Between the age of 55 and 85 years, 4.2% of all women and 6.1% of all men 
develop PD.2 The major motor symptoms in PD are tremor, rigidity, bradykinesia and 
postural instability, resulting in problems with gait, balance, transfers and posture.3 
These problems can lead to reduced mobility and less activity, which in turn can 
cause increased dependency and social isolation and thereby reduce quality of life.4 
It is therefore important to encourage patients to maintain their mobility and to stay 
active, for example by referring them to physical training programmes.5-7
In a randomized controlled trial (RCT) with the acronym Rescue (REhabilitation in 
Parkinson’s disease Strategies for CUEing), it was shown that a cueing programme 
improved Posture and Gait scores (PG), gait speed, step length and timed balance 
tests in patients with PD.8 In addition, secure mobility during functional activities was 
improved and freezers showed a reduction in the severity of freezing. These Rescue 
trial results are single, cross-sectional snapshots of the capacity of the PD patients 
and were obtained in the on-phase of medication. Results from such clinical testing 
are assumed to reflect patients’ ‘real-world’ activities related to gait. However, test 
performance achieved in optimally medicated situations, often when patients are not 
fatigued, combined with patients’ desire to perform optimally, may overestimate their 
actual performance. 
Contrastingly, ambulatory activity monitoring (AM) provides an objective way 
to determine type and amount of gait-related activities for several hours per day.9 
Therefore AM could provide more ‘real-world’ information about patients’ behaviour 
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during a day, irrespective of daily fluctuations in on- and off-phases. AM is a reliable 
and valid method for determining walking activity in PD patients.10,11 In a recent 
reliability study, high Intra Class Correlation coefficients (ICCs) ranging from .81 to 
.96 were found for monitoring walking in patients with PD.10 
The objective of the present study is to investigate the effect of cueing training on the 
amount of physical activity, specifically walking, in patients with PD, when monitored 
in their own home environment. It was hypothesized that overall dynamic activity, 
specifically walking activity, would increase following cueing training. A second aim 
of this study was to investigate the reliability of AM over a three-week interval. 
Methods
For the Rescue trial 153 patients were recruited in three different countries: 48 patients 
were recruited at Northumbria University, Newcastle upon Tyne (UK), 51 patients 
were recruited at the Katholieke Universiteit Leuven (Belgium), and 54 patients were 
recruited at the VU University Medical Center, Amsterdam (The Netherlands). Main 
eligibility criteria were (1) idiopathic PD; (2) Hoehn and Yahr12 stage II−IV; (3) showing 
mild to severe gait disturbances; (4) stable medication usage; (5) age 18−80 years; and 
(6) absence of cognitive impairment and disorders interfering with participation in 
cueing therapy. A more detailed description of all eligibility criteria can be found in 
Nieuwboer et al.8 All patients gave a written informed consent. The study was approved 
by all medical ethics committees of participating centres.
Design and procedures
The Rescue trial was a single blind, randomized clinical trial with crossover design. 
Patients were randomly allocated using permuted blocks of six to an early or late 
intervention group by an independent person, otherwise not involved in the study. 
Allocation was concealed, using opaque sealed envelopes. The early intervention group 
received cueing training for a period of 3 weeks immediately after randomization. The 
training programme consisted of nine sessions of 30 minutes over 3 weeks and was 
immediately followed by a control period of 3 weeks. The late intervention group was 
put on a waiting list for the first 3 weeks and subsequently received the same cueing 
programme in the second 3 weeks. The early intervention group had a follow-up period 
of 9 weeks, the late training group of 6 weeks. Medication treatment stayed stable 
throughout the study. Prior to the trial all Rescue therapists and assessors participated 
in joint training sessions to standardize their treatment and assessment procedures. 
Each country had one therapist and one assessor.
Intervention 
Each participant received cueing training in the home situation with the help of 
a prototype cueing device. This cueing device was specifically developed for this 
project and provided three rhythmical cueing modalities: (1) an auditory modality 
(a beep); (2) a visual modality (a flashing light at the side of the spectacles); and (3) a 
somatosensory modality (a miniature vibrating cylinder on the wrist).8 Patients tried 
out every modality during the first week and practised with their preferred cueing 
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modality in the second 2 weeks. In addition to the cueing device, parallel lines on the 
floor or pavement were used in the training as visual cues. Cueing training was aimed 
at improving gait and gait-related activities (such as step length, walking speed and 
management of freezing).
Based on previous experiments undertaken by the Rescue consortium13-16 and 
the literature,17,18 evidence based guidelines were drawn up, specifying the cueing 
parameters and instructions for different profiles of patients (available on CD-ROM, 
http://www.rescueproject.org). Patients were instructed to use the cues and encouraged 
to practise without the assistance of the therapist outside the regular training time.
Outcome measures
In addition to recording time, the following outcomes were analyzed: 
(1) The percentage time spent on static activity (% static activity). Static activity was 
defined as all activities without movements. In the present study statistic activity 
reflected the actual amount of standing, sitting and lying. 
(1a) Percentage time spent on standing alone (% standing), and
(1b) Percentage time spent on sitting alone (% sitting); 
(2) The percentage time spent on dynamic activity (% dynamic activity). Dynamic 
activity was defined as all activities where movements were involved. In the present 
study dynamic activity reflected the actual time spent on walking, transfers, 
turning, stair walking and cycling. 
(3) Percentage time spent on walking alone (% walking), further specified as: 
(3a) Average number of walking periods registered per hour exceeding 5 seconds 
(Walk>5s), and
(3b) Average number of walking periods registered per hour exceeding 10 seconds 
(Walk>10s).
Assessment Protocol
All patients were tested by an assessor in their home environment prior to randomization 
(t1) and at 3 (t2), 6 (t3) and 12 weeks (t4). The assessor was blind to group allocation. 
Each patient was visited at approximately the same time of the day in the on-phase, 
about 1 hour after medication intake, in order to control for variations due to the 
medication cycle. A test battery was used to assess gait and gait-related activities of 
the patient (for results, see Nieuwboer et al.).8 In addition, an AM (Vitaport3, TEMEC 
instruments b.v., Kerkrade, The Netherlands) was applied by the assessor to record the 
body movements of the subject during the day. On average 5 hours later the assessor 
visited the patient again to remove the AM. In order to measure the effects of practice 
with cueing and not the immediate effects during cueing, the cueing device was not 
used during monitoring. Moreover, training was not received on testing days.
The activity monitor consisted of a montage of five accelerometers connected to a 
portable data recorder worn on a belt around the waist. The accelerometers were 
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attached to the body as follows: one on each leg positioned on the lateral aspect of the 
thigh midway between the greater trochanter of the femur and the midpoint of the 
patella, orientated in the sagittal plane; three accelerometers were placed on the lower 
third of the sternum, with the sensors on a specially designed block positioned so 
that they were orientated in the sagittal, longitudinal and transverse planes. The skin 
was prepared by cleaning the area with an alcohol swab and shaving when necessary. 
The accelerometers were mounted on a piece of thin foam and attached to the skin 
using Hypafix tape (HypafixR, BSN Medical). Each accelerometer was connected to 
a portable battery powered activity monitor (Vitaport 3, TEMEC Instruments Inc) by 
cables that ran under the clothes. 
Data were sampled at a frequency of 256 Hz and stored at 32 Hz on a removable flash 
memory card for offline analysis. The accelerometers recorded gravitational force and 
accelerations of the moving lower limbs and trunk. The data were analyzed using a 
specifically designed software program (Vitagraph) (TEMEC Instruments Inc) which 
classified activity into static activity (i.e. sitting and standing) and dynamic activity 
(amount of walking and walking periods exceeding 5 seconds and 10 seconds). The 
patient was kept naïve about the function of the activity monitor and was instructed 
to maintain the usual daily activities.
Analysis
AM data was initially processed using Vitagraph (TEMEC Instruments Inc). Data 
were analyzed using SPSS (SPSS-Inc, Chicago, IL, USA). As data were not normally 
distributed, non-parametric tests were used for data comparison between the early 
and the late intervention group (Mann-Whitney U test). Demographic details, PD 
characteristics and clinical measures were compared using independent two-tailed t 
tests. The level of significance was set at p=0.05.
Data from t1 and t2 of the late intervention group was used to investigate the reliability 
of AM. ICCs, using a two-way mixed model with an absolute agreement definition, 
were employed to calculate reliability of % static and % dynamic activity.19 According 
to the recommendations of Fleiss,20 ICC values under .40 represent poor reliability, 
values between .40 and .75 moderate to good reliability and ICCs above .70 represent 
excellent reliability. Agreement was further analyzed using the Bland and Altman 
method;21 the ‘limits of agreement’, defined as ±1.96  standard deviation of the 
difference scores, were computed.
Intervention effects were estimated using the first three assessments (t1, t2, t3). Random 
coefficient analysis was used assuming a normal distribution for evaluating the effects 
of intervention on % static activity, % dynamic activity, % standing, % sitting, % 
walking, W>5s, and W>10s (MLWinN version 2.02).22 When the outcome variable 
failed to show a normal distribution on visual inspection, a logarithmic or square 
root transformation was applied. In this multilevel model effects of intervention were 
corrected for differences of the outcome variable at baseline, time effects and carry-
over effects. In addition, possible interaction effects between intervention and time 
were investigated for significance.22 Change at follow-up was assessed by comparing 
the change between t3 and t4 using a model with two factors (time and group) fitted 
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onto outcomes of t1, t2, t3, t4 for distribution, for early and late intervention groups 
together. Two-tailed analysis was performed on all tests with a significance level of 
5%. Intervention effects are reported as β estimates. 
Results
Out of 289 potential candidates, 153 patients participated in the present study. A trial 
flow chart is presented in Nieuwboer et al.8 Participants were randomly allocated to 
the early intervention group (n=76) or late intervention group (n=77). Both groups 
showed comparable baseline characteristics (see Table 1) confirming the success of 
the randomization procedure. 
As all patients received training, with only one drop-out occurring 3 weeks after 
randomization because of a necessary change of medication, an ‘intention-to-treat’ 
analysis was not necessary. Patients did not report any falls or other problems while 
wearing the activity monitors. In total 556 of all 612 AM data, representing collected 
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Table 1  Comparison between early and late intervention groups for demography, 
characteristics of Parkinson’s disease, clinical data and data derived from activity monitoring 
at baseline
AM, activity monitoring; N, number; Q1−Q3, interquartile range; PD, Parkinson’s disease; M/F, male and female; 
H&Y (on), Hoehn and Yahr during on; UPDRS, Unified Parkinson’s Disease Rating Scale; Y/N, yes/no. aExpressed 
as number of patients and p values based on Mann-Whitney U tests.
Early intervention 
group (n=76)
Median (Q1−Q3)
Late intervention 
group (n=77)
Median (Q1−Q3)
p value
Demography
Gender (M/F)a 48/28 40/37 0.16
Age (years) 67.5 (61.5−72) 69 (62.5−73) 0.70
PD Characteristics
Disease duration (years) 7 (4−11) 8 (4−12) 0.59
H&Y (on) 2.5 (2.5−3) 3 (2.5−3) 0.56
Freezers/non-freezersa 31/45 32/45 0.92
Clinical data
UPDRS total 54 (46−65.5) 56 (49−63) 0.62
UPDRS motor scale 31 (25−37) 34 (28−41) 0.32
Levodopa (mg) 500 (300−700) 350 (200−550) 0.07
Data derived from AM
Registration time (hours) 4.9 (3.5−5.8) 4.56 (3.7−5.5) 0.17
% time spent on dynamic activity 9.4 (5.2−16.7) 10.6 (4.8−16.3) 0.74
% time spent on static activity 90.6 (81.8−94.8) 89.1 (83.7−95.2) 0.55
% time spent on sitting 50.3 (38.6−65.6) 49.2 (35.5−63.6) 0.49
% time spent on standing 25.0 (15.5−36.0) 25.8 (16.0−32.6) 0.69
% time spent on walking 7.3 (4.0−10.9) 7.9 (4.2−13.6) 0.55
N walking period > 5 sec per hour 13.7 (7.9−21.5) 13.5 (8.6−18.9) 0.65
N walking periods > 10 sec per hour 8.6 (4.4−13.0) 8.0 (5.2−12.0) 0.93
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data of actual intended four repeated measurements within 153 included patients, 
were available for random coefficient modeling. 
All AM data showed a normal distribution upon visual inspection. Monitoring proved 
to be reliable over a three-week interval as can be seen in Table 2. Figure 1 shows the 
Bland and Altman plots for the different outcome measurements with the upper and 
lower dashed lines for 95% limits of agreement and the bold line representing the mean 
difference score between two assessments. The visual plots showed sufficient agreement 
between two consecutive measurements for the different outcomes of AM.
Table 3 shows the median and interquartile ranges of all outcomes at test 1−4. Average 
recording time was 4.6 hours (median 4.8 hours) and did not differ between testing 
days (p>0.9). The mean amount of therapy received in the early intervention group 
(271.8 minutes) was not significantly different from the late intervention group (270.4 
minutes) (t=0.27; p=0.79). In addition, no significant differences were observed in the 
type of cueing modality (t=0.24; p=0.86) or the aims of the cueing intervention (t=0.29; 
p=0.91). Most patients (n=95, 67%) chose auditory cueing as their preferred cueing 
modality, while 57 patients (n=58, 33%) favoured somatosensory cueing.
Treatment effects
Table 4 shows the estimated intervention effects corrected for time and carry-over; 
correction for interaction effects was not necessary. The % dynamic activity improved 
by 4.2% (p< 0.01); an equal decrement in % static activity was shown. No significant 
effect was shown for % sitting and % standing. The % walking increased by 4.5% 
(p<0.001). W>5s was 2.6 times higher per hour (p<0.01) after cueing training and on 
average W>10s was 2.9 higher per hour (p<0.001) after the intervention phase. 
Follow-up (t3−t4)
Table 4 also shows the change at follow-up. All intervention effects declined between 
6 to 12 weeks. The % dynamic activity was reduced by 4.2% (p<0.001) and the % static 
activity by 4.7% (p<0.001). The % sitting increased by 4.2% (p=0.02); the % standing 
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Table 2  Intraclass correlation coefficients, two-mixed model with absolute agreement 
definition
ICC, Intra Class Correlation coefficients; CI, Confidence Interval.
Variable ICC (95% CI)
Registration time .68 (.53−.78)
Dynamic activity .81 (.71−.87)
Static activity .76 (.65−84)
Sitting .59 (.42−.72)
Standing .50 (.31−65)
Walking .72 (.58−.81)
Walking periods exceeding 5 seconds .68 (.53−.78)
Walking periods exceeding 10 seconds .73 (.60−.82)
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did not change significantly. The % walking decreased by 3.6% (p<0.001), while W>5s 
decreased by 3.3% (p<0.001) and W>10s by 2.7% (p<0.001).
Discussion
The present study was aimed at investigating the effects of cueing training on the 
amount of physical activity in patients with PD, when monitored in their own home 
environment. In line with a previous study,10 AM proved to be a reliable method for 
monitoring gait performance with fair to good reliability (ICC=.50−.72) for registration 
time, static activities, sitting, standing, and excellent reliability (ICC=.76−.81) for 
dynamic activities, W>5s and W>10s. In addition, Bland Altman plots20 showed good 
to excellent agreement between two consecutive AM measurements with respect to 
the different static and dynamic activities of AM. 
The present study showed that cueing therapy has a significant positive effect on 
dynamic activity, especially on % walking. The amount of walking in the training group 
Chapter 6 
Figure 1  Agreement of eight outcome measurements following Bland Altman plots.
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Table 3  Medians and interquartile ranges of the outcomes in the early and late intervention 
groups at t1−t4
Q1−Q3, interquartile range; N, number; s, seconds; h, hour. aof total registration time.
SE, standard error; s, seconds; N, number. aof total registration time. bp<0.01. cp<0.05.
t1
Median 
(Q1−Q3)
t2
Median 
(Q1−Q3)
t3
Median 
(Q1−Q3)
t4
Median 
(Q1−Q3)
Registration time (hours)
Early 4.9 (3.5−5.8) 4.6 (3.6−5.6) 4.8 (3.6−5.5) 4.5 (3.4−5.7)
Late 4.6 (3.7−5.5) 4.7 (3.7−5.8) 4.8 (3.6−5.5) 4.9 (3.5−5.5)
% time spent on dynamic 
activitya
Early 9.4 (5.2−16.7) 13.7 (7.3−22.7) 11.7 (6.4−21.3) 9.6 (5.5−15.4)
Late 10.6 (4.8−16.3) 9.6 (5.8−18.9) 15.1 (7.4−22.8) 11.3 (6.6−20.5)
% time spent on static 
activitya
Early 90.6 (81.8−94.8) 86.3 (76.9−92.7) 88.3 (77.9−93.6) 90.3 (83.5−94.5)
Late 89.1 (83.7−95.2) 89.8 (80.6−94.2) 84.0 (73.9−92.4) 88.7 (79.4−93.4)
% time spent on sittinga
Early 50.3 (38.6−65.6) 40.8 (32.2−59.3) 46.8 (33.7−60.7) 49.6 (34.2−59.5)
Late 49.2(35.5−63.6) 48.7 (34.5−59.4) 45.9 (35.5−57.4) 48.8 (34.2−65.3)
% time spent on standinga 
Early 25.0 (15.5−36.0) 25.8 (19.1−37.8) 24.3 (17.6−35.7) 25.3 (16.0−38.7)
Late 25.8 (16.0−32.6) 28.7 (17.4−39.2) 23.5 (16.2−32.1) 25.6 (19.0−38.0)
% time spent on walkinga
Early 7.3 (4.0−10.9) 10.4 (6.0−18.7) 8.5 (4.8−13.0) 6.6 (4.1−11.7)
Late 7.9 (4.2−13.6) 7.6 (3.4−12.9) 11.8 (5.9−18.5) 7.9 (4.5−15.0)
N walking periods > 5 s per h
Early 13.7 (7.9−21.5) 15.1 (11.1−24.2) 15.3 (9.4−23.7) 14.1 (10.0−20.3)
Late 13.5 (8.6−18.9) 14.9 (8.3−20.3) 15.7 (9.6−26.1) 14.8 (10.1−22.6)
N walking periods > 10 s per h 
Early 8.6 (4.3−13.0) 9.6 (5.9−14.5) 8.8 (5.5−14.7) 7.8 (5.4−12.0)
Late 8.0 (5.2−12.0) 8. 5 (4.2−12.2) 9.8 (6.2−17.1) 8.1 (5.6−14.9)
Table 4  Intervention effects (t1−t2) and change at follow-up (difference t3−t4)
Intervention 
β estimate (SE)
Change in minutes Follow-up β estimate 
(SE) 
% time spent on dynamic activitya 4.23b 11.9 −4.17b
% time spent on static activitya −3.34b 9.4 4.69b
% time spent on sittinga −3.48 9.8 4.20c
% time spent on standinga −1.41 4.0 −0.98
% time spent on walkinga 4.46b 12.6 −3.57b
N walking periods > 5 s per hour 2.63 c 2.6 numbers −3.32b
N walking periods > 10 s per hour 2.90b 2.9 numbers −2.68b
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improved by 4.5% when compared to patients allocated to the control group. When 
extrapolating the increased walking performance to a whole day of 12 waking hours, 
the present finding suggests an increased amount of walking activity of 32 minutes per 
day. This amount meets the criteria of 30 minutes of recommended physical activity 
per day by the Center of Disease Control and Prevention/American College of Sports 
Medicine.23 
The present findings are in line with the results from clinical assessments in the 
Rescue trial.8 Briefly, clinical assessments showed a 4.2% increase on the posture and 
gait score, a 5.0 cm/s increase in walking speed, a 4.0 cm increase in step length, and 
a 5.5 % reduction in severity of freezing symptoms according to the Freezing of Gait 
Questionnaire when analyzed in freezers only.8 The agreement in effects between AM 
and clinical gait assessments suggests that improvements in clinically used outcomes 
such as posture and gait score, step length and gait speed reflect a general enhancement 
in patients’ actual walking performance. A major advantage of AM is that patients do 
not have to undergo a fatiguing test battery and more detailed information about the 
actual activity profile is achieved.24
The improvement in dynamic activity was diminished at follow-up, assessed at 9 weeks 
after the end of cueing training for the early intervention group and 6 weeks for the 
late intervention group. This suggests that the effect of cueing training wears off and 
that continuous training with use of a permanent cueing device may be indicated for 
people with PD. The optimal dose-response relationship needs to be investigated in 
future studies. The impact of placebo effects as a result of increased attention during 
therapy was not controlled for, which is a limitation of this study.
AM may cause so-called ‘reactivity effects’: subjects may, consciously or subconsciously, 
limit their movements due to the presence of the recorder, its weight and the wiring, 
or because they are afraid to break or damage the monitoring equipment. On the 
other hand, subjects may be more active in order to ‘make the measurement better’ 
and meet the expectations of the research goal. Therefore it is important to prevent 
AM-induced behavioural adaptations by keeping the participants naïve about the 
purpose of the AM device, and giving appropriate instructions about maintaining 
usual daily routines.
A limitation of the AM device used in the present study is that the accelerometers do 
not produce valid information about spatial parameters of gait such as step length, 
walking distance and with that speed. In particular, it is difficult to quantify parameters 
such as step length in patients with PD where the variability in step-to-step length is 
large.25,26 Lack of insight into patients’ on-off status is another limitation in this study. 
It is, for example, not known whether patients walked more during their off periods 
after receiving cueing training. This may be addressed by asking patients to record 
their on-off status in a diary whilst undertaking AM to provide complementary data. 
Future studies should focus on gait parameters including walking speed, step length and 
interlimb coordination of parkinsonian gait during ‘on’ and ‘off ’ periods. In addition, 
efforts should be made to develop smaller and cheaper AM devices that are wireless-
enabled and better able to monitor continuously for more than 48 hours.
The application of AM in patients with neurological disorders such as PD to evaluate 
Chapter 6 
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the effects of a rehabilitation programme is new in the field of neurology. However, 
it should be noted that AM can also be used for evaluating other interventions such 
as medication27 and deep brain stimulation on motor performance. Moreover, AM 
proved to be a harmless, non-invasive way of collecting ‘real world’ information about 
postures and activity undertaken in patients’ own environment for extended periods 
of time. 
Data from the current study further support the positive effects of cueing in PD as 
found in earlier studies,8,18 however, the neurological mechanisms underpinning 
these effects are still unclear. Studies suggest that cueing may stimulate alternative 
cortical pathways (e.g. visual motor pathways)28 to bypass the basal ganglia, whereas 
other studies suggest that cueing synchronizes the simultaneous timing of interlimb 
coordination in the cerebellum needed for normal gait.29,30 Further studies are needed 
to investigate the neurophysiological mechanisms underpinning the effectiveness of 
rhythmic cueing in patients with PD.
Acknowledgements
This research project was supported by a grant from the European Commission (QLK6-
CT-2001-00120; Rehabilitation in Parkinson’s Disease: Strategies for Cueing).
References
(1) Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are 
the “common” neurologic disorders? Neurology 2007; 68: 326-337.
(2) De Lau LM, Giesbergen PC, De Rijk MC, Hofman A, Koudstaal PJ, Breteler MMB. Incidence of 
parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004; 63: 
1240-1244.
(3) Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Archives of Neurology 1999; 
56: 33-39.
(4) Herman T, Giladi N, Gruendlinger L, Hausdorff JM. Six weeks of intensive treadmill training improves 
gait and quality of life in patients with Parkinson’s disease: a pilot study. Archives of Physical Medicine and 
Rehabilitation 2007; 88: 1154-1158.
(5) Stankovic I. The effect of physical therapy on balance of patients with Parkinson’s disease. International 
Journal of Rehabilitation Research 2004; 27: 53-57.
(6) Brichetto G, Pelosin E, Marchese R, Abbruzzese G. Evaluation of physical therapy in parkinsonian 
patients with freezing of gait: a pilot study. Clinical Rehabilitation 2006; 20: 31-35.
(7) Morris ME. Locomotor training in people with Parkinson disease. Physical Therapy 2006; 86: 1426-
1435.
(8) Nieuwboer A, Kwakkel G, Rochester L, Jones D, Van Wegen E, Willems AM, Chavret F, Hetherington 
V, Baker K, Lim I.Cueing training in the home improves gait-related mobility in Parkinson’s disease: the 
RESCUE trial. Journal of Neurology, Neurosurgery, and Psychiatry 2007; 78: 134-140.
(9) Salarian A, Russmann H, Vingerhoets FJ, Burkhard PR, Aminian K. Ambulatory monitoring of 
physical activities in patients with Parkinson’s disease. IEEE Transactions on Biomedical Engineering 
2007; 54: 2296-2299.
88
(10) White DK, Wagenaar RC, Del Olmo ME, Ellis TD. Test-retest reliability of 24 hours of activity 
monitoring in individuals with Parkinson’s disease in home and community. Neurorehabilitation and 
Neural Repair 2007; 21: 327-340.
(11) White DK, Wagenaar RC, Ellis TD. Monitoring activity in individuals with Parkinson disease: a 
validity study. Journal of Neurologic Physical Therapy 2006; 30: 12-21.
(12) Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-
442. 
(13) Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems A-M, Kwakkel G, Van Wegen E. The 
effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of 
people with Parkinson’s disease. Archives of Physical Medicine and Rehabilitation 2005; 86: 999-1006.
(14) Van Wegen E, De Goede C, Lim I, Rietberg M, Nieuwboer A, Willems A, Jones D, Rochester L, 
Hetherington V, Berendse H, Zijlmans J, Wolters E, Kwakkel G. The effect of rhythmic somatosensory 
cueing on gait in patients with Parkinson’s disease. Journal of the Neurological Sciences 2006; 248: 210-
214.
(15) Van Wegen E, Lim I, De Goede C, Nieuwboer A, Willems A, Jones D, Rochester L, Hetherington V, 
Berendse H, Zijlmans J. The effects of visual rhythms and optic flow on stride patterns of patients with 
Parkinson’s disease. Parkinsonism & Related Disorders 2006; 12: 21-27.
(16) Willems AM, Nieuwboer A, Chavret F, Desloovere K, Dom R, Rochester L, Jones D, Kwakkel G, 
Van Wegen E. The use of rhythmic auditory cues to influence gait in patients with Parkinson’s disease, 
the differential effect for freezers and non-freezers, an explorative study. Disability and Rehabilitation 
2006; 28: 721-728.
(17) Rubinstein TC, Giladi N, Hausdorff JM. The power of cueing to circumvent dopamine deficits: a 
review of physical therapy treatment of gait disturbances in Parkinson’s disease. Movement Disorders 
2002; 17: 1148-1160.
(18) Lim I, Van Wegen E, De Goede C, Deutekom M, Nieuwboer A, Willems A, Jones D, Rochester L, 
Kwakkel G. Effects of external rhythmical cueing on gait in patients with Parkinson’s disease: a systematic 
review. Clinical Rehabilitation 2005; 19: 695-713.
(19) Shrout PE, Fleisss JL. Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin 
1979; 86: 420-428.
(20) Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1986. 
(21) Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical 
measurements. Lancet 1986; 1: 307-310.
(22) Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Statistics in Medicine 
2002; 21: 3291-3315.
(23) Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath 
GW, King AC, Kriska A, Leon AS, Marcus BH, Morris J, Paffenbarger RS, Kevin P, Pollock ML, Rippe 
JM, Sallis J, Wilmore JH. Physical activity and public health. A recommendation from the Centers for 
Disease Control and Prevention and the American College of Sports Medicine. Journal of the American 
Medical Association 1995; 273: 402-407.
Cueing training to improve physical activityChapter 6 
89
 (24) Bussmann JB, Martens WL, Tulen JH, Schasfoort FC, Van den Berg-Emons HJG, Stam HJ. Measuring 
daily behavior using ambulatory accelerometry: The Activity Monitor. Behavior Research Methods, 
Instruments, & Computers 2001; 33: 349-356.
(25) Willems AM, Nieuwboer A, Chavret F, Desloovere K, Dom R, Rochester L, Kwakkel G, Van Wegen 
E, Jones D. Turning in Parkinson’s disease patients and controls: the effect of auditory cues. Movement 
Disorders 2007; 22: 1871-1878
(26) Almeida QJ, Frank JS, Roy EA, Patla AE, Jog MS. Dopaminergic modulation of timing control and 
variability in the gait of Parkinson’s disease. Movement Disorders 2007; 22: 1735-1742.
(27) Moore ST, MacDougall HG, Gracies JM, Ondo WG. Locomotor response to levodopa in fluctuating 
Parkinson’s disease. Experimental Brain Research 2008; 184: 469-478.
(28) Azulay JP, Mesure S, Amblard B, Blin O, Sangla I, Pouget J. Visual control of locomotion in Parkinson’s 
disease. Brain 1999; 122: 111-120.
(29) Cerasa A, Hagberg GE, Peppe A, Bianciardi M, Gioia MC, Costa A, Castriota_Scanderbeg A, 
Caltagirone C, Sabatini U. Functional changes in the activity of cerebellum and frontostriatal regions 
during externally and internally timed movement in Parkinson’s disease. Brain Research Bulletin 2006; 
71: 259-269.
(30) Chuma T, Faruque Reza M, Ikoma K, Mano Y. Motor learning of hands with auditory cue in patients 
with Parkinson’s disease. Journal of Neural Transmission 2006; 113: 175-185.
Cueing training to im
prove physical activity
Chapter 6 
90
 Cueing training to improve physical activityChapter 6 
Movement Disorders 
2008; 23: 2411-2415
7
Identifying fallers with Parkinson’s 
disease using home-based tests: 
Who is at risk?
I. Lim, E. van Wegen, D. Jones, L. Rochester, 
A. Nieuwboer, A. Willems, K. Baker, 
V. Hetherington, G. Kwakkel 
92
Chapter 7 Identifying fallers with PD using home-based tests
Abstract
Objectives: To determine risk factors for falling in patients with Parkinson’s disease (PD) 
using home-based assessments and to develop a prediction model.
Methods: Data on falls, balance, gait-related activities and non-motor symptoms were 
obtained from 153 PD patients (Hoehn-Yahr 2−4) in their home. Fifty-one candidate 
determinants for falling were independently tested using bivariate logistic regression 
analysis. A multivariate logistic regression model was developed to identify patients 
susceptible to falls.
Results: Sixty-six subjects (43%) were classified as fallers. Eighteen determinants for falling 
were selected. The final multivariate model showed an accuracy of 74% and included: 
(1) Freezing of Gait Questionnaire, (2) Timed Get Up and Go (TGUG) score, (3) disease 
duration, and (4) item 15 of the Unified Parkinson’s Disease Rating Scale.
Conclusion: Based on disease duration, freezing symptoms, walking problems and a 
prolonged TGUG duration, assessed in the home situation, it was possible to accurately 
identify 74% of PD patients as fallers. 
Introduction
According to the USA Centre of Disease Control and Prevention (CDC),1 more than 
one third of community-dwelling older adults experienced one or more falls every 
year, and approximately 460.000 of these patients were hospitalized. The incidence of 
falls in patients with Parkinson’s disease (PD) is disproportionably high, with several 
prospective cohort studies reporting an incidence between 50 and 70%.2-4 
In addition to the fact that falls in PD can lead to injury and even death,5 most 
patients may suffer from lack of activity and psychosocial consequences such as fear of 
falling, and indirectly from social isolation and depression.6 Falls also have economic 
implications for health services; a recent study showed that the direct medical costs of 
fallers with PD are on average about twice as much as for non-fallers with PD.7
In contrast with the burden of falling in PD, risk factors related to falls are largely 
unknown and the underlying mechanisms responsible for falling are not well 
understood. Although many studies have been aimed at identifying factors related 
to falls, only a few studies investigated the underlying prognostic factors for falling. 
To date prediction models have identified age,8 gender,9 disease duration,3,9 disease 
severity,2,10 dementia,3 autonomic dysfunction,8 incontinence for urine,9 symmetrical 
onset of the disease,3 variability of stride time,10 loss of arm swing,3 a slow score on 
the Timed Get and Go test (TGUG),9 a high score on the Romberg test,4 prior falls,2-4 
impaired ambulation,11 impaired lower limb motor planning11 and orthostatis as 
prognostic factors.2,3 
Factors found to be related with the incidence of falling should be easy to assess, 
preferably in the patient’s own home,12-14 by health care professionals who can play an 
important role in fall prevention for PD patients.
The first aim of the present study was to establish factors related with the risk of falling 
in PD patients from measurement instruments that can be used in patients’ homes. 
Subsequently, a multivariate logistic regression model was derived to identify those 
patients who are fallers.
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Subjects and methods
Design
The data presented in the current study were obtained from baseline measurements 
of a multi-centre, single-blinded randomized clinical trial (RCT) with crossover 
design.13 In this RCT, known as “Rescue”, PD patients received cueing training in their 
home situation. All assessments to evaluate the predictive validity of this study were 
performed in the patient’s own home (for complete description of variables see reference 
13). During testing patients were in the ‘on-phase’, when medication is optimal.
Study population
Data from 153 patients with idiopathic PD were used. Patients were recruited in three 
international centres and the study was approved by the medical ethics committee 
of each participating centre. All patients gave informed written consent to the study. 
Eligibility criteria included age 18−80 years, mild to moderate PD symptoms, Hoehn 
and Yahr (H-Y)15 stage II−IV, mild to severe gait disturbances, sufficient cognitive 
functioning, and absence of co-morbidity that may influence mobility. A complete 
description of the eligibility criteria can be found in Nieuwboer et al.13
Chapter 7
Table 1  Scores on candidate determinants and bivariate analysis on subject characteristics 
(n=153)
Candidate determinant
Median 
(Q1−Q3) Bivariate analysis
B (β coefficient) SE
Odds ratio
(95% CI) p value
Age (years) 67 (7.5)a .42 .36 1.52 (.75−3.08) .25
Gender (male/female) −.11 .33 .90 (.47−1.72) .75
Weight (kg) 70.9 (13.2)a .14 .33 1.16 (.61−2.19) .44
Height (m) 1.7 (0.1)a .25 .33 1.29 (.68−2.44) .44
Leg length difference (cm) 0.4 (0.9)a .14 .37 1.15 (.56−2.35) .70
Disease duration (years) 8.3 (5.1)a .732 .33 2.08(1.08−3.99) .03
Hoehn and Yahr stage 3 (2.5−3) 1.22 .49 3.39 (1.29−8.92) .01
Dominant side of the disease (L/R) .32 .33 1.37 (.72−2.6) .34
Use of levodopa (yes/no) −.05 .51 .95(.35−2.57) .34
Use of other medication −.38 .36 .68 (.34−1.39) .29
No medication use .44 1.24 1.55 (.14−17.44) .72
N, number of patients; Q, interquartile range; SE, standard error of estimate; CI, confidence interval; kg, kilo-
grams; m, meter; cm, centimetre; L, left; R, right. amean (standard deviation).
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N, number of patients; Q, interquartile range; SE, standard error of estimate; CI, confidence interval; UPDRS, 
Unified Parkinson’s Disease Rating Scale; MFI, Multi Dimensional Fatigue Inventory; FOGQ, Freezing of Gait 
Questionnaire; m, meter; min, minute. amean (standard deviation).
Table 2  Scores on candidate determinants and bivariate analysis on bodily functions 
(n=153)
Candidate determinant Median 
(Q1−Q3)
Bivariate analysis
B 
(β coefficient) SE
Odds ratio
(95% CI) p value
Mini Mental State Examination 29 (27−30) −.84 1.17 .43 (.04−4.24) .47
Hospital Anxiety and Depression 
Scale−depression 7 (5−9.5) −.06 .38 .95 (.45−1.99) .88
UPDRS 3 depression 1 (0−1) .32 .33 1.37 (.72−2.62) .34
MFI
general 14 (11−17) −.038 .33 .96 (.508−1.827) .91
physical fatigue 14 (11−18) .12 .33 1.12 (.59−2.13) .73
reduced activity 14 (10−17) −.19 .33 .82 (.43−1.57) .56
reduced motivation 11 (8−14) .00 .33 1.01 (.53−1.91) .99
mental fatigue 11 (6−14) .60 .34 1.83 (.10−3.53) .07
Falls Efficacy Scale 82 (61−104.5) −1.04 .34 .36(.18−.69) .00
Brixton test (scaled score) 4 (2−6) .44 .38 1.55 (.80−3.01) .19
Modified Dyskinesia Scale 0 (0−0) .43 .41 1.53 (.68−3.45) .30
UPDRS
42 hypotension 0 (0−0) −.37 .54 .69 (.24−1.98) .49
32 dyskinesia duration 0 (0−1) .38 .34 1.46 (.75−2.84) .27
33 dyskinesia severity 0 (0−0) .35 .40 1.42 (.65−3.10) .38
34 dyskinesia pain 0 (0−0) .82 .60 2.26 (.70−7.27) .17
35 dyskinesia dystonia 0 (0−0) .40 .34 1.49 (.77−2.87) .24
14 freezing 1 (0−2) 1.20 .37 3.31 (1.60−6.84) .00
22 rigidity 6 (4−8) .35 .33 1.41 (.74−2.71) .30
31 bradykinesia 3 (2−4) .56 .33 1.76(.91−3.38) .09
29 gait 2 (1−2) 1.02 .35 2.78 (1.41−5.51) .00
FOGQ, items 3, 4, 5, 6 5 (0−8.5) 1.42 .35 4.16 (2.10−8.23) .00
6 meter walk test 
speed (m/s) 0.8 (0.3−1.3) a .44 .34 1.55 (.80−3.0) .20
cadence (steps/min) 100.3 (11.8) a .72 .34 2.05(1.06−3.95) .03
step length (m) 0.5 (0.1)a .16 .33 1.18 (.61−2.25) .62
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Dependent variable
A fall was defined as ‘an event that results in a person coming to rest unintentionally 
on the ground or lower level, not as a result of a major intrinsic event or overwhelming 
hazard.16 Subjects were classified as fallers or non-fallers, based on item 13 of the 
Unified Parkinson’s Disease Rating Scale (UPDRS).17 Fallers were defined as patients 
scoring one point (rare falls) or higher. Non-fallers were defined as patients who 
scored a zero on this item.
Independent variables
Existing literature was reviewed for known determinants which are associated with 
falls in PD. Based on the literature and expert opinion 51 candidate determinants were 
identified (see Tables 1−4).
Data analysis
The 51 selected variables for prediction were dichotomized on the basis of clinically 
meaningful cut offs. If this information was absent or data showed a skewed 
distribution, either a split-median approach or an optimal cut off in sensitivity and 
specificity analysis in a Receiver Operating Characteristic (ROC) curve was adopted. 
The association between these variables and falls among PD patients was investigated 
performing a bivariate logistic regression analysis for each candidate determinant 
separately. Only candidate determinants with a liberal significance level of p<0.2 
were selected for multivariate regression analysis. To avoid collinearity between 
included determinants, candidate determinants were removed if Spearman rank order 
correlation coefficients were above 0.7. In the multivariate analysis, stepwise backward 
and forward approaches (both conditional) were applied to verify robustness of the 
model. Each hypothesis was tested two-tailed (p<0.05).
Results
Table 5 presents the main patient characteristics. Sixty-six patients (43%) were classified 
as fallers and 87 (57%) as non-fallers. No severe injuries due to falls were reported. 
Bivariate associations between falls and independent variables
Table 6 shows the test results, odds ratios (OR) and their 95% confidence interval (95% 
CI) for the 18 determinants who were related to falls with a liberal significance level of 
p<0.2, as determined with bivariate logistic regression. Thirteen of these determinants 
were statistically significant related to falls (p<0.05) Significant collinearity (r>.7) was 
found for the sum score of items 3, 4, 5 and 6 of the Freezing of Gait Questionnaire 
(FOGQ)18 and UPDRS item 14, of which the latter was consequently removed.
Multivariate modelling
A model for the probability of falling was derived, containing four determinants 
(Table 6).
Accuracy of the model with FOGQ alone was 65.3%, adding the TGUG increased the 
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N, number of patients; Q, interquartile range; SE, standard error of estimate; CI, confidence interval; PDQ, Par-
kinson’s Disease Questionnaire.
Candidate determinant Median (Q1−Q3) Bivariate analysis
B (β coefficient) SE Odds ratio (95% CI) p value
PDQ, mobility 50 (32.5−67.5) −.15 .65 .86 (.46−1.64) .33
PDQ, Activities of Daily Life 50 (33.3−68.8) 1.21 .35 3.34(1.69−6.61) .00
PDQ, emotions 33.3 (16.7−50) .31 .34 1.37 (.72−2.60) .33
Table 4  Scores on candidate determinants and bivariate analysis at participation level 
(n=153)
Table 3  Scores on candidate determinants and bivariate analysis at activity level (n=153)
Candidate determinant Median 
(Q1−Q3)
Bivariate analysis
B (β coefficients) SE Odds ratio (95% CI) p value
UPDRS 15 walking 2 (1−2) 1.49 .39 4.46 (2.06−9.64) .00
UPDRS 30 pull test 1 (1−2) .46 .46 1.32 (.54−3.22) .55
Timed Single Leg Stance 
left (s) 12.2 (29.7)a,b .42 .42 1.21 (.53−2.75) .66
right (s) 12.9 (10.6)a,b −.49 .43 .61 (.26−1.42) .25
Timed Tandem Stance 
left (s) 19.3 (10.9)a,b −.39 .34 .68 (.35−1.31) .25
right (s) 20.3 (10.6)a,b −.15 .34 .86 (.45−1.67) .66
Functional reach (cm) 25.5 (7.9)a −.65 .34 .52 (.27−1.01) .05
UPDRS 28 posture 1 (1−2) .76 .55 2.14 (.72−6.33) .17
Timed Get Up and Go test (s) 13.5 (11.5− 7.8)a 1.10 .35 2.99(1.51−5.93) .00
NEAI
mobility 19 (15−21) .96 .34 2.61(1.35−5.04) .02
kitchen 17 (14−20) .33 .33 1.39 (.73−2.65) .32
domestic 14 (9−16) .78 .33 2.10(1.14−4.19) .02
leisure 16 (13−20) −1.21 .34 .30(.15−.59) .00
N, number of patients; SE, standard error of estimate; Q, interquartile range; CI, confidence interval; UPDRS, 
Unified Parkinson’s Disease Rating Scale; s, seconds; cm, centimetre; NEAI, Nottingham Extended ADL Index. a 
mean (standard deviation). b maximum duration 30 seconds.
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accuracy to 70.7%, adding item 15 of the UPDRS (i.e., walking) improved accuracy 
to 71.4%, and completing the model with disease duration correctly classified 74% of 
the patients as fallers or non-fallers.
Using a forward approach, the model showed 71% sensitivity for identifying fallers 
and a 76% specificity for identifying non-fallers, a positive predictive value (PPV) of 
70% and a negative predictive value (NPV) of 77%. Using a backward approach, 72% 
sensitivity and 77% specificity and a PPV of 70% and a NPV of 79% were found.
Discussion
The present study shows that 43% of the 153 PD patients could be identified as fallers 
according to the UPDRS item 13. This finding confirms that falling is a common event 
in PD patients and is comparable to previous results.2,4,9,10 Our multivariate regression 
model suggests that patients who are fallers are more likely to suffer from freezing (FOGQ 
sum score of items 3, 4, 5 and 6), have longer disease duration, experience problems with 
walking (UPDRS item 15) and need more time for standing up, walking, turning and 
sitting down (TGUG). The accuracy of this prediction model was 74%, also suggesting 
that in 26% of the cases the model was inaccurate. This accuracy is in line with the existing 
literature and we believe that the model could be used as an indication for identifying 
patients who are at risk of falling, using home-based tests, especially when fall history is 
unknown. Therefore, the present model may serve as a direction for further research in 
order to refine and develop tests that reflect the underlying mechanisms of falling.
N, number of patients; SD, standard deviation; Q, interquartile range; kg, kilogram; m, meter; cm, centimeter; L, 
left; R, right; UPDRS, Unified Parkinson’s Disease Rating Scale.
Table 5  Patient characteristics and scores (n=153)
Number Mean  (SD) Range Median
(Q1−Q3)
Age (years) 67 (7.5) 41−82 68 (62−72.5)
Disease Duration (years) 8.3 (5.1) 1−25 8 (4−12)
Gender (male/female) 88/65
Weight (kg) 70.9 (13.2) 44−115 70 (62−76.7)
Height (m) 1.7 (0.1) 1.5−2.0 1.7 (1.6−1.8)
Leg length difference (cm) 0.4 (0.9) 0−1.0 0 (0−1)
Dominant side of the disease (L/R) 72/81
Medication (number of patients)
users of levodopa
users of other  anti-Parkinsonia medication (e.g. ago-
nists, selegiline)
no medication users
134
16
3
Presence of hypotension, UPDRS item 42 (yes/no) 17/136
Hoehn and Yahr stage 2.8 (0.6) 1−3 2.5
Falls (fallers/non-fallers)
UPDRS item 13 66/87
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In earlier studies, disease duration3,9 and the TGUG,9 but not freezing and gait problems 
according to the UPDRS, have been identified as independent factors predicting falls. 
Disease duration,2,10 freezing10 and UPDRS item 15 (walking)10 were investigated for 
their predictive validity for falling in the literature. They failed, however, to be included 
in existing prediction models due to their high association with other related factors 
and differences in the patient population. 
Clinical symptoms related to falling, for example freezing, tend to show variations with 
respect to medication intake as well as day to day fluctuations. Traditional prediction 
models do not account for the impact of these time-dependent fluctuations on the 
changing relationship between determinants and outcome (i.e. falls). Future prognostic 
studies should therefore investigate the longitudinal relationship between candidate 
determinants and observed outcomes by monitoring patients on a continuous basis 
in the home environment, using, for example, ambulatory accelerometry.19,20
A limitation is the retrospective design of this study. It has been suggested that more 
fallers can be classified correctly by using a prospective design.2,6 Moreover, previous 
falls seem to be a key predictor for falls.2,4 Due to the retrospective design previous 
falls could not be assessed validly in this study. 
In the present study, patients with mild to moderate PD symptoms participated. 
To obtain a better view on falls, more mildly affected patients and severely affected 
patients should also be studied. In addition, future studies should also include patients 
with symptoms such as dementia, knowing that cognitive disorders seem to be an 
independent factor that contributes to a high incidence of falling.3,21 
In conclusion, the present study provides clinically important insight into factors related 
to falls in mild to moderately affected PD patients obtained using home-based tests. 
These patients typically show a reduced walking ability and are referred for physical 
therapy to improve gait and prevent falls.
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Introduction
The major aim of this thesis was to determine the effectiveness of external rhythmic 
cues to improve gait and gait-related activities, and with that, increasing the amount 
of physical activity in patients with Parkinson’s disease (PD). This was also the major 
aim of the Rescue project, a collaborative project of the VU University Medical Center 
in Amsterdam, the Katholieke Universiteit Leuven (Belgium) and the Northumbria 
University in NewCastle (UK). Other objectives of the Rescue project were to: 
(1) generate new knowledge on external rhythmic cues, as well as behavioral and 
environmental factors affecting their use; (2) develop an optimized set of cueing 
strategies, including a prototype cueing device, and test this in a randomized controlled 
trial (RCT); and (3) communicate the results of the RCT widely to patient organizations 
and health care professionals.
The Rescue project fits within the aims of the Fifth Framework of the European 
Commission (EC), to keep patients longer in their own home situation, independently 
and safe, with preservation of their quality of life,1 acknowledging that approximately 
800.000 people in Europe suffer from PD in 2008,2,3 and that about 60% of these 
patients have walking problems. The present thesis further supports the hypothesis that 
rhythmic cueing is a simple, effective and safe adjunct therapy to normalize gait.
The Rescue project consisted of three phases: 
Preparation phase: Prior to the Rescue project, there was limited knowledge about 
the optimal use of rhythmic cues in PD, as shown in the systematic review on cueing 
studies presented in Chapter 2 of this thesis.4 In the preparation phase experiments in 
the laboratories at Amsterdam and Leuven were involved to investigate the effects and 
stability of visual, auditory and somatosensory cues.5-7 These experiments made use 
of a cueing device, which was developed within the preparation phase and provided 
three cueing modalities: (1) a visual cue (with a flashing light attached to the patient’s 
spectacles); (2) an auditory cue (beep); and (3) a somatosensory cue (a vibrating mini-
cylinder, which could be worn under a wrist band). The study on visual cueing, which 
is presented in Chapter 4 of this thesis, found positive effects of visual cueing on step 
length and step frequency.6 Cognitive and behavioral profiles facilitating cueing and 
contextual factors impeding effective cueing were studied in Newcastle.8,9
The results of these experiments were used to develop practical guidelines for optimal 
use of the cueing device (available on CD-ROM, http://www.rescueproject.org). Three 
physical therapists, one in each participating centre, were trained in the use of these 
cueing guidelines and providing standardized cueing training to the patients who were 
included in the RCT. Furthermore, three assessors, one in each centre, were trained in 
applying the activity monitor and executing the generic test battery to ensure reliability 
of assessments across all centers involved. The clinical assessments with the test battery 
were all tested for inter- and intra-rater reliability, feasibility and responsiveness when 
applied in the home situation.10 The results which are presented in Chapter 3 of the 
present thesis, showed moderate to high intra-class correlation coefficients for inter- 
and intra-rater reliability.10
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Generalisation phase: The effects of guideline-based cueing training were investigated 
in a crossover randomized controlled clinical trial across all centers involved. Patients 
were randomly allocated to an early intervention phase or in a late intervention phase, 
using sealed opaque envelopes. The intervention for patients in the early intervention 
phase ended after 3 weeks, while patients allocated to the late intervention phase 
received their training in the second 3-week period. After this period, there was a 
6-week sustainability period. During the intervention phase, patients received cueing 
training in their own home environment. The cueing intervention consisted of 30-
minute sessions of cueing training, three times a week, for 3 weeks. The training was 
provided by one trained physical therapist in each country (i.e. stratum of the RCT). 
Assessments were executed at the start of the trial, after the first 3 weeks, after the 
second 3 weeks and after the sustainability phase. Results obtained with the clinical test 
battery are presented in Chapter 5 of this thesis,11 and show positive effects of cueing 
on gait and gait-related activities. Results obtained with activity monitoring (AM) are 
presented in Chapter 6 of this thesis,12 and show an increase in walking activity after 
cueing training.
Dissemination phase: In the final phase of the Rescue project, results of the Rescue 
study were communicated at conferences, including a special ‘Rescue conference’. 
In addition materials presenting cueing strategies for PD patients, caregivers and 
professionals have been developed and physical therapists and movement therapists 
are being trained by members of the Rescue team. 
This final chapter of the thesis discusses the specific and non-specific effects of cueing 
followed by a critical appraisal of some methodological issues, the cueing training 
offered and the international collaboration in the Rescue project. This thesis ends 
with some recommendations for future research. 
Effects of cueing in PD  
Impact of specific effects of cueing in PD
The RESCUE trial11 is the largest trial on gait training in PD to date.13 It involved 153 
patients, who followed a 3-week cueing programme in their own home environment. 
After the intervention period, significant effects were found on the Posture and Gait 
score (PG), a composite score of gait and balance items from the Unified Parkinson’s 
Disease Rating Scale14,15 (4.2%), as well as on gait speed (5 cm/s) and step length 
(4 cm). These findings suggest that instantaneous effects of cueing reported in the 
systematic review4 and the laboratory studies of the preparation phase of the Rescue 
project5-7 can be transferred to the home setting of PD patients. Since effects washed 
out when patients did no longer receive cueing training at home any more, cueing 
training should ideally be continued in order to sustain its effects. Future studies 
should focus on investigating the dose-response relationship of cueing in order to 
determine the optimal dosage of cueing training. It is important to note that patients 
were assessed without using a cueing device or rhythms, suggesting that cueing-
induced improvements are not entirely instantaneous.11 This finding may support 
suggestions from recent studies on intensive training in animal models of PD that 
cueing training could involve anatomical and metabolic plasticity.13 These studies16-20 
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suggested that higher training intensities (without cueing) may be neuroprotective by 
reducing striatal dopaminergic loss and promoting improved behavioral outcomes.13 
This neuroprotective mechanism and the dose-response relationship for cueing training 
in PD need to be studied further. If cueing training has neuroprotective effects, it can 
offer a breakthrough method in the treatment of PD. The study by Fisher21 showed 
small changes in brain excitability following transcranial magnetic stimulation (TMS) 
after an intensive exercise programme in early PD, underpinning the hypothesis of 
learning-dependent plasticity. 
Future studies should focus on mechanisms of cueing in the brain, involving the various 
kinds of cues and dose-response relations. Participants of the Rescue trial varied in the 
experiences they reported when using cues. Some patients reported that the rhythm 
made them focus on when or where (in the case of lines on the floor) to put their foot 
on the ground, whereas others had the feeling that they were being ‘pushed’ to walk, 
when using a rhythmic cue. These two different kinds of experiences among the PD 
patients may suggest that different brain systems are involved. Using cues consciously, 
thus forcing patients to pay attention to the cyclic rhythm of gait, suggests that there 
is an emphasis on cortical pathways, avoiding the automatic motor control of the 
basal ganglia. The feeling of being pushed into the right rhythm by enforcing time 
constraints in cyclic motor control such as gait, may support the theory of avoiding the 
basal ganglia by rerouting motor control via the sensorimotor cortex and anchoring the 
optimal timing of cyclic movements by the cerebellum. This suggestion was supported 
by Rochester and colleagues,22 who concluded in a recent publication that external 
rhythmic cues can reduce attentional load as it informs the motor system about the 
temporal sequencing of a task thus avoiding the need to internally plan and prepare. 
Currently, Van Wegen and colleagues are investigating the involvement of different 
parts of the brains during cueing in a study called ‘Unravelling the effect of rhythmic 
external cueing on mobility: synchronization and use of alternative brain circuitry in 
the parkinsonian brain’ at the VU University Medical Center in Amsterdam.23 
Although the reported effects of cueing training on gait and gait-related activities 
reported in the Rescue trial are relatively small, they are comparable to calculated overall 
effect sizes or standardized mean differences reflecting the impact of exercise therapy 
in rehabilitation medicine.24 The small but significant improvement in parkinsonian 
gait is an important finding that reflects an improvement in gait performance. For 
example, improvement in gait speed is accompanied by improvement in kinematic 
parameters6 and is a genuine reflection of ambulatory performance.25
Chapter 6 of this thesis12 also shows that these small improvements in gait and 
gait-related activities translate into increased daily activity as measured by activity 
monitoring (AM). This latter finding suggests that improvements in gait measured by 
using standard assessments, such as gait speed and PG, reflect increased ambulatory 
‘real world’ activity performed in the patients’ own home setting.12 Interestingly, not 
only gait performance but also standing balance improved significantly in our patient 
sample as was shown by the tandem and one leg standing tests. The probability of 
failing to pass the one leg standing tests was decreased by 36% in those who had 
received the cueing training.11 This finding may be related to the aim of the therapy 
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in which patients were trained to prolong their single leg support, by increasing their 
step length and normalizing their step frequency. In other words, this prolonged single 
leg support phase may have positively influenced standing balance. 
Although the effects we found did not result in a significantly reduced number of falls 
or near falls, they did not result in an increase in fall incidences either. However, the 
time interval between two consecutive assessments may have been too short to identify 
significant differences in fall frequencies. 
The results of the 6 meter walking test allow the conclusion that step length did increase 
with increased walking speed. However, the Rescue trial provided no information 
about, e.g., inter-limb coordination, pelvic thoracic rotations, postural inflexibility or 
arm swing, neither from the 6 meter walking test, nor from AM. These parameters 
are disturbed in most patients26-29 and are closely related to falls.30-32 Using additional 
accelerometers for the upper limbs and gyroscopes with AM in future studies may 
yield more detailed information on arm and trunk movements. 
Non-specific effects of cueing in PD 
The improvements in walking speed and amount of walking activity indicate a 
significant improvement in mobility. The literature suggest that these improvements 
generalize to other parameters in PD. Unpublished results of the Rescue study show 
a significant decrease in fatigue for the domains of ‘activity’ and ‘general fatigue’, 
assessed with the Multi Dimensional Fatigue Inventory (MFI-20). This is in line with 
other studies, where an increase in activity leads to a conception of reduced fatigue.33 
Confidence not to fall during gait-related tasks (assessed with the Falls Efficacy Scale) 
improved as well. 
A significant improvement was also found for depression, assessed with the ‘depression’ 
subscale of the Hospital Anxiety and Depression Scale.34 The attention component 
as well as the training sessions may have led to a reduction in depressive feelings, as 
supported by studies on physical exercises and depressive feelings.35 
No significant improvements were found in terms of other non-specific measurements 
An explanation could be that the training period was too short to allow the amount of 
ADL and caregiver load to be adjusted to the newly acquired strategies.
Learning from the Rescue study and how to proceed
Methods
Design
The research reported on in the present thesis, used a crossover design. A requirement 
for the use of a crossover design is that the effects of an intervention are instantaneous 
preferably showing a return to baseline state at the point of crossover after the end of 
the intervention. Preliminary experiments with cueing did show that the effects of 
rhythmic cueing are instantaneous and disappear after ending rhythmic cueing. The 
study of Morris36 supports the wash-out of effects after the removal of a cue as reviewed 
in Chapter 2 of this thesis.4 Using a crossover design gives all patients the opportunity 
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to profit from the intervention, avoiding ethical issues about receiving or not receiving 
therapy. A crossover design also offers a more efficient comparison of treatment 
modalities than a parallel design.37 As a result, fewer patients are required to achieve 
the same statistical power and precision, because all patients are their own control.37 
A disadvantage of a crossover design can be the risk of carry-over effects, interfering 
with the intervention effects, when the effects of the intervention do not completely 
return to the baseline state after the intervention ends, making comparisons between 
the two after the moment of crossover impossible. The Rescue trial therefore used an 
analysis that took carry-over effects into account in the calculation of intervention 
effects. A significant positive carry-over effect was found only for step length.
Because of the fluctuations in performance over the day due to medication, PD 
patients should preferably undergo a number of assessments over time to reduce the 
large within-subject variances in outcomes. A randomized clinical trial with repeated 
measures in time may give more precise estimates of outcome measures and should 
be considered in future research on PD.38
The impact of placebo effects resulting from increased attention during training was 
not controlled for, which is a limitation of the Rescue trial. However, the specificity 
of treatment effects in terms of gait performance suggests that findings are difficult to 
explain on the basis of attention alone. To control for placebo effects in future studies, 
cueing training given by a therapist would preferably need to be compared with a non-
cueing therapy given by a therapist, controlling for the amount of attention. However, 
the study may be threatened by contamination which should be prevented.
More high quality RCTs should be initiated to study the effect of cueing programmes 
in order to underpin existing guidelines with high quality research. Studies should 
work on the basis of the CONSORT agreement1 to ensure high methodological quality 
and sufficient statistical power by using an appropriate number of subjects.
Optimizing the clinical test battery
A key issue in PD research is that the primary outcome measure should be in line with 
the focus of the therapy.38 An example of a frequently used test is the Timed Get Up and 
Go test (TGUG)39 where standing up, walking, turning and sitting down are combined 
in one test, with the total time needed for these actions as an outcome measurement. 
This time does not reflect a patient’s ability to make a safe turn, since pivoting is less 
safe but much faster than a ‘stepping through strategy’. In other words, the therapeutic 
aim of getting patients to perform normal safe gait is incompatible with the aim of 
increasing the speed in the TGUG.38 Ideally, the primary outcome measure should 
reflect the change that is likely to be introduced by the therapy applied. 
In addition, clinical tests should fit in with the domains of the International Classification 
of Functioning, Disability and Health (ICF).40 Unfortunately, this can not be said of 
most tests. For example, the Unified Parkinson’s Disease Rating Scale (UPDRS)14,15 is 
multidimensional and reflects a mixture of different constructs at different levels of 
the ICF, making findings from trials difficult to interpret.38 Obviously, there is a need 
for a valid and feasible test battery in which each test reflects one specific symptom 
or one underlying construct.38 This requires a better understanding of the underlying 
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mechanisms of symptoms such as rigidity or freezing in order to develop valid tests. 
There is a general need for a comprehensive core set of valid measurements recommended 
for trials and clinical practice. This core set should be recommended in the rehabilitation 
guidelines for PD allowing comparison of effects that are claimed.38 
Improving ambulant monitoring
The benefits of cueing training for walking performance in patients’ own environment 
can only be understood if additional information is available about the association 
between improvement in gait speed and performance and walking ability in the 
community.41 The literature offers no studies about this relationship. In addition, the 
impact of cueing-induced gait improvements on ADL independency needs further 
investigation in combination with the tendency to increase on ADL, according to the 
Nottingham Extended ADL Index (NEAI) after receiving cueing training. 
Our study used activity monitoring (AM) to examine the amount of activity over 
a regular week day, AM was used. AM is a reliable12,42 and valid43 method to record 
movements in PD. Some disadvantages of the used monitor in the Rescue project are 
the size and weight of the monitor, the wires connecting accelerometers and recorder, 
and the limitation of battery and storage capacity. 
The development of a light-weight, wireless device with the capacity to store data for 
a couple of days would help to investigate activity patterns for several days and nights. 
Small wireless ambulatory monitors, using Bluetooth to send their information directly 
to a researcher’s computer, already exist.44 These systems are small and do not interfere 
with movements. Unfortunately these systems only work within a limited radius of the 
receiver. To avoid this problem, data can be sent to the assessor with the help of SMS, 
but activity monitors with this option are still heavy and large, and lack sufficient battery 
capacity.45,46 Newly developed systems could also be used to monitor the amount of 
activity on optimal medication installation, as well as in studies on new medications or 
neurosurgery in PD and other neurological disorders. Newly developed algorithms to 
detect and classify freezing and falling symptoms will offer the opportunity to develop 
new intervention programmes aimed to prevent these problems. 
Small, light weight and wireless AM may reduce reactivity effects, that is the effects 
that some people may have avoided activities, because of wires connecting the data 
logger and sensors or because of the size and weight of the data logger. Finally, the use 
of AM that monitors daily activities may introduce a Hawthorne effect, i.e. a temporary 
chance to behavior in response to a change in the environmental conditions. In our 
study, however, AM was applied in patients in the early and late phases.
Improving the identification of falls
In the Rescue project, 43% of the patients could be classified as fallers on the basis of 
item 13 of the UPDRS. Other prospective studies have reported incidence rates for 
falling in PD patients of between 50 and 70%.30,47 Still, a major problem with recording 
falls is the lack of a uniform definition of falls in the literature, and hence a valid way 
to record falls and near falls.48 In the present study ‘a fall’ was defined as ‘an event that 
results in a person coming to rest unintentionally on the ground or another lower level, 
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not as the result of a major intrinsic event or overwhelming hazard’.49 The incidence 
of falling was measured by means of a falls diary. The problem of a falls diaries is that 
of recalling a fall. Asking specific questions about falls encourages a full account, 
including details on embarrassing or insignificant falls that fallers might have omitted 
otherwise.50 In the Rescue trial a diary was used asking about falls and details, with 
questions such as (1) where did you fall? (2) What were you doing or trying to do at 
the moment you fell? (3) What caused the fall? (4) How did you land on the floor? (5) 
How did you get up from the floor?
In a recent study on fall diaries,50 8% of the diaries were excluded from analysis, because 
they were unintelligible, due to micrographia, or unusable due to incomplete data. In 
the Rescue trial, assessors asked the patients about fall events at every assessment (four 
times in 12 weeks), while therapists asked the patients about falls at every session (for 
3 weeks) and helped them to fill out the diaries if necessary, to reduce recall problems 
and unusable falls diaries.
An alternative way to detect ‘fall movements’ might be the use of accelerometers on 
the chest44 or pelvis.51 However, this detection of fall movements probably does not 
offer sufficient sensitivity to identify falls: most patients lack the right strategies to lie 
themselves down in their beds and therefore let themselves fall on their beds. Other 
patients let themselves fall on the floor to pull themselves onto their beds thereafter. 
This example illustrates that it can be difficult to use accelerometers to discriminate 
between an intentional fall and an accident. Therefore, future studies will need to 
discriminate between intentionally and unintentionally coming to rest at a lower level. 
The construction of algorithms to detect and classify freezing and falling symptoms 
will offer opportunities to develop new intervention programmes to prevent these 
problems.
The multivariate regression model presented in Chapter 7 of this thesis52 suggests that 
patients who are fallers are more likely to suffer from freezing, have longer disease 
duration, experience problems with walking and need more time to complete the 
TGUG. The accuracy of this prediction model was 74%, implying that model was 
inaccurate in 26% of the cases. This accuracy is in line with the existing literature and 
we believe that the model could be used as an indication for to identify patients at risk 
of falling using home-based tests, especially when the fall history is unknown. The 
present model may therefore serve to indicate directions for further research in order 
to refine and develop tests reflecting the underlying mechanisms of falling.52
A more accurate model for falling requires a better understanding of the underlying 
constructs. Laboratory research on falls, e.g. by using a catwalk with unexpected trips as 
was done in the studies by Pijnappels,53 can provide more insight into the biomechanics 
of falls and fall avoidance. Knowledge of mechanisms underlying problems of freezing 
and turning, both of which are risk factors, may provide the opportunities to develop 
tests and algorithms based on the underlying constructs of falling. 
In addition to this, longitudinal models are required in which the quasi-causal relation 
between time-dependent determinants, such as severity of freezing, are associated with 
observed changes in postural control and the incidence of falling.
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Improving guidelines and improving implementation strategies for cueing training
In the first week of the intervention period in our study, patients tried all cueing 
modalities: auditory, visual, and somatosensory cueing. In the remaining 2 weeks, 
patients used a cue type of their choice, to practice with: 67% of these patients chose 
the auditory cue, 33% chose the somatosensory cue (33%). In a survey that was 
held after the intervention period, patients were asked to explain their choice. Most 
patients reported that they had opted for the ‘clearest cue’, being the auditory cue. 
Other patients reported that they preferred a concealable cue, the somatosensory 
cue. The somatosensory cue was worn under a wrist band, which could be hidden in 
a sleeve. Patients who frequently walked outside and used their cue to facilitate gait 
while shopping for example, preferred this less visible cue. In addition to the cueing 
device, visual spatial cues, like stripes on the floor, or lines in the pavement were used 
for 11.22±11.4% of the total time spent on therapy.54 
Patients with severe dyskinesia showed problems with (1) inserting the cylinder of 
the somatosensory cue under their wrist band, and (2) pulling out cables, connecting 
the earpiece or cylinder with the cueing device, due to uncontrolled large movements 
of their arm or neck.
Visual rhythmic cues, provided by a flashing light on the spectacles, were less popular 
than other cue types. Findings from the study by Rochester and colleagues, suggest 
that visual rhythmic cueing demands for double tasking and consequently worsens 
gait.22 
There is thus a need for a cheap cueing device providing an auditory and a somatosensory 
cue, to give patients the opportunity to use cues in daily life. This cueing device should 
preferably be smaller than the prototype cueing device, and the vibrating cylinder 
should be replaced by something that is easier to use by patients with severe dyskinesia. 
One option could be a kind of watch with an integrated vibration device (like that 
in a cell phone). A wireless system using Bluetooth to connect the earpiece to the 
rhythmic signals from the watch would help patients with dyskinesia. This would also 
be perceived as a more elegant solution than one using wires, probably stimulating 
patients to use the device for ADLs outside their house. 
A multiple regression analysis was utilized for all used guidelines and cue types, to 
explain the variance of outcomes for the positive outcome measurements of the Rescue 
trial. This analysis indicated that the positive effects of cueing were irrespective of the 
cue type, confirming our hypothesis that each modality, provided by the cueing device, 
has the same effects. This implies that therapists and patients can use any available 
cue, mostly a metronome in the absence of somatosensory cues.56 
The same analysis showed that using gait-specific guidelines for therapy led to an 
improvement in gait and gait-related activities. These findings further support the 
theory by Kwakkel and colleagues38 that the effects of physical therapy are specific to 
task and context in patients with PD, and are similar to other neurological diseases 
such as stroke38,55 and MS.57 Therapists therefore need to be specifically trained to use 
guidelines and give cueing training.
It is important to emphasize that the cueing training did not lead to an increase in fall 
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events. It was expected that patients would walk much when using cues and a possible 
side effect of increased activity can be an increase in fall events. Walking and paying 
attention to a cue could be experienced as double tasking, which is also known to be 
a risk factor for falling.58 The effect of the three different cueing modalities (auditory, 
visual and somatosensory) on gait performance has been investigated using a single 
and a double task.22 Patients were asked to walk with a tray with two glasses filled with 
water. Gait parameters were recorded, using AM. Results showed an improvement in 
walking speed for the auditory and somatosensory cue, indicating that these types of 
cues might facilitate double tasking. By contrast visual cues worsened gait velocity, 
implying that paying attention to a flashing light interfered with gait performance. 
This experiment suggests that auditory and somatosensory cues do not act as distracters 
while walking and therefore probably do not increase the number of fall events. The 
results on the interferences between the different cue types and gait supported the 
finding on preference for auditory and somatosensory cue types found among the 
patient population in the Rescue trial. 
Improving international collaboration and dissemination of knowledge
The Rescue trial was the first RCT in rehabilitation medicine that was financed by the 
European Commission (EC). This project taught us much about the cultural similarities 
and differences between the British, Belgium and Dutch situations. 
Differences in the content of cueing training were minimized by training the three 
therapists prior to the trial to ensure that they used the guidelines and the cueing device 
in a similar way and used the same diary to record their therapy goals as well as the same 
strategies to work on these goals. During the period of the trial, they stayed in contact 
using e-mail, phone and MSN Messenger, to make sure that they were still working 
in the same way. Difficult cases were analyzed by the therapists together to make sure 
that they kept using the same strategies. Despite this training, the client-therapists 
interactions differed between the countries. For example, the role of the therapists 
as a helping assistant was less prominent in The Netherlands and more pronounced 
in Belgium and the UK, whereas in The Netherlands more of the responsibility for 
the success of implementing therapy guidelines was put on the client. These cultural 
differences were probably the reason why the content of the cueing programmes was 
slightly different, in that the Dutch therapist put more emphasis on gait, the Belgian 
therapist concentrated more on postural control, and the British therapist emphasized 
posture in therapy.54 
Other differences relate to governmental issues and reimbursement policies of 
insurance companies. These differences may have led to differences in e.g. visits to the 
doctor, the amount of physical therapy provided and the use of medication. Because 
we had expected these differences patients were stratified on the basis of country and 
subsequently randomized to the early or late intervention regime. 
The Rescue team met a few times a year to stay updated on the state of affairs and 
work on further developments within the project. E-mail and internet were used 
frequently to keep each other informed. A website facilitated the exchange of data 
and information on therapy and assessments. The collaboration between the three 
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countries was successful. 
As the core of Rescue was concerned with the transfer of evidence-based rehabilitation 
methods to the environment of patients’ everyday lives, it was of major importance 
that the results of the project were disseminated internationally. A special ‘Rescue 
conference’ was held in Amsterdam, in March 2005, where results of the study were 
presented. Additionally, results of the study have been presented world wide at 
various conferences on Parkinson’s disease, neurology, rehabilitation medicine and 
physical therapy. Work sheets on strategies in cueing have been developed for PD 
patients, caregivers and professionals, and are available through the internet (www.
rescueproject.org). A DVD is available with demonstrations of cueing, with clear 
(printable) instructions for patients (Dutch version via www.parkinson-vereniging.
nl and English version available via www.Parkinsondvd.com). Physical therapists 
and movement therapists in The Netherlands have the opportunity to join networks 
specializing in PD.59 Within these networks, physical therapists are trained to use 
guidelines for physical therapy in PD, including the use of rhythmic cues, by members 
of the Rescue team.
Recommendations for future research on cueing
Involvement of a wider variety of patients with parkinsonisms
In the Rescue trial one patient was classified as Hoehn and Yahr (H-Y)60 stage 1, 134 
patients were classified as H-Y stages 2 and 3, whereas 18 patients were classified as 
H-Y stage 4. By definition these stage 4 patients experienced walking and balance 
problems and were at risk for falls. The effects of cueing training in H-Y stage 4 need 
further investigation. It would also be interesting to study the effects of rhythmic cueing 
in PD patients in early stages, H-Y 1. Patients in early stages often do not complain 
about walking problems, but already show deviations in their gait pattern.61 Recently, 
Fisher and colleagues showed improvements in gait speed, step length and range of 
motion of different joints after intensive treadmill training in early stages of PD.21 
When training patients at different stages of their disease it is important to work on 
therapy aims that are compatible with these stages.62
Future studies on cueing in PD should also include patients suffering from cognitive 
disorders, since PD is often associated with cognitive impairment. Prospective studies 
show incidence rates for dementia in PD ranging from 19 to 78.2%.63 Disturbed 
executive functioning is also a major problem in PD. Since patients may not rely on 
higher functioning planning and sequencing,64 cueing might be suitable for patients 
with cognitive impairments, because of its instantaneous character and because it has 
been suggested that external rhythmic cues can reduce attentional load as they inform 
the motor system about the temporal sequencing of a task.22 
Patients with parkinsonisms such as Progressive Supranuclear Palsy (PSP) and Multi 
System Atrophy (MSA) might also benefit from cueing training. Yet, more research 
is needed to study the effects of cueing on gait in these specific patients groups. In 
addition, recent studies also suggest that other patient groups with neurological 
disorders, such as stroke, benefit from rhythmic cueing.65,66
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Efficiency of cueing training
Cueing training is a relatively cheap intervention, because it requires only a cueing 
device (or metronome). A physical therapist can provide appropriate instructions that 
allow patients to cue themselves. Moreover, in view of to the benefits of cueing therapy, 
there might be less need for medication and inpatient health care, thanks to fewer falls 
and increased mobility. Future studies should focus on the cost-effectiveness of cueing 
programmes in terms of reduced medication intake and the opportunity for patients 
to continue to live at their own home with improved health-related quality of life. 
Conclusion
The research presented in this thesis allows the conclusion that cueing training is 
an important addition to the multidisciplinary treatment of PD patients with mild 
to moderate disease characteristics. The cueing training did not lead to additional 
falls and the effects of the training were irrespective of the cue type. More research is 
required to develop outcome measures to match the goals of the therapy. Such a core 
set of assessments used by different disciplines should preferably be unidimensional at a 
specific ICF level. More research needs to be done to examine the neuronal mechanisms 
behind cueing, to investigate possible neuroprotectiveness of cueing training and to 
determine the optimal dose-response relationship for a long-lasting effect of cueing 
training. Therapists worldwide need to be trained to provide cueing training and 
financial resources should be provided, through insurance companies and ministries 
of health, to make cueing training at home available for every patient with PD. 
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Parkinson’s disease (PD) is a severe progressive neurological disorder. Many patients 
suffer from problems with mobility, especially gait and gait-related activities. Physical 
therapy and especially training by the help of external rhythms (‘cueing’) can help to 
optimize gait and gait-related activities. 
The main focus of this thesis is on the effects of cueing training on gait and gait-related 
activities in patients with PD. The aims were to determine the effectiveness of optimal 
therapeutic treatment and self management strategies on (1) functional performance 
and health-related quality of life (HrQoL), (2) the amount of physical activity, and (3) 
the risk of falls. The transferability of therapeutic cueing to health-related quality of 
life and patients’ own social setting was studied as well.
In Chapter 1 the aims and outlines of the present thesis are introduced. Background 
information is presented from the perspective of history, epidemiology and medical 
management, including pharmaceutical and neurosurgical treatment options for 
patients with PD. Subsequently, the state of the art regarding the role of rehabilitation 
medicine in the management of patients with PD is presented and discussed, and in 
particular the use of external rhythms to improve gait and gait-related activities is 
addressed.
In the introduction the Rescue project is presented. ‘Rescue’ is an acronym for 
‘Rehabilitation in Parkinson’s Disease: Strategies for Cueing’. This project was an 
international collaboration and was financed by the European Commission. The lack 
of high quality studies on the effect of cueing in PD and the call from the European 
Commission for development and evaluation of technologies and systems designed 
to reduce the impact of disabilities on older people, stimulated the initiation of this 
project. 
Within the Rescue project, a large randomized clinical trial (RCT) was conducted to 
determine the efficacy of cueing training in the home situation of PD patients. The 
preparations for this RCT were described in the introduction of this thesis, including 
the development of a prototype cueing device, the development of guidelines for home-
based cueing training and the composition of a comprehensive and valid test battery 
for evaluating the effects of cueing in terms of functions, activities and participation 
in patients with idiopathic PD. 
In Chapter 2 a systematic review is presented, evaluating the literature regarding the 
effects of external rhythmical cueing on gait in patients with PD. Articles published 
from 1966 to January 2005 were identified by two physical therapists. To be included, 
articles had to investigate the effects of external rhythmical cueing (i.e. auditory, visual 
or tactile cueing) on gait parameters in patients with idiopathic PD. Both controlled 
and non-controlled studies were included. The methodological quality of 24 studies 
(total number of patients = 626) out of the 159 screened studies was evaluated by two 
independent reviewers. Two of the 24 studies were RCTs, both of high methodological 
quality. One of these RCTs focused specifically on the effects of auditory rhythmical 
cueing in patients with PD and found positive effects on walking speed. The other 
RCT did not focus specifically on external rhythmical cueing of individual patients 
with PD, but on group exercises in general, including walking with cues. All other 
studies were pre-experimental studies. A best-evidence synthesis was applied on 
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included studies, showing strong evidence for improving walking speed with the help 
of auditory cues. Insufficient evidence was found for the effectiveness of visual and 
somatosensory cueing. 
It is unclear whether positive effects identified in the laboratory can be generalized 
to improved activities of daily living (ADLs), HrQoL and reduced frequency of falls 
in the community. In addition the sustainability of a cueing training programme 
remained uncertain.
In Chapter 3 a study is presented in which the reliability, responsiveness and feasibility 
of a part of the Rescue test battery was determined in patients’ own home situation. 
The test battery contained the Unified Parkinson’s Disease Rating Scale (UPDRS), a six 
meter timed walking test, the Timed Get Up and Go test (TGUG), the Berg Balance 
Scale and the Functional Reach test. All tests were applied in random order by three 
independent observers on 26 PD patients to determine the inter-rater reliability. One 
of these three observers applied the test battery two times on all patients, with 7 days 
between the test moments, to determine the intra-rater reliability. The test battery was 
shown to have moderate to excellent Intraclass Correlation Coefficients for reliability, 
despite the non-standardized home environment and limited clinical experience of 
the observers in assessing PD patients. 
Responsiveness was determined by calculating the smallest detectable differences 
and the Reliable Change Indexes (RCI) for each assessment. All tests showed RCIs 
under 11%. Due to a lack of consensus on how to quantify responsiveness, strict 
comparison with the literature proved difficult. However, results from this study can 
be used as indicators for an approximate threshold in the utility of the tests as outcome 
measurements in a larger clinical trial. 
Feasibility was determined by measuring the time needed to apply the whole test 
battery, including the time needed to adapt the home environment for assessments 
(e.g. moving furniture). The whole test battery was applicable within 30 minutes, 
showing sufficient feasibility.
The study in Chapter 4 was aimed at determining the effects of rhythmic visual cueing 
under changing visual conditions on stride frequency and step length in patients 
with PD (n=21) and healthy age matched controls (n=7). All subjects performed five 
conditions on a motorized treadmill: walking (1) without visual cue or optic flow 
to determine baseline stride frequency; (2) with optic flow, using a rear-projection 
screen in front of the treadmill, providing the illusion of walking through a corridor; 
(3) with visual rhythmic spatial cueing (VRS), i.e. optic flow with transverse lines on 
the floor; (4) with visual temporal rhythmic cueing (VRT), i.e. a rhythmically flashing 
light attached to a pair of glasses, without optic flow; (5) with VRT and optic flow. 
After a baseline measurement, conditions 2 to 5 were randomly offered. During each 
condition, the speed of the treadmill was systematically increased and decreased 
after reaching a maximum speed. In the 4th and 5th condition subjects were asked 
to synchronize their stride to the VRT, with the frequency set at 10% below baseline 
stride frequency. Stride frequency and step length were determined using an activity 
monitor (AM).
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PD patients on average walked with a higher stride frequency and shorter step length 
compared to controls. In addition, a hysteresis effect was observed during the walking 
speed manipulations, in which stride frequency was lower at the decreasing speeds 
compared to the same speed levels in the increasing speed range. Both VRS and VRT 
resulted in lower stride frequencies (and thus larger strides) compared to the non-
cued conditions. 
The study showed that stride frequency and stride length in PD patients, as well 
as in controls, is not rigidly coupled to walking speed and can be manipulated by 
manipulation of walking speed as well as by using spatial and temporal rhythmic visual 
cues. This indicates that for patients with PD, the regulation of stride parameters may 
be susceptible to relatively straightforward therapeutic intervention strategies by using 
systematic manipulation of walking speed as well as rhythmic visual cueing.
In Chapters 5 and 6 results of the Rescue trial are presented. The Rescue trial 
investigated the effects of cueing training in the home using cueing techniques during 
gait and gait-related activities in three countries (i.e., New Castle, UK, Leuven, Belgium 
and Amsterdam, The Netherlands). Hundred-and-fifty-three PD patients with mild 
to moderate disease severity were included in a single-blind randomized cross-over 
trial. Subjects allocated to early intervention (n=76) received a three-week home cueing 
programme using a prototype cueing device followed by 3 weeks without training. 
Patients allocated to late intervention (n=77) underwent the same intervention and 
control period in reverse order. After the first 6 weeks post randomization, both 
groups had a 6 week follow-up without training. The Posture and Gait score (PG score) 
assessed at baseline, 3, 6, and 12 weeks was the primary outcome measure. Secondary 
outcomes included specific measures on gait, freezing and balance, functional activities, 
quality of life and carer strain, covering all levels of the International Classification 
of Functioning (ICF). In addition, all subjects wore an AM on testing days to record 
body movements and postures. Within each district, all clinical assessments as well as 
AM measurements were applied by trained assessors who were blinded for treatment 
allocation.
In Chapter 5 results of the clinical tests are presented, showing small but significant 
improvements after intervention on the PG scores, severity of freezing, gait speed, step 
length, timed balance tests and a greater confidence to carry out functional activities 
(Falls Efficacy Scale). No carry-over effects were observed in ADLs and quality of 
life domains. In Chapter 6 results of the AM are presented, showing significant 
improvements for dynamic activity, walking, and walking periods exceeding 5 
seconds and 10 seconds and a reduction of static activity. Cueing training may thus be 
considered a useful therapeutic adjunct to the overall management of gait disturbance 
in PD. Effects of intervention, measured with clinical tests and with AM, reduced 
significantly at 6 weeks follow-up. The wearing off of intervention effects underscores 
the need for permanent cueing devices and follow-up treatment. 
In Chapter 7 a prediction model for the risk of falling in PD was developed based 
on determinants extracted from home-based assessments. Data on gait, gait-related 
activities, balance and on non-motor symptoms were obtained from 153 patients in 
their own home. Sixty-six patients were classified as fallers. Based on the existing 
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literature and expert opinions, 50 candidate determinants for falling were selected. 
Eighteen out of these 50 candidate determinants for falling showed a significant 
association with falling in a bivariate logistic regression analysis. Multivariate logistic 
regression modelling showed that: (1) Freezing of gait, (2) TGUG score, (3) disease 
duration, and (4) problems with walking, assessed with UPDRS item 15, significantly 
identified patients at risk for falling. The multivariate model identified fallers accurately 
in 74% of the cases. This accuracy is in line with the existing literature and we believe 
that the model could be used as an indication for identifying patients who are at risk of 
falling using home-based tests, especially when the fall history is unknown. Therefore, 
the present model may serve as a direction for further research in order to refine and 
develop tests that reflect the underlying mechanisms of falling, such as freezing, more 
validly, and that can be reliably implemented in the home situation. In line with this 
aim, future studies should further investigate the underlying mechanisms that cause 
falling in PD, in order to optimize the identification of patients at risk. 
In Chapter 8 the impact of specific and non-specific effects of cueing is discussed 
in the light of the aims of the Rescue project. Methodological issues, the content of 
the applied cueing training and international collaboration of the Rescue project 
are critically appraized in this general discussion, and recommendations for future 
research are presented. Based on this thesis, it is concluded that cueing training is an 
important evidence based component of the multidisciplinary treatment of patients 
with mild to moderate idiopathic PD. In addition, cueing training does not lead to 
falls and effects of training were irrespective of the cue type.  Recommendations on 
future research are focused on the development of measurement outcomes in line 
with the aims of therapy or training. These measurement outcomes should preferably 
be constructed unidimensionally in line with the domains of the ICF. Apart from 
a test battery consisting of a comprehensive core set of measurement instruments, 
more research is needed to develop a light weight, small AM with sufficient storage 
and battery capacity to record physical activity for several days. With such an AM, a 
reliable way to detect and classify freezing and falls should be developed and with that 
new interventions aimed at preventing these problems. Other recommendations for 
future research are to investigate the neurophysiological mechanisms behind cueing, 
to investigate a possible neuroprotective role of cueing training and to determine the 
optimal dose-response relationship for more permanent effects of cueing training on 
mobility. Future studies on cueing should also involve patients with early and late stages 
of idiopathic PD including cognitive impairments. In addition, effects of cueing in 
patient groups with other parkinsonisms, such as multisystem atrophy or progressive 
supranuclear palsy, should be studied. Furthermore, a cheap permanent ‘cueing device’ 
providing auditory or somatosensory cues needs to be developed, giving patients the 
opportunity to use cues during performance of ADL. Finally, attention should be paid to 
the implementation of evidence based guidelines for health care professionals in which 
cueing is used as a safe way of training in the home environment of their patients.
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De ziekte van Parkinson is een ernstige progressieve neurologische stoornis. Veel 
patiënten met deze ziekte ervaren problemen met mobiliteit. Vooral lopen en 
activiteiten die gerelateerd zijn aan lopen leiden tot een afname in Activiteiten van 
het Dagelijks Leven (ADL). Het belangrijkste doel in dit proefschrift was om vast 
te stellen of het aanbieden van externe ritmes (cueing) tijdens het lopen onder 
begeleiding van een fysiotherapeut een veilige methode is om de loopvaardigheden 
bij Parkinsonpatiënten in hun thuissituatie te verbeteren. In dit proefschrift werd 
onderzocht wat de effecten zijn van optimale cueingtherapie, inclusief strategieën 
waarbij patiënten zelf cueing leren gebruiken, op het gebied van (1) functionele 
prestaties en gezondheidgerelateerde kwaliteit van leven, (2) de hoeveelheid fysieke 
activiteit, en (3) het risico op vallen. Daarnaast werd gekeken in hoeverre door 
cueingtherapie geïntroduceerde verbeteringen in loopvaardigheid ook aanleiding 
gaven tot een betere ervaren kwaliteit van het leven. 
In Hoofdstuk 1 werden de doelen en de structuur van dit proefschrift uiteengezet. 
Achtergrond informatie werd gegeven vanuit historisch, epidemiologisch en medisch 
perspectief. Vervolgens werd de ‘state of the art’ van revalidatiegeneeskunde bij 
Parkinsonpatiënten beschreven en bediscussieerd. In het bijzonder werd daarbij 
het gebruik van externe ritmes, om het lopen en daaraan gerelateerde activiteiten te 
verbeteren, belicht. In de inleiding werd het Rescue-project gepresenteerd. Rescue 
is een acroniem voor ‘Rehabilitation in Parkinson’s Disease: Strategies for Cueing’ 
(revalidatie bij de ziekte van Parkinson: strategieën voor cueing). Dit project betrof 
een internationale samenwerking en werd gefinancierd door de Europese Commissie. 
De initiatie van het Europese project werd enerzijds gelegitimeerd door een gebrek 
aan kennis over de eventuele meerwaarde van ritmische cueing tijdens het lopen 
bij patiënten met de ziekte Parkinson, en anderzijds door de vraag van de Europese 
Commissie om nieuwe technologieën te ontwikkelen die in staat zouden zijn om, 
onder andere, Parkinsonpatiënten langer in hun eigen woonomgeving te laten 
functioneren. 
Binnen het Rescue-project werd een multicenter gerandomiseerd klinisch onderzoek 
(RCT) uitgevoerd, verdeeld over drie Europese landen. De Rescue-trial had tot doel 
om de effecten van cueing bij Parkinson patiënten in de thuissituatie te onderzoeken. 
De voorbereidingen voor de uitvoering van deze multicenter trial zijn beschreven in de 
inleiding. Deze voorbereidingen bestonden, onder andere, uit (1) de ontwikkeling van 
een draagbaar cueingapparaat waarmee verschillende soorten ritmes kunnen worden 
gegenereerd; (2) de ontwikkeling van behandelrichtlijnen voor het gebruik van het 
prototype cueingapparaat en toepassen van cueingstrategieën in de thuissituatie, en 
(3) de samenstelling van een alomvattende testbatterij om de effecten van cueing te 
kunnen meten op het niveau van functies, activiteiten en participatie.
In Hoofdstuk 2 is een systematische review gepresenteerd, bedoeld om alle literatuur 
over het effect van cueing op het lopen van Parkinsonpatiënten te evalueren voor 
wat betreft methodologische kwaliteit en effectiviteit. Twee fysiotherapeuten zochten 
systematisch via verschillende elektronische databestanden naar alle effectstudies 
die gepubliceerd waren tussen 1966 en januari 2005. In deze artikelen moest een 
studie beschreven zijn over het effect van cueing (auditief, visueel of tactiel) op 
gangparameters van patiënten met idiopatische Parkinson. Uiteindelijk werden 24 
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van de 159 gescreende studies voor methodologische beoordeling geïncludeerd. 
Twee onafhankelijk beoordelaars evalueerden de methodologische kwaliteit van de 
geïncludeerde studies. Twee van de 24 studies waren RCT’s. Beide studies hadden een 
hoge methodologische kwaliteit. Eén van deze RCT’s was specifiek gericht op effecten 
van auditieve ritmes op het lopen van Parkinsonpatiënten. In deze studie werd een 
positief effect op loopsnelheid gevonden. In de andere RCT werd onderzoek gedaan 
naar oefentherapie in groepsverband; cueingtraining was in deze studie slechts een 
onderdeel van de oefentherapie. Alle andere studies waren pre-experimentele studies. 
Een ‘best evidence synthese’ werd toegepast op alle geïncludeerde studies en liet sterke 
bewijskracht zien voor het verhogen van loopsnelheid met behulp van auditieve cues. 
Er werd onvoldoende bewijs gevonden voor het effect van visuele en tactiele cues. 
Het is onduidelijk of de positieve effecten die gevonden zijn in het laboratorium ook 
gegeneraliseerd kunnen worden naar verbeteringen van ADL’s, gezondheidgerelateerde 
kwaliteit van leven en een vermindering van valincidenten. Daarnaast is het ook nog 
onduidelijk of cueingtraining beklijft na het stoppen van de therapie. 
In Hoofdstuk 3 werd de betrouwbaarheid, responsiviteit en gebruiksvriendelijkheid 
van een deel van de RESCUE-testbatterij onderzocht. Dit onderzoek vond plaats 
bij 26 Parkinsonpatiënten in de thuissituatie. De testbatterij bestond uit de Unified 
Parkinson’s Disease Rating Scale (UPDRS), een geklokte 6-meter looptest, de Timed 
Get Up and Go test (TGUG), de Berg Balance Scale en de Functional reach test. Om 
de interbeoordelaarbetrouwbaarheid te bepalen werden alle tests, in gerandomiseerde 
volgorde, afgenomen door drie onafhankelijke beoordelaars bij 26 Parkinsonpatiënten. 
Om de intrabeoordelaarbetrouwbaarheid vast te stellen nam één van de beoordelaars 
de testbatterij twee keer af, met een periode van 7 dagen tussen beide meetmomenten. 
Er werden matige tot uitstekende intraclass correlatiecoëfficiënten (ICC’s) gevonden. 
De responsiviteit werd bepaald door de 95% grenzen van de meetfout (Smallest 
Detectable Difference en Reliable Change Index; RCI) van ieder meetinstrument te 
berekenen. Alle meetinstrumenten hadden een RCI onder de 11%. Het is moeilijk 
om deze waarde met de literatuur te vergelijken omdat er geen consensus is over 
hoe responsiviteit gekwalificeerd zou moeten worden. Wel kunnen de resultaten van 
deze studie gebruikt worden als een richtlijn om vast te stellen hoe groot het effect 
minimaal moet zijn om voorbij de 95% betrouwbaarheidsgrenzen van de meetfout te 
kunnen komen. De gebruiksvriendelijkheid werd bepaald door het meten van de tijd 
die nodig was om de hele testbatterij af te nemen, inclusief de tijd die nodig was om 
de thuisomgeving van de patiënt aan te passen aan de tests, zoals het verschuiven van 
meubelstukken. De hele testbatterij kon worden afgenomen binnen 30 minuten, wat 
als voldoende beschouwd werd voor de praktijk. 
In Hoofdstuk 4 werd het effect van ritmische visuele cues op de staplengte en de 
schrede frequentie tijdens het lopen onderzocht. In dit pre-experiment werden aan 
patiënten en gezonde proefpersonen verschillende visuele condities aangeboden tijdens 
het lopen op een lopende band. Deze metingen werden gedaan bij Parkinsonpatiënten 
(n=21) en gezonde proefpersonen van dezelfde leeftijd (n=7). Alle proefpersonen 
voerden vijf condities uit op een lopende band: 
(1) Lopen zonder een visuele cue of optische flow, om de uitgangswaarde van 
de schredefrequentie te bepalen.
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(2) Lopen met een virtuele gang geprojecteerd op een scherm op 75 cm afstand 
voor de lopende band. Tijdens het lopen op de band had de virtuele gang dezelfde 
‘optische flow’ als de lopende band, waardoor de proefpersonen het idee hadden 
dat zij door een gang liepen. 
(3) Lopen op de band met visuele ritmische spatiële cues (VRS) met behulp van 
dwarse strepen op de vloer van de virtuele gang. 
(4) Lopen op de band met visuele ritmische temporele cues (VRT), met behulp 
van een ritmisch knipperend lampje dat aan een bril was vastgemaakt.
(5) Lopen op de band met de combinatie VRT en optische flow. 
Na de baselinemeting werden de condities 2 tot en met 5 in een gerandomiseerde volgorde 
aangeboden. De snelheid van de lopende band werd bij iedere conditie systematisch 
verhoogd. Na het behalen van de maximale loopsnelheid werd de band weer met 
dezelfde stappen verlaagd. Proefpersonen werden tijdens de vierde en vijfde conditie 
gevraagd om hun schrede af te stemmen op het ritme van de VRT, waarbij de frequentie 
10% onder de uitgangswaarde werd ingesteld. De schredefrequentie en staplengte 
werden gemeten met behulp van een activiteitenmonitor (AM). Parkinsonpatiënten 
liepen gemiddeld met een hogere schredefrequentie en een kortere staplengte dan de 
gezonde proefpersonen uit de controlegroep. Daarnaast bleek de schredefrequentie 
tijdens het opvoeren van de loopsnelheid op de lopende band systematisch hoger te 
zijn dan bij overeenkomstige snelheid tijdens het verlagen van de snelheid van de 
lopende band. Zowel VRS als VRT resulteerde in lagere schredefrequenties (en dus 
grotere schredelengtes) vergeleken met de condities zonder cues.
Dit onderzoek liet zien dat schredefrequentie en staplengte bij een gegeven loopsnelheid 
kunnen worden genormaliseerd door patiënten met de ziekte van Parkinson visuele 
ritmes aan te bieden tijdens het lopen op een lopende band. Dit laatste suggereert 
dat het gebruik van visuele cues therapeutisch kunnen worden aangewend om het 
gangbeeld bij Parkinsonpatiënten gunstig te beïnvloeden.
In Hoofdstuk 5 en 6 worden de resultaten van de Rescue-trial gepresenteerd. In 
de Rescue-trial werden de effecten van cueing training in de thuissituatie van 
Parkinsonpatiënten onderzocht tijdens lopen en aan lopen gerelateerde activiteiten. 
Dit onderzoek werd uitgevoerd in drie landen (Newcastle, Verenigd Koninkrijk, 
Leuven, België en Amsterdam, Nederland). Honderddrieënvijftig Parkinsonpatiënten 
met milde tot matige symptomen van de ziekte van Parkinson werden geïncludeerd 
in een enkelblind gerandomiseerd cross-over onderzoek. Proefpersonen die in de 
vroege interventiegroep ingeloot waren (n=76), kregen gedurende de eerste 3 weken 
een cueingprogramma van 9 behandelingen van 30 minuten aan huis aangeboden. 
Tijdens deze behandelingen werd cueing aangeboden met behulp van een prototype 
cueingapparaat. Vervolgens werden de patiënten in de vroege interventiegroep nog 
eens 3 weken zonder training vervolgd. Patiënten die in de late interventiegroep 
ingeloot waren (n=77) werden eerst 3 weken op de wachtlijst geplaatst en kregen pas 
na deze weken een cueingprogramma. Zes weken na de randomisatie werden beide 
groepen nog eens gedurende een follow-upperiode van 6 weken zonder training 
gevolgd om vast te stellen in hoeverre de behandeleffecten ook blijvend van aard 
waren. De primaire uitkomstmaat was de Posture and Gait score (PG score). Deze 
werd bepaald op de baseline, na 3, 6, en na 12 weken. Tot de secundaire uitkomstmaten 
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behoorden metingen die gericht waren op het lopen, freezing en balans, functionele 
activiteiten, kwaliteit van leven en de belasting van de partner, waarbij alle niveaus 
van de ‘International Classification of  Functioning, Disability and Health’ (ICF) aan 
bod kwamen. Aanvullend droegen alle proefpersonen een AM op de dagen dat ze 
getest werden om lichaamsbewegingen en houdingen te registreren. Binnen ieder land 
werden zowel alle klinische metingen, als de AM-metingen afgenomen door getrainde 
onderzoekers, die er niet van op de hoogte waren of de geïncludeerde patiënt in de 
vroege of de late interventiegroep was ingeloot.
In Hoofdstuk 5 werden de resultaten van de klinische metingen weergegeven. Deze 
lieten kleine, maar significante verbeteringen zien na interventie op de PG scores, mate 
van freezing, loopsnelheid, stapgrootte, geklokte balanstests en een groter vertrouwen 
bij het uitvoeren van functionele activiteiten (Falls Efficacy Scale). Er werden geen 
effecten gevonden in ADL’s en kwaliteit van leven, die het gevolg van de klinische 
verbeteringen hadden kunnen zijn. 
In Hoofdstuk 6 werden de resultaten van de AM weergegeven. Resultaten lieten 
conform de klinische metingen, een toename zien van zogenaamde dynamische 
activiteit. Lopen en loopperioden met een duur van meer dan 5 en 10 seconden bleken 
statistisch significant toe te nemen, terwijl een afname te zien was van alle statische 
activiteiten zoals zitten en liggen. De resultaten met AM bevestigen dat het geven van 
9 behandelingen cueingtherapie loopvaardigheid en aan lopen gerelateerde activiteiten 
in de thuissituatie een gunstige invloed heeft op patiënten met de ziekte van Parkinson. 
Echter, de RESCUE-trial laat ook zien dat de effecten over 6 weken weer verdwijnen na 
het stoppen van de cueingtherapie. De tijdelijke aard van het effect van cueingtherapie 
op het lopen benadrukt de noodzaak van permanent gebruik van cueingapparaten en 
het voortzetten van de behandelingen.
In Hoofdstuk 7 werd een predictiemodel voor het risico op vallen ontwikkeld. Data 
aangaande lopen, aan lopen gerelateerde activiteiten, balans en non-motor symptomen 
werden bij 153 Parkinsonpatiënten in hun eigen thuissituatie verkregen. Zesenzestig 
patiënten werden op basis van item 13 van de UPDRS  als ‘vallers’ geïdentificeerd. Met 
behulp van bestaande literatuur en meningen van experts werden 50 verschillende 
determinanten geselecteerd die een mogelijke voorspelling zouden kunnen geven 
voor de kans op vallen bij patiënten met de ziekte van Parkinson. Op basis van een 
bivariate regressieanalyse bleek dat achttien van deze 50 determinanten een significante 
associatie hadden met vallen. Modelleren met behulp van een multivariate logistische 
regressietechniek liet zien dat patiënten een significant hoger risico liepen om te 
vallen wanneer zij slecht scoorden op: (1) Freezing bij het lopen, (2) TGUG score, (3) 
ziekteduur en (4) problemen met lopen als gemeten met item 15 van de UPDRS. Op 
basis van deze vijf determinanten in het multivariate regressiemodel konden ‘vallers’ 
in 74% correct worden geïdentificeerd. Deze positief en negatief voorspelde waarde in 
het predictiemodel is vergelijkbaar met de bestaande literatuur. Het model kan gebruikt 
worden om patiënten die een verhoogd risico hebben op vallen te identificeren, vooral 
wanneer de valgeschiedenis van de patiënt nog onbekend is. Het klinische model zou 
ook richtinggevend kunnen zijn voor verder onderzoek naar de oorzaak van vallen, met 
als uiteindelijk doel nieuwe meetinstrumenten te ontwikkelen die de achterliggende 
mechanismen van vallen valide kunnen meten. 
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In Hoofdstuk 8 werd de impact van de specifieke en non-specifieke effecten van cueing 
bediscussieerd, gezien vanuit de doelen die gesteld werden in het Rescue-project. 
Methodologische vraagstukken, de inhoud van de cueingtraining en de internationale 
samenwerking in het Rescue-project werden in dit hoofdstuk kritisch beschouwd. 
Daarnaast werden er aanbevelingen voor toekomstig onderzoek gedaan. Op basis van 
deze thesis werd geconcludeerd dat cueingtraining een belangrijke ‘evidence based’ 
behandelmethode is, die deel uit moet maken van de multidisciplinaire behandeling 
van patiënten met milde tot matige symptomen van de ziekte van Parkinson. Bovendien 
laat de RESCUE-trial zien dat cueingtraining een veilige therapie is die het risico tot 
meer valincidenten niet onnodig vergroot. Tenslotte lijken de effecten onafhankelijk te 
zijn van het type cue dat aangeboden wordt, zoals visueel, auditief of somatosensorisch. 
Aanbevelingen voor toekomstig onderzoek richten zich voornamelijk op het 
ontwikkelen van meetinstrumenten die meer in lijn zijn met de doelen van therapie. 
Huidige meetinstrumenten zijn veelal multicomponentindexen die niet specifiek een 
vaardigheid, zoals lopen, meten. Toekomstige meetinstrumenten zouden dan ook bij 
voorkeur unidimensioneel geconstrueerd moeten zijn en specifiek een vaardigheid 
binnen het domein ‘activiteiten’ van het ICF in kaart moeten kunnen brengen. 
Naast een testbatterij, bestaand uit een alomvattende basisset van meetinstrumenten, 
zou er ook aandacht moeten zijn voor het ontwikkelen van een kleine, draadloze 
AM. Deze AM moet voldoende opslagcapaciteit hebben en genoeg accucapaciteit om 
bewegingen op een aantal opeenvolgende dagen te registreren. Met een dergelijke AM 
zou het ook mogelijk moeten zijn om een manier te ontwikkelen waarmee freezing 
en vallen op een valide wijze gemeten kunnen worden. Op basis van identificatie 
van nieuwe algoritmes voor freezingverschijnselen tijdens het lopen kunnen betere 
interventietechnieken ontwikkeld worden.
Qua onderzoeksdesign zou voor toekomstig revalidatieonderzoek bij patiënten met 
de ziekte van Parkinson meer gebruik moeten worden gemaakt van gecontroleerde 
effectonderzoeken met herhaalde metingen in de tijd, om effecten van fluctuaties in 
medicatiegebruik beter te kunnen controleren. 
Verder werd in dit hoofdstuk aanbevolen om het achterliggende neurofysiologische 
werkings mechanisme van cueing te onderzoeken. Kennis over het werkingsmechanisme 
geeft nieuw inzicht in de mogelijke neuroprotectieve rol van ritmische cueing en geeft 
inzicht in de optimale dosis-respons-relatie van cueing bij de ziekte van Parkinson. 
In toekomstig onderzoek zullen ook patiënten uit vroege en late stadia van 
idiopathische Parkinson moeten worden geïncludeerd, evenals patiënten met 
cognitieve functiestoornissen. Daarnaast zouden effecten van cueing ook onderzocht 
moeten worden bij patiënten met parkinsonisme, zoals multiple systeem atrofie of 
progressieve supranucleaire paralyse. Tot besluit zou er in de toekomst een goedkoop 
cueingapparaat ontwikkeld moeten worden, dat zowel auditieve als tactiele ritmes 
kan genereren, om op deze manier patiënten de mogelijkheid te geven om cues te 
gebruiken tijdens ADL’s. Daarnaast zou er dan ook aandacht gegeven moeten worden 
aan de implementatie van richtlijnen voor professionals, om hun patiënten op een 
veilige wijze in hun eigen thuisomgeving met cues te trainen. 
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Ik houd niet zo van die uitgebreide, overenthousiaste dankwoorden. Maar een kort, 
zakelijk en nuchter dankwoord dat hebben jullie niet verdiend, ook jij, die ik ongetwijfeld 
ga vergeten, niet. Een middenweg proberen dan maar.
Ik ben nooit aan dit proefschrift begonnen, ik schreef een stukje. Dat stukje was na 21 
keer bijvijlen publicabel en dat herhaalde zich met een ander stukje. ‘Je bent halverwege’, 
werd mij aanmoedigend van de zijlijn toegeschreeuwd, dus door… Maar terugblikkend 
lijkt altijd alles gemakkelijker dan wanneer je er midden in zit. Die eerste helft leek 
achteraf dus een makkie, het aantal versies van beide artikelen was ik voor het gemak 
vergeten. Gedurende de tweede helft heb ik me vaak afgevraagd waar ik aan begonnen 
was. Maar met jullie hulp, ook die van jou, is het allemaal gelukt!
Allereerst bedank ik de deelnemers van het Rescue-project. Wat een ervaring om bij 54 
Noord-Hollanders drie keer per week, drie weken lang, welkom te zijn. Het ‘Man-Bijt-
Hond-Gevoel’ bekroop me wel eens, in al die verschillende levens, met verschillende 
interieurs en verschillende achtergronden. Velen bedankten me na afloop met de 
woorden: ‘dank je voor alle behandelingen, ik deed eigenlijk mee voor de wetenschap, 
maar ik heb er zelf ook nog wat aan gehad, ik loop écht beter’. Dankzij jullie en de 
deelnemers in België en Engeland konden we ook bewijzen dat de behandelingen 
‘beter lopen’ tot gevolg hebben! In het bijzonder bedank ik de deelnemer die ik filmde 
in een dik pak sneeuw rondom haar huis. Beelden van deze opname mocht ik van haar 
gebruiken voor de omslag van dit proefschrift.
Dan mijn promotor en co-promotor. Gert, schreeuwen aan de zijlijn, maar ook rustig 
alle methodologie nog eens uitleggen op het white board in zijn kamer en eindeloos 
mijn stukken lezen en suggesties aandragen voor verbeteringen. Gert, je hebt me tot dit 
project aangezet, me er doorheen geloodst (soms gesleurd) en bent tot het einde blijven 
aanmoedigen: het moest af. Dat is gelukt! Dank! Erwin, co-promotor en voorbeeld. Rust 
en relativeringsvermogen, dat kon ik wel gebruiken in dit traject. Als het allemaal ‘heel 
erg’ leek wat ik opgeschreven had, liet jij me zien wat er al ‘heel erg goed’ was en hielp 
me de rest van afstand nog eens goed te bekijken en aan te passen. Dank!
Dank ook aan de leden van de leescommissie, prof. dr. E.Ch. Wolters, prof. dr. G.J. 
Lankhorst, prof. dr. B.R. Bloem en prof. dr. H.J. Stam, voor het lezen en beoordelen 
van mijn proefschrift.
Ook dank aan mijn collega’s: de fysio’s van het VUMC, die de omstandigheden creëerden 
waarin het Rescue-onderzoek uitgevoerd kon worden en altijd belangstellend vroegen 
hoe het ging met het project, maar ook met mij persoonlijk los van het project. Dank 
voor jullie warmte en steun. My colleagues from the Rescue project in Belgium and the 
UK, I have learned a lot from this international adventure, thank you for everything. 
De fysiotherapeuten die mij vervingen bij ziekte en vakantie, Cees en Ingrid, die mij 
ook zo veel hebben geleerd over de ziekte van Parkinson. En natuurlijk ook dank aan 
mijn kamergenoten, de eerste jaren Cees, Erwin (ik noem jullie gewoon twee keer!) 
en Alex, de laatste jaren, Marc, Cees (vooruit, drie keer) en Benno. Het was fijn tussen 
deze mannen, naast stoere praat, gezellige klets en emotionele steun, vooral discussie en 
hulp over en weer in de wetenschappelijke taken: samen literatuur zoeken, met elkaar 
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puzzelen op lastige statistiek, presentaties van elkaar bekijken en nog veel meer. 
Beste Renate, fijn dat je jouw scherpe blik over dit boekje liet gaan, wat zaten er nog 
veel foutjes in… Je hebt het boekje prachtig vorm gegeven. Lieve Ivar, wat een mooi 
idee had jij voor de omslag, prachtig uitgewerkt ook. Renate en Ivar, zonder jullie was 
dit boekje nooit zo mooi geworden! Dank!
Lieve vrienden, lieve familie, dank voor jullie support. Marieke en Marije, fijn dat jullie 
mijn paranimfen zijn, jullie hebben me echt geholpen. Op me in gepraat als ik het niet 
meer zo zag zitten, maar ook flessen open getrokken als er iets te vieren was. Verder 
iedereen die op Maarten paste als ik echt even een stuk wilde opschieten. Vooral Mama 
en Hans, dank voor de weekenden waarin ik Maarten écht heel graag kwijt wilde (en 
daarna weer heel graag terug). 
Mensen die overleden zijn kun je niet bedanken, wel kun je ze noemen, dat doe ik dan 
ook. Allereerst mijn vader die ik nooit gekend heb, 3 was ik toen hij stierf. Zenuwarts 
was hij, ik vind het een bijzonder gevoel dat ik de fascinatie voor het brein deel met 
hem. Ik vond nog een studieboek van hem, uit de jaren ’50. De behandelwijzen zijn 
sindsdien gelukkig erg veranderd, ook voor wat betreft ‘paralysis agitans’, maar even 
voelde ik me erg verbonden met mijn vader, bij het lezen en begrijpen van de teksten 
in dat boek. 
Dan natuurlijk mijn lieve Ditmer. ‘Ik moest maar niet promoveren’, hadden zijn collega’s 
gezegd, ‘dat kost je je huwelijk: zij alleen maar stress en achter de computer, dat wordt 
niets’. In het nieuwe huis richtte hij wél een werkkamer voor me in, met groot bureau. 
Aan iedereen die een rondleiding kreeg in ons nieuwe huis zei hij trots: ‘en hier gaat 
Inge haar proefschrift afschrijven’. Ik heb het gedaan, maar hij was er niet meer bij. 
Wel in mijn gedachten, iedere dag. Ik heb de flessen champagne gemist, de etentjes 
bij sjieke tenten, waar we ongetwijfeld alle kleine succesjes van de afronding hadden 
gevierd, de geaccepteerde artikelen, het inleveren van het boekje, de goedkeuring van 
de leescommissie en straks de grande finale: Het is stil zonder jou…
Als laatste bedank ik mijn zonnestraaltje. Lieve kleine Maarten, je hebt geen idee wat ik 
aan het doen ben, maar je hield me op de grond. Voordat jij er was werkte ik regelmatig 
tot laat op de VU door, thuis vervolgens tot diep in de nacht en vond ik het heel belangrijk 
om alles zo goed en snel mogelijk te doen. Toen jij kwam, kwam je op de allereerste 
plaats: ik moest voor jou een goede moeder zijn, dus fit blijven, regelmatig leven en 
goed eten. Eén keer floot je me terug, ik zat te werken tot diep in de nacht en was de 
tijd vergeten. Toen stond jij ineens in je pyjamaatje naast me of je bij mij in bed mocht. 
Ik schrok, was helemaal de tijd vergeten. De computer ging onmiddellijk uit. Ik weet 
zeker dat ik tegen je vader had gezegd dat ik nog ‘heel even’ iets moest afmaken. 
Allen dank, ja, ook jij.
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Inge Lim werd geboren op 13 oktober 1974 in Leiden. Na het behalen van het 
gymnasiumdiploma aan het Stedelijk Gymnasium te Haarlem studeerde zij een 
jaar Pedagogische en Onderwijskundige Wetenschappen aan de Universiteit van 
Amsterdam. Na het behalen van de propedeuse in 1995 begon zij aan de studie 
Bewegingswetenschappen aan de Vrije Universiteit te Amsterdam. In 1999 deed zij 
een deel van haar studie in Boston (VS), waar ze stage liep aan Sargent College, Boston 
University. In 1999 behaalde zij haar doctoraal examen. In datzelfde jaar begon zij aan 
de verkorte opleiding tot fysiotherapeut aan de Hogeschool van Utrecht en in 2002 
haalde zij haar diploma.
In 2002 werd Inge aangesteld als fysiotherapeut en onderzoeker door (inmiddels 
professor) dr. Gert Kwakkel aan het VU Medisch Centrum, voor het Rescue-project. In dit 
door de Europese Commissie gefinancierde project gaf zij aan alle Parkinsonpatiënten, 
die in het kader van de studie in Nederland waren geïncludeerd, in de thuissituatie 
training met behulp van ritmen. Het Rescue-project heeft geleid tot dit proefschrift. 
Hoewel het project in 2005 eindigde, is Inge doorgegaan met het schrijven van 
artikelen. 
Tijdens het zeventiende wereldcongres voor ‘Parkinson’s Disease and Related Disorders’ 
in december 2007 won zij de eerste prijs voor ‘young scientists’ door een deel van het 
Rescue-project, over de relatie tussen de inhoud van het trainingsprogramma en de 
resultaten van de hoofdstudie, te presenteren.
Van 2005 tot 2008 was Inge regiocoördinator voor Noord-Holland binnen een door 
ZonMw gesubsidieerd doelmatigheidsonderzoek (ParkNet-onderzoek) naar de 
kosteneffectiviteit van het implementeren van evidence based behandelrichtlijnen voor 
fysiotherapie bij patiënten met de ziekte van Parkinson. Inge is nauw betrokken geweest 
bij de scholing van fysiotherapeuten in het ParkNet-onderzoek
Inge is gastdocent bij de Vrije Universiteit, het Nederlands Paramedisch Instituut en 
het ParkinsonNet. Momenteel werkt zij als fysiotherapeut op de afdeling neurologie 
van het VU Medisch Centrum.
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